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Abstract 
La presente tesi di Dottorato riporta i risultati di ricerche svolte nell’ambito di alcune 
collaborazioni tra Università ed industria nel campo della progettazione e sviluppo di librerie di 
trasduttori primari per biosensori. In particolare l’attenzione si è rivolta da un lato a piccoli 
peptidi come recettori di xanthine (caffeina e teofillina), dall’altro ad una molecola di grandi 
dimensioni, la palitossina, verso la quale al momento sono stati preparati anticorpi con tecniche 
più convenzionali. Il contributo di un chimico in questo tipo di progetti è analogo, e consiste in 
un’attività di sintesi di derivati modificati delle molecole di interesse, nella loro bioconiugazione a 
proteine ed enzimi, nella sintesi di peptidi, nello studio dell’interazione ligando-recettore 
attraverso misure di attività, analisi conformazionale e strutturale, modellizzazione. L’attività 
svolta è brevemente descritta nei punti seguenti. 
1) I coiled-coil sono motivi strutturali presenti in natura dati dall’unione di due o più α-eliche 
avvolte su loro stesse al fine di generare un’unica super-elica. L’analisi di tali strutture rivela 
spesso la presenza di sequenze ripetute di 7 amminoacidi ripetuti (g-a-b-c-d-e-f) con precise 
caratteristiche: la posizioni a e d per esempio sono occupate sempre da amminoacidi con 
caratteristiche idrofobiche, atti a generare una interfaccia idrofobica interna alla super-elica molto 
stabile e non esposta al solvente esterno. Parallelamente, le posizioni e e g sono invece occupate 
da amminoacidi polari carichi che si trovano sulla superficie esterna della super-elica e possono 
iteragire tra di loro rinforzando l’interazione e provocando effetti di orientamento. 
La nostra attenzione si è focalizzata sul coiled-coil denominato EK, sviluppato agli inizi degli anni 
’90 da Hodges e colleghi. In questa struttura due catene peptidiche denominate appunto E e K si 
avvolgono su loro stesse al fine di generare una super-elica anfipatica di notevole 
stabilità.Partendo da tale struttura e sfruttando la tecnica biomolecolare del phage display che 
permette l’esposizione di strutture a carattere proteico sulla superficie di un batteriofago, sono 
state create librerie di EK mutati con l’obiettivo di generare all’interno della super-elica siti 
recettoriali eventualmente utilizzabili all’interno di biosensori come trasduttori primari per 
caffeina e teofillina, due piccole molecole organiche altamente correlate e ampiamente presenti 
nella vita quotidiana. E’ stata prodotta una prima libreria fagica di dimensioni notevoli (108 
elementi), all’interno della quale sono stai isolati due cloni specifici per le xanthine; i due cloni 
sono stati denominati E1 ed E8. La caratterizzazione del binding è avvenuta sia con tecniche 
biomolecolari che prevedono l’immobilizzazione dell’analita su superficie solida (test ELISA e 
dot-blot), sia con teniche chimiche con analiti liberi e privi di modificazioni strutturali. 
Al fine di ridurre il più possibile le dimensioni dello scaffold di partenza è stata sviluppata una 
seconda libreria fagica in cui è stata randomizzata soltanto la catena K dell’originario EK 
proposto da Hodges. La libreria finale presenta una dimensione di 108 elementi, tra i quali è stato 
isolato e caratterizzato attraverso test ELISA il clone denominato KE1. Le ridotte dimensioni di 
tale peptide (35 amminoacidi) hanno permesso la sua sintesi chimica su una buona scala (40 mg), 
una cartterizzazione strutturale attraverso spettroscopia di dicroismo circolare, un’analisi 
dell’interazione in soluzione con la teofillina sfruttando sempre la tecnica CD e quella 
calorimetrica ed infine un’analisi cristallografica attraverso luce di sincrotrone. 
2) Una seconda parte del lavoro è stata finalizzata, invece, allo sviluppo di pool anticorpali mono- 
e policlonali quali trasduttori primari in biosensori per l’individuazione della palitossina. 
Tale tossina algale con elevato indice di pericolosità (LD50=0.45 μg/kg) negli ultimi anni ha 
causato notevoli disagi in campo ambientale, inquinando flora e fauna acquatica di diverse zone 
marittime, compreso il Mediterraneo e l’alto Adriatico. 
Per lo sviluppo di anticorpi specifici contro tale tossina, sono state condotte immunizzazioni su 
coniglio e su topo con palitossina coniugata a due tipi di proteine carrier (BSA e KLH) al fine di 
ridurre la sua tossicità e indurre una risposta immunitaria nell’animale. Il pool anticorpi policolnali 
di siero di coniglio è stato isolato e caratterizzato attraverso sandwich ELISA contro palitossina 
libera e palitossina chimicamente modificata allo scopo di ottimizzare tale tipo di test e utilizzarlo 
come possibile dosatore nei confronti dell’analita presente in campioni di acqua oppure in sistemi 
più complessi quali mitili o ulteriore fauna marina. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
This PhD thesis reports the results of research activities carried out at the Dept. of Chemistry of 
the University of Trieste, in collaboration with several industries, in the field of design and 
development of libraries of primary transducers for biosensors. We have focused our attention 
on one side on short peptides as xanthine (caffeine and theophylline) receptors, and on the other 
side on a very large molecule, palytoxin, which has been considered to raise antibodies by more 
conventionals techniques. The chemist’s contribution to such projects is similar, consisting in the 
synthesis of modified target molecules, in their bioconjugation to protein and enzymes, in peptide 
synthesis, in studying the receptors-ligand interactions by affinity measurements, conformational 
and structural analysis, modelling. The activity is briefly described in the following points. 
1) Coiled-coil are natural motifs made by bundles of two or more α-helix that generate a super-
helix. Structural analysis of these motifs reveals often the presence of a repeated sequence 7 
aminoacids along the helix (g-a-b-c-d-e-f). a and d are hydrophobic aminoacids able to generate an 
internal hydrophobic core most important for the overall stabilization of the bundle, e and g are 
polar or charged aminoacids that can contribute to the final stability of the coil via electrostatic 
interchains interactions. 
Starting from the EK coiled-coil developed by Hodges et al., made by two different peptide 
chains (E:EVSALEK; K:KVSALKE) and exploiting phage display techniques, two different 
phage libraries of E and K mutants were generated, in order to obtain receptors molecules 
suitable as primary transducer in biosensors for caffeine and theophylline. 
In the first library, both E and K were randomized, obtaining 108 differents peptide clones; two 
specific clones was isolated against immobilized caffeine and theophylline, their characterization 
was carried out both by biomolecular experiments (ELISA test; dot-blot) and by chemical 
techniques. 
In a second library, we have further reduced the scaffold size, using only a single K chain. A new 
library of 108 elements was obtained and characterized. The isolation of KE1 clone as the best 
xanthine binder, allowed chemical synthesis on a good scale (40 mg); structural characterization 
and binding analysis of its interaction with theophylline in water was performed by circular 
dichroism and calorimetry; the X-ray structure of the peptide was obtained exploiting 
sincrothrone light. 
2) In a second part of this work, the development of mono- and polyclonal antibodies towards 
palytoxin was stated. Palytoxin is one of the most dangerous algal toxin in nature (LD50=0.4 
μg/kg in mice) and its presence in the last years in Mediterranean sea, both in the water sea and 
in fish or mussels, constitues a real problem for tourism economy and for the fish market. 
In order to obtain specific antibodies as bioreceptors towards palytoxin, a series of 
immunizations on rabbits were carried out with palytoxin-BSA and palytoxin.KLH conjuagtes in 
order to generate immune response in the animals; the pool of high reactivity bleeds of rabbits, 
were isolated and usedto set up ELISA sandwich system towards palytoxin. 
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Chapter 1: Peptide scaffolds and libraries 
 
1.1 The interactions between biomolecules and small molecules  
The regulation of numerous processes in living systems is often based on the interaction between 
a large macromolecule as a protein, enzyme or antibody, and a small organic molecule that can 
interact with the host at a binding site. Inside the binding site, amino acids with hydrophobic or 
hydrophilic character are able to generate different structural motives in which small organic 
molecule are complexed by covalent or non-covalent binding.  
During the recent years several proteins have been studied with the aim of identifing peculiar 
peptides sequences that could be able to bind small molecules; the idea was to use such peptides 
as bioreceptors in a biosensor or sensors array.  
A first example was given by olfactory receptors.1 The mammalian olfactory system has 
been recognized as one of the most effective sensing system with extraordinary capability. 
Humans and other mammalians can detect some odourants at low ppb levels and discriminate 
10000 distinct odours.2 The initial event in odour discrimination is represented by the odourant 
over binding inside the receptor molecules, which reside on the cilia of sensory neurons in the 
olfactory epithelium.3 Is would be desireable to use directly these biomolecules as a bioelement in 
a sensor with a suitable physical transducer, for the detection of organic molecules present in 
different samples; several attempts have indicated that such a sensor could effectively 
discriminate between different odourants molecule; however, the system suffers from many 
limitations, due to scarce reproducibility and standardization in probe preparation because of the 
variation in animal species, bacteria degradation and orientation problems in protein 
immobilization. In order to avoid these problems a series of oligopeptides have been synthesized 
having theirs sequences corresponding to a selective portion of a putative binding site between 
olfactory receptors and small target molecules;4 these peptides were designed, synthesized and 
coated onto the electrode surface for target odourant binding assays.5By this way a proof of 
concept was given by Wu, with a sensor that was able to identify trimethylamine with a certain 
selectivity.6 
 Proteome offers many small-protein motifs organized in a stable conformation: one 
example is represented by conotoxins, 15-20 aminoacid peptides organized in a small α-domain 
                                                 
1 Hines E.L., Gardner J.W., Potter C.E.R. Measure Cont., 1997, 262-268. 
2 Persaud K.C., Khaffad S.M., Payne J.S., Pisaneeli A.M., Lee D.H., Byun H.G. Sensor Actuatators B, 1996, 36, 267-273.   
3 a) Sheperd G.M. Neurobiology, 1988, Oxford University Press Inc., 205-221. b) Raming K., Krieger L., Strotmann J., Bockhoff L., 
Kubick S., Brcer H. Nature, 1993, 361, 353. c) Chen Z., Lancet D. Proc. Natl. Acad. Sci. USA, 1984, 81, 1859-1863. d) Chen Z., 
Ophir D., Lancet D. Brain Research, 1986, 368, 328-338. Linda B., Axel R. Cell., 1991, 65, 345-367. 
4 Ephraim K.K., Shariv I., Eisenstein M., Friesen A.A., Vakser I.A. Proc. Acad. Natl. Sci. USA, 1992, 89, 2195-2199. 
5 Wu T.Z., Lo R.Y., Chan E.C. Biosensor Bioelectron., 2001, 16, 945-953. 
6 Wu T.Z. Biosensor Bioelectron., 2001, 16, 945-953. 
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and joined together by one or two disulfide bonds; this constitute the bottom of a small 
interacting site which involves also a loop; more than 50000 different types of conotoxins are 
known and they could be considered as candidates for the development of large libraries of small 
receptors by molecular biology techniques (Figure 1.1).7 
 
 
Figure 1.1 
 
Cyclic peptides are another example of potential small receptors. To develop a library of cyclic 
peptides is very difficult due to the cyclization step. However, E. Coli produces a cyclotide, the 
microcine J25 (MccJ25), with an extraordinary lassoed tail structure (Figure 1.2). 
 
 
Figure 1.2 
 
These two examples introduce us to a more general insight on the structural features that are 
required in order to identify and design a small peptide receptor. A conformationally stable 
peptide is required (scaffold), in order to allow the insertion of a new flexible and randomizable 
binding sequence. 
                                                 
7 Terlau H., Olivera B.M. Physiol. Rev., 2004, 84, 41-68. 
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 As to the scaffold, the following definition has been recently given: “a protein framework that 
can carry altered  amino acids or sequence insertion, that confer on protein variants different functions, usually for 
binding specific targets”.8   
Peptide scaffold can be derived from structural proteins, sub-unit peptides from a multimeric 
structure and also enzymes,9 but it is possible to design de novo structures.10 They can be selected 
by in vivo and in vitro techniques, isolating new molecules with better affinity against specific 
ligand.11  
As to the binding area, loops are the most accessible regions for the recognition of the small 
target molecules, they can link together structural elements like α-helices and β-sheets of the 
scaffold. Also α-helices12 and internal cavities of protein13 can be involved in target recognition. 
However loops are the most accessible region for modification of the sequence, thus integrating 
an affinity function onto or into the structural framework without changing the overall structure 
and generating a stable folded peptide. It is important to choose carefully the residues to be 
randomized because some modifications may cause misfolding or instability of the scaffold itself.  
Several different type of scaffolds, and their possible modifications, are shown in Figure 1.3:     
 
 
Figure 1.3 
 
Based on the architecture of their scaffold peptide receptors can be classified as 
1. based on α-helices structures 
2. based on β-sheets structures 
3. small scaffolds with an irregular architecture of α-helices or β-sheets. 
 
                                                 
8 Biniz H.K., Berell G., Hytuani G.F., Santos J.A. Nat. Biotechnol., 2005, 23(10), 1257-1268. 
9 Vita C. Curr. Opin. Biotechnol., 1997, 8(4), 429-434. 
10 a) Custon A.S., Sherman J.C. Bioorg. Med. Chem., 1999, 7(1), 23-27. b) O’Shea E.K. Curr. Biol., 1993, 3(10), 658-667. 
11 Biniz H.K., Pluckthun A. Curr. Opin. Biotechnol., 2005, 16(4), 459-469. 
12 Enander K., Sullivan D., Kiyonari N.H. J. Am. Chem. Soc., 2004, 126(14), 4464-4465. 
13 Lee M. J. Org. Chem., 2006, 71(14), 5082-5092. 
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1.1.1 Scaffolds with α-helices domains 
Although α-helix is the most important motif present in nature protein, the number of scaffolds 
based on this backbone is limited respect to the scaffolds based on β-sheet motif.  
 
1. Affibodies are small proteins derived from an engineered version (Z domain)14 of the five 
stable three α-helices bundle domains of the immunoglobulin Fc-binding region of 
staphylococcal protein A (Figure 1.4).15  
 
 
Figure 1.4 
 
These scaffolds are soluble, proteolytically and thermally stable and they don’t contain disulfide 
bonds. They have been used for construction of phage libraries and selection against several 
proteins and enzymes, like Tag DNA polymerase, human insulin and human apolipoprotein, 
while there are not reputed examples of an affibodie directed towards small molecules 
The small dimension and the strong protein structure are fundamental properties of these 
molecules for a brod range of biotechnology applications: affibodies have been described for 
purification, detection and targeting, also suggesting the therapeutic diagnostic potential of this 
protein scaffold.16 
2. α2p8 peptide is a polypeptide of 38 amino acids; it is assembled in two α-helices structure 
bound together with a disulfide bond in order to obtain a final hairpin structure (Figura 1.5). 
 
                                                 
14 Nord K. Protein Eng., 1995, 8(6), 601-608. 
15 Nilsson B., Moks T., Jansson B., Abrahmsen L., Elmblad A., Uhlen M. Protein Eng., 1987, 1(2), 107-113. 
16 Renberg B., Shiroyama I., Engfeldt T., Nygren P., Karlstrom A.E. Anal. Biochem., 2005, 341(2), 334-343. 
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Figure 1.5: NMR structure of α2p8 peptide (red) overlying at the p8MTCP1 structure (green). 
 
α2p8 peptide is present in the N-terminal region of human protein p8MTCP1 that also present a 
hairpin motif in its tridimensional structure. The α2p8 peptide has not been currently used for 
the development of combinatorial libraries or for a phage-display selection against any targets 
molecules. 
3. Repeat proteins or proteins with ankyrin repeat domains. The ankyrin repeat is a 33-residue 
motif in proteins, consisting of two α-helices separated by loops; they are present in bacterial, 
archaeal, and eukaryotic proteins (Figure 1.6).17 Designed ankyrin repeat proteins (DARPins) are 
versatile binding proteins which display great advantages over other binding protein. These 
repeat-motifs protein offer an advantage for libraries construction because the surface of binding 
interface depends on the number of randomized repeats. In a recent example, libraries of ankyrin 
repeat proteins have been used to select high affinity inhibitors of aminoglycoside 
phosphotransferase (3’)-IIIa (APH).18 The selected proteins showed the great DARPins ability 
for modulation of intracellular enzyme activity, with implication for therapeutic applications. 
However also this example refers to the recognition of a large protein domain rather to the 
recognition of a small molecule.  
 
 
Figure 1.6: a) Molecular model of DARPins with red randomized residues. b) Molecular model of a single domain. 
 
4. TASPs (Template-Assembled Synthetic Proteins) are very small structures stable to high 
temperature, strong acidic conditions and at denaturating agents (Figure 1.7) 
Three 12-15 aminoacids α-helices, are bound on a support molecule (ciclotribenzylene) in order 
to obtain a particular cylinder scaffold.  
                                                 
17 Binz H.K., Stumpp M.T., Forrer P., Amstutz P., Pluckthun A. J. Mol. Biol., 2003, 332(2), 489-503.   
18 Kohl A., Amstutz P., Parizek P., Binz H.K., Briand C., Capitani G., Forrer P., Grutter M.G. Structure, 2005, 13(8), 1131-1141. 
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Figure 1.7: schematic representation of TASPs in which three α-helix peptides are bound at the beneath on a support molecule. 
 
 
1.1.2 Scaffolds with β domains 
1. Antibodies and related fragments represent the most important natural binding protein 
formed by β-sheet motifs.  
Antibodies, also known as immunoglobulins (Ig), are globular proteins that are found in blood or 
other bodily fluids of vertebrates and are used by the immune system to identify and neutralize 
foreign objects such as bacteria and viruses. They are typically made of basic structural units each 
with two long heavy chains and two shorter light chains assembled to form different structures as 
monomers with one unit, dimers with two units or pentamers with five units.  
Though the general structure of all antibodies is very similar, a small region at the top of the 
protein is extremely variable, allowing millions of antibodies with slightly different top structures, 
or antigen binding sites, to exist. This region is known as the hypervariable region. Each of these 
variants can bind to a different target, known as antigen. The huge diversity of antibodies allows 
the immune system to recognize an equally wide diversity of antigens; the unique part of the 
antigen recognized by an antibody is called epitope. Epitopes bind to their antibody in a highly 
specific interaction, that allows antibodies to identify and bind only their unique antigen in the 
midst of the millions different molecules in the organism, with affinities in the sub picoM range. 
The antibody dimer is a “Y”-shaped molecule that consists of four polypeptide chains; two 
identical heavy chain and two identical light chains connected by disulfide bonds. Each chain is 
composed of structural domains called Ig domains. These domains contain about 70-110 amino 
acids and are classified into different categories, according to their size and function. They have a 
characteristic immunoglobulin fold in which two β-sheets create a “sandwich” shape, held 
together by interactions between conserved cysteines and other charged amino acids (Figure 1.8). 
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Figure 1.8 
 
The specificity is mediated by the complementary determining regions (CDR), hypervariable loop 
regions that mediate binding to the antigen. Immunoglobulins can bind proteins, sugars and 
diverse small proteins, but there are some limitations for biotechnology applications, for example 
due to the dimensions of antibodies. These are motivations, in some cases, to find alternative 
binding molecule.  
2. Knottins: knottins are small disulfide-rich proteins characterized by a special “disulfide through 
disulfide knot”. The knottin motif is found in some plant-protease inhibitors, toxines and 
antimicrobial peptides. 
 
Figure 1.8: NMR structure of a typical knottin motif with particular disulfide bridges. 
 
A typical “knotted topology” unit consist in a small triple-stranded β-sheet with at least 3 
disulfide bridges and interspersed variable peptide loops. 
Residue in the loops can be mutated and with affinity selection methods a better binding activity 
can be obtained.19 The knot proteins are an attractive scaffold for drug design and they have been 
considered a good starting point for grafting recognition sites onto it for the production of new 
bioactive molecules.20 
                                                 
19 Kolmar H. Curr. Opin. Pharm., 2009, 9(5), 608-614. 
20 Souriau C. Biochemistry, 2005, 44(19), 7143-7155. 
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3. Statine is a protein made by seven β-sheets strands in order to form a β-sheet sandwich, in a 
structure similar to that of immunoglobulins. Generally in a statin protein two loops make a deep 
pocket where is possible to obtain binding towards organic molecules as anticancer drugs.  
 
Figure 1.9: neocarzinostatin binds small organic molecule. 
 
Heyd et al. have shown that the binding region of the neocarzinostatin can be engineered in 
order to obtain a strong birdin bind with organic molecules (Figure 1.9).21 In another example, by 
randomizing thirteen amino acids in the pocket of statin, Heyd et al. have obtained three 
different peptide libraries with one component able to bind testosteron.  
4. Lipocalins are a family of proteins that are able to transport small hydrophobic molecules such 
as steroids, lipids and retinoids in the human organism. They are 160 to 180-residues 
polypeptides that share a common tertiary architecture, consisting in a β-barrel of six or eight 
anti-parallel β-strands, connected by four hypervariable loops (Figure 1.10).  
 
Figure 1.10 
 
The conical structure encloses an internal ligand binding site which is ideal to randomized 
residues, allowing generation of protein binders with high affinity and specificity. Some new 
                                                 
21 Heyd B., Castel G., Tordo N. Virologye, 2009, 13(8), 93-102. 
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binders have been isolated from a bilin-binding protein library and selected against fluorescein 
and digoxygenin with nanomolar Kd.22 
 
1.1.3 Scaffolds with irregular domains 
1. Defensins are small cysteine-rich cationic protein made by 15-20 amino acids residues. They 
are present in both vertebrates and invertebrates; they play very important roles against invading 
bacteria, fungi and viruses. The group comprises peptides with an irregular architecture of α-
helices and β-sheets, or less structured sequences. Insect defensin A has been proposed as a new 
scaffold for the construction of a mutant library: seven residues were randomized within the two 
loops of the peptide.23 The library was screened against tumor necrosis factor A, TNF receptor 1 
and TNF receptor 2 (Figure 1.11). 
 
 
Figure 1.11 
 
2. Kunitz domain inhibitors are a group of short and irregular peptides of about 60 amino acids, 
stabilized by three disulfide bonds. They act as reversible inhibitors of serine proteases. They 
possess high stability and, most important for library generation, a loop that can be mutated 
without destabilizing the structural folding. Therefore, they have been used for modelling 
specificity to novel protease targets and entered clinical trials.24 
 
1.2 Coiled-coil domains 
The α-helix is involved in the folding of another important protein domain: the coiled-coil.25 The 
coiled-coil motif is found in approximately 10% of all protein sequences and is responsible for 
                                                 
22 Schlehuber S, Skerra A. Expert Opin. Biol. Ther., 2005, 5(11), 1453-1462. 
23 Zhao W.-M., Chen Y., Thian Y.-C. Peptides, 2004, 25(4), 629-635.  
24 Williams A., Baird L.G. Transfus. Apher. Sci., 2003, 29(3), 255-258. 
25 Lupas A.N., Gruber M. Adv. Proteins Chem., 2005, 70, 37-78. 
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the oligomerization of proteins in a highly specific manner. Coiled-coil proteins exhibit a large 
diversity of function (gene regulation, cell division, membrane fusion, drug extrusion) thus 
demostrating the significance of oligomerization in biological systems.26 
 It existence was first predicted in a series of seminal papers by Crick27 and supported by an 
observation by Perutz and others that the long fibrous protein tropomyosin and other members 
of the k-m-e-f proteins exhibited diffraction peaks with a repeated spacing of 5.15 Å. Crick 
proposed that this could be explained by an arrangement in which two α-helices wrapped around 
each other at an angle of approximately 20° such that their side chains were interlocked together 
in a motif that repeated itself every 7 residues, or 2 turns of the helix. 
Crick referred to this packing as a “knobs into holes” arrangement in which one residue (knob) 
fits into a space generated by four resdiues of the opposing helix (hole). The simplest coiled-coil 
structure is the dimer, but trimers, tetramers, pentamers28 and heptamers29 have been reported. In 
addition, if the helices come from the same protein chain, the resultant coiled-coil is described as 
a homooligomer. Conversely, if the helices originate from different protein chains, the coiled coil 
is referred to as a hetero-oligomer. 
 
1.2.1 Structure of coiled-coils 
The primary sequence of a coiled-coil embodies a combination of semplicity and  repetitiveness. 
A typical coiled-coil sequence is made of seven-residue repeats called heptads. The number of 
heptads in coiled-coils can vary from up to 200 heptads in fibrous proteins,27 down to only two 
heptads in a de novo designed synthetic coiled-coil.30 The seven position in a heptad are 
conventionally denoted as a-b-c-d-e-f-g. Positions a and d are always occupied by hydrophobic 
residues (the most common ones are Leu, Ile and Val). Position e and g  are often occupied by 
charged rsidues (the most common are Lys and Glu). Such a distribution of amino acids residues 
makes the helices amphipathic with residues at a and d forming the inter-helical hydrophobic core 
and residues at e and g forming inter-helical ionic interactions. The arrangements of residues in 
coiled-coil are most conveniently illustred by the helical-wheel diagram (Figure 1.12) 
 
                                                 
26 a) Cohen C, Parry A.D.D. Proteins, 1990, 7, 1-15. b) Kohn W.D., Mant C.T., Hodges R.S. J. Biol. Chem., 1997, 272, 2583-2586.  
27 a) Crick F.H.C. Nature, 1952, 170, 882-883. b) Crick F.H.C. Acta Crystallogr., 1953, 6, 685-689. 
28 Efimov V.P., Engel J., Malashkevich V.N. Proteins, 1996, 24, 259-262. 
29 Liu E., Mui S., Brown J.H., Strand J., Reshetnikova L., Tobacman L.S., Cohen C. Proc. Natl. Acad. Sci. USA, 2002, 99, 7378-
7383. 
30 Burkhard P., Meier M., Lustig A., Protein Sci., 2000, 9, 2294-2301.  
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                  Figure 1.12  : Helical-wheel diagram of a dimeric coiled-coil showing the helical cross-section. 
                 The seven position are labeled a-b-c-d-e-f-g; generally a and d position are occupatied by 
hydrophobic side-chains, e and g positions are mostly occupied by charged or polar side-chains. 
Amino acids in a and d positions form the hydrophobic core while side-chains at the e and g positions 
form inter-helical ionic interactions. 
 
Furthermore, the e and g edge position can shield the hydrophobic core from aqueous 
surrondings. The characteristic hydrophobic repeat is strongly maintained, it is a fundamental 
feature for structural reasons, for folding and stability of protein.31 
 
1.2.2 The hydrophobic core 
The analysis of several natural and designed coiled-coils showed the relevance of apolar amino 
acids in the core: in de novo designed peptides, leucine or isoleucine in a and d position showed 
better stability;32d position is typically leucine or alanine, contributing to dimerization stability but 
not to specificity. In contrast the a position is more variable and, thus, may contribute to both 
dimerization stability and specificity.  
The amino acids variability can be explained by side-chain residues orientation relative to the axis 
formed by two α-helices. The side chains of a residues point towards the external super-coil 
surface, favoring β-branched residues for tight packing (for example isoleucine or valine). The 
side-chains of d residues point straight away the hydrophobic interface, favoring unbrached 
amino acids;33 this is the characteristic packing for the “knob-into-holes” described by Crick.27 
 
                                                 
31 Steinmetz M.O. Proc. Natl. Acad. Sci. USA, 2007, 104(17), 7062-7067. 
32 a) Litowski J.R., Hodges R.S. J. Pept. Res., 2001, 58(6), 477-492. b) Litowki J.R., Hodges R.S. J. Biol. Chem., 2002, 207(40), 37272-
37279. 
33 a) Zhu B.Y. Protein Sci., 1993, 2(3), 383-394. b) Chao H., Bautista D.L., Litowski J., Randall Irvin T., Hodges R.S. J. Chromatogr. B 
Biomed. Sci. Appl., 1998, 715(1), 307-329.  
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Figura     : Schematic representation of “kno-into-hole” described by Crick for two parallel right-handed helices. 
 
 
1.3 Biological combinatorial libraries of peptide 
Combination of a relatively small number of amino acids is the strategy used by nature to 
construct proteins which are the most variable and adaptable molecules of life. No other 
molecule can be organized in such a large number of different structures and carry out so many 
different functions as proteins. Proteins are the principal mediators of molecular “crosstalking” 
and their extreme variability makes them suitable mediators of specific molecular interactions. 
Interactions between proteins or between proteins and other molecules, mediate all the 
physiological and pathological phenomena of life and as such can be the targets of specific drugs 
to modify physiological or pathological events. 
Evolution of chemical and biological technologies for the production of peptides and proteins in 
the laboratory has made it possible to use the same natural molecular approach to construct new 
peptide sequences which recognize specific target. The intrinsic variability of peptide sequences 
and their ability to specifically recognize other molecules can therefore be used to design peptide 
drugs. 
A biological library consists of a pool of microorganisms expressing different polypeptides. 
Each microorganism carries only one encoding DNA or RNA sequence for certain peptide, 
representing one clone; each single clone of the library can be propagated and it will express the 
same peptide.34 
A polypeptide library construction starts with the design of encoding DNA sequence; the source 
for this insert can be a pool of chemically synthesized degenerated oligonucleotides, cDNA, 
genomic DNA fragments or mutagenized specific gene fragments. The library will be constitued 
by viral particles or by cells. 
                                                 
34 Mersich C., Jungbauer A. J. Chrom.B, 2008, 861, 160-170.  
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The next important step will be the screening of the library against tha target molecule. Clones, 
identified as binders to the target substance, will be sequenced and their coding regions will be 
translated into the particular peptide sequences. One method of designing a random peptide 
library is the use of random oligonucleotides. In a fully degenerated oligonucleotide each triplet 
will code for one of the 64 possible codons and at each coupling reaction an equal mixture of all 
four nucleotides will be used for all three position in the triplet. In this way the oligonucleotide 
will contain all 64 possible codons and all 20 amino acids and three stop codons will be 
represented. 
Peptide libraries can be used to “fish” active ligands from a large variety of structural 
combinations making it possible to identify peptide mimotopes, which mimic the structure and 
function of a native protein. The principle for selecting of new ligands for a variety of biological 
targets by means of combinatorial peptide libraries exploits the natural diversity of protein-
protein and protein-ligand interactions. 
 Molecular biology techniques make it possible to build polypeptide libraries expressed by 
different biological entities including bacteria, phages and ribosomes. 
 
1.3.1 Phage display 
Phage display is the most well-studied high-throughput screening method to study protein 
interactions, based on displaying peptides or proteins on the surface of a bacteriophage. 
The origin of the phage display dates to the mid-80s when Smith first expressed a foreign 
segment of protein on the surface of bacteriophage M13 virus particle.35 Smith demonstrated that 
a fusion phage can be isolated from a background of phage particles displaying no antigen with 
more than 1000-fold enrichment, allowing phages displaying the correct antigen to be affinity 
purified against the cognate antibody. 
 Phage are viruses that infect bacterial cells and many of the vectors used in recombinant 
DNA research are phages that infect the standard recombinant DNA host: the bacterium 
Escherichia Coli. The key feature of recombinant DNA vectors, including phages, is that they 
accommodate segments of “foreign” DNA-pieces, human DNA, for instance, or even stretches 
of chemically synthesized DNA. As vector DNA replicates in its E. Coli host, the foreign insert 
replicates along with it as a sort of passenger. An “expression vector”, including a phage-display 
vector, has an additional feature compared to vectors in general: the foreign DNA is expressed as 
a protein. Phage display differs from conventional expression system, however, in that the 
foreign gene sequence is spliced into the gene for one of the phage coat proteins, so that the 
foreign amino acid sequence is genetically fused to the endogenous amino acids of the coat 
protein to make a hybrid fusion protein. 
                                                 
35 Smith G.P., Petrenko V.A. Chem. Rev., 1997, 97, 391-410. 
 14
The hybrid coat protein is incorporated into phage particles (virions) as they are released from 
the cell, so that the foreign peptide or protein domain is displayed on the outer surface. 
The most investigated phage used for the phage–display are fF phage, including fd, f1 and M13; 
display systems based on bacteriophage T4 and λ are extremely promising but their use is not so 
frequently. 
Filamentous phages are flexible rods about 1 μm long and 6 nm in diameter, composed mainly of 
a tube of helically arranged molecules of the 500-residue major coat protein pVIII; there are 2700 
copies in wild-type virions, encoded by a single phage gene VIII. Inside this tube lies the single-
stranded viral DNA (Figure 1.13). 
 
 
Figure 1.13: phage structure with pIII, pVI, pVIII, pVII and pIX protein. 
 
At one tip of the particle there are five copies each of the minor coat proteins pIII and pVI 
encoded by gene III and gene VI respectively; minor coat proteins pVII and pIX (genes VII and 
IX) are at the other tip. 
 
1.3.2 Phage display libraries 
Generally the phage display cycle starts with the creation of diversity at the DNA level, creating a 
library of different variants. The DNA fragments are usually cloned upstream the gene encoding 
the protein III or the protein VIII of the phage: in the first case there are 3 to 5 recombinant 
proteins at one end of the phage; in the second, all 2700 copies of the major coat protein are 
recombinant. Excluding the display of short peptides, the protein III based system is generally 
prefereed. Although pIII and pVIII have been used to display proteins, pIII is the display protein 
of choice, having been used to display large numbers of different proteins. 
In a typical phage display selection, the phage displaying the protein of interest P is retained on a 
surface, coated with an antigen or antibody recognizing P, while non-adherent phage are washed 
away. Bound phages can be removed from the surface, re-infected into bacteria and re-grow for 
further enrichment and eventually for binding analysis. The possibility to perform successive 
round of selection permits the isolation of proteins present in very low number in a population 
of billions different phages. Usually, three or five rounds of panning are sufficient to enrich for 
binding peptide sequence. 
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Phagemide vectors have been developed, containing an Ff origin of replication and the gene 
encoding pIII can be manipulated and propagated as plasmids, and when display is required, 
bacteria containing the vectors are infected with a helper phage, which provides all other 
components necessary for the creation of recombinant, selectable phage particles. 
 
 
 
Figure 1.14  – Schematic representation of a typical round selection with phage display 
 
Over the past year, significant advances have been achieved through the use of phage-displayed 
peptide libraries. A wide variety of bioactives molecules, including antibodies, receptors and 
enzymes, have been selected high-affinity and/or highly-specific peptide ligands from a number 
of different types of peptide library. The demonstrated therapeutic potential of some of these 
peptides, as well as new insights into a protein structure and function that peptide ligands have 
provided, highlight the progress made within this rapidly expanding field. 
A number of different groups have screened peptides libraries with monoclonal antibody (mAbs) 
and have isolated “peptide mimics” that cross react with the mAbs. Typically, phage libraries are 
generated to encode small foreign peptides which can range in size from 6 to 45 amino acids, 
while retaining large diversity. Peptide libraries may be displayed as linear or cysteine-constrained 
sequences. Traditionally, the process of affinity selection is an iterative process of several rounds 
of selection, elution and amplification of phage; recently new developments in high throughput 
methods have allowed for the screening and characterization of large numbers of phage clones 
simultaneously . Most procedures are performed in multiwell plates and involve fluorimetric and 
spectrophotometric data measurements. 
Demanegl et al. previously isolated clones bearing linear –epitope-mimic peptides by screening a 
disulfide constrained 6-mer (CX6C; single letter amino acid code where X may be any amino acid) 
peptide library with a malaria-specific mAb. More recently, this group isolated two mAbs from 
the malaria-binding, anti-phage response and compared their heavy chain variable region and 
 16
light chain variable region sequences with those of the parent mAb that was initially used to 
isolate the phage clone. 
 There is also evidence that immunogenic-mimic peptides can be isolated by polyclonal 
serum Abs. In previous work, Mennuni et al. isolated several diabetes-specific peptides by 
screening two peptide libraries with serum IgGs from among these were bound by the serum 
Abs from a number of patients having full-blown diabetes. Mennuni et al. showed that, on 
immunization of rabbits, a phage clone bearing one of these peptides elicited Abs that recognized 
pancreatic-islet cells. Thus this immunogenic-mimic peptide may reveal new antigens (or 
epitopes) involved in the evolution of type-1 diabetes, especially if it appears to produce 
pathogenic Abs as a hapten on its own. 
In another case, phage display libraries of small peptides have been used in the chemical 
catalysis.36 Peptide possessing aldolase activity, in fact, was produced by Tanaka at all., displayed 
on the surface of phage and selected by reaction of peptide phage with 1,3-diketone that heve 
been employed for the induction of alodolase antibody.  
 
1.3.3 Bacterial display 
Surface display of heterologous proteins in bacteria has been employed as a tool for basic and 
applied research in microbiology, molecular biology, vaccinology and biotechnology.  
The most frequently used host for bacterial display is Gram-negative bacterium Escherichia Coli 
owing to rapid growth rate, ease of genetic and physical manipulation, and its suitability for 
making large libraries of up to 1011 members.  
Bacterial display scaffolds can be broadly grouped into those allowing N-terminal, C-terminal and 
sandwich fusions. Display of passenger polypeptides as N-terminal fusions with a surface-
exposed N-terminus of the display scaffold can be accomplished via fusion to autotransporter 
proteins. Autotransporters used for library screening include the IgA protease from Neisseria 
gonorrhoeae, E. Coli AIDA-I or EstA from Pseudomonas aeruginosa.37 
Display via the scaffold’s C-terminus may be beneficial to enhance the diversity of peptide 
libraries since stop codons arising from common randomization schemes and nonintended errors 
(primer deletions or PCR errors) can yield functional binders without truncating the carrier 
protein. C-terminal libraries display have been generated and screened using intimins (EaeA), 
invasins and the LppOmpA vector.  
Sandwich fusion is the most commonly used strategy for the surface display of proteins in Gram-
negative bacteria. Three classes of protein have been used as carrier proteins: outer membrane 
proteins (OMPs), subunit proteins of extracellular appendages and S-layer proteins. OMPs form 
                                                 
36 Tanaka F., Barbas III C.F. Chem.Comm., 2001, 769-770. 
37 Yang T.H., Pang J.G., Seo Y.S., Rhee J.S. Appl. Environ. Microbiol., 2004, 70, 6968-6976. 
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transmembrane β-barrels on the outer membrane. The β-barrels are composed of antiparallel β-
strands pair connected by short loops on the periplasmic side and by long loops on the external 
side. The external loops are generally less conservative and therefore seem to be tolerant to a 
certain degree of modification such as sustitution, insertion and deletion. The external loops can 
potentially be used as fusion sites for the display of heterologous proteins. It has generally been 
believed that the external loops of OMPs could only accept foreign peptides of 70 amino acids or 
less owing to the disruption of membrane integrity of carrier protein. However, it has more 
recently been demonstrated that E. Coli OmpC could be used as a sandwich fusion partner, 
displaying much longer polypeptides of 162 amino acids, which is the largest peptide inserted to 
date using the sandwich fusion method.38 
 In many cases for to generate bacterial libraries is possible to use Gram-positive bacteria. 
Many surface proteins of Gram-positive bacteria are covalently immobilized to the cell wall, 
typically involving a specific C-terminal sorting signal consisting of 32-38 amino acids.39 
Staphylococcal protein A (SpA) has often been used as a model system to study anchoring 
mechanisms of surface protein in Gram-positive bacteria. The sorting signal includes an LPXTG 
sequence motif, where X denotes any amino acid, followed by a stretch of 23 hydrophobic 
residues at the extreme C-terminus.39 The LPXTG sequence contains a cleavage site for sortase, 
which is an enzyme of 206 amino acids that cleaves polypeptides between the treonine and the 
glycine of the LPXTG motif. The anchoring domain, which includes a standard cell wall sorting 
signal as well as an appropriate cell wallspanning region, has been used to display various 
polypetides and proteins. 
 
1.3.4 Ribosome display 
Ribosome display is a totally “cell-free” method of selection and evolution of proteins that is not 
limited by any cell-based translation steps. It is an in vitro selection method for the isolation of 
proteins and peptides from large libraries that was successfully applied to the affinity maturation 
of antibodies using eukaryotic or procaryotic systems. The use of ribosome display overcomes 
current limitations for protein selection technologies as diversity is not limited by transformation 
efficiency but by the physical number of ribosome present and different mRNA molecules 
available in vitro. 
The process results in translated proteins that are associated with their mRNA progenitor that is 
used, as a complex, to bind to an immobilized ligand in a selection step. The mRNA-protein 
hybrids that bind well are then reverse-transcribed to cDNA and their sequence amplified using 
PCR. The end result is a nucleotide sequence that can be used to create tightly binding proteins. 
                                                 
38 Xu Z., Lee S.Y. Appl. Environ. Microbiol., 1999, 65, 5142-5147.  
39 Schneewind O. EMBO J., 1993, 12, 4803-4811. 
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The key issue of the strategy is dependent on coupling individual nascent proteins to their 
corresponding mRNA for selection. This selection enables the isolation of proteins against 
virtually any antigen including self-molecules, certain drugs, potent toxins and haptens, which 
would normally be impossible to raise with in vivo-based systems because o toxicity and lacj of 
immunogenicity. 
 Ribosome display offers two important advantages: first, large libraries can be made rapidly 
because there is no need to transform large numbers of mutant plasmid into a host and second, 
additional mutations can be introduced at every round because a PCR step is included in each 
selection cycle rather than an in vivo amplification step. 
One of the most powerful applications of ribosome display has been the isolation of 
recombinant antibodies with high affinity specificity. In this regard ribosome display technologies 
can be used: 
1. to isolate human antibodies from patients exposed to certain viral pathogens to understand 
better the immune response during infection and how protective antibodies are generated, 
2. to generate human antibodies, significant for cancer immunotherapy, and 
3. elucidate the specificity of autoimmune antibodies 
A protocol of production of human single-chain Fv antibodies by ribosome display is established 
by Hell et al. 
Because of ribosome display avoids the problems of cytotoxicity, soluble protein expression and 
secretion bias in cell-based systems, it could be an ideal means by which to display functional 
proteins for drug discovery applications like target discovery and functional identification. With 
the completion of genome sequences, it is possible to design general cDNA libraries for 
ribosome display. In combination with high-throughput proteins arrays, the screening power of 
ribosome display could be further increased, permitting library-versus-library screening and 
genome-wide analysis of protein-protein interactions. 
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Chapter 2: Biosensors and microarrays 
 
2.1 Biosensors 
Good analytical devices are available now but new reliably, cheaply and rapidly devices are 
urgently needed to detect enviromental pollutants and medical-related targets. The conventional 
techniques of high-pressure liquid chromatography (HPLC), gas cromatography (GC) or enzyme-
linked immunoassorbent assay test (ELISA-test) allow for a highly accurate and sensitive 
determination of the exact chemical composition of many samples, but these methods 
disadvantages including the following: 
1-they enable only the detection of a single compound or a group of structurally related 
compounds at any given time, 
2-they cannot assure the biological effects of the tested compounds (e.g. cytotoxicity or 
genotoxicity) 
3-these test may take a few days and require highly skilled people as well as expensive equipment 
to conduct.40 
To analyse a molecular interaction with or without the use of reporter labels, it is necessary 
to couple a molecular recognition element (e.g. an antigen or target receptor) to a transducer that 
converts a chemical or biological interaction into an electrical signal. A biosensor is thus defined 
as a unique combination of a receptor for molecular recognition and a transducer for trasmitting 
the interaction information into an electrical signal.41 
 
 
  
 
 
 
Finally the role of biosensors is to convert a biological response into an electrical signal: 
biological material is direcly associated with a physicochemical transducer. Only certain 
substances, that are supposed to be interactors of biological part, will result in an optical or 
electrical signal of physical transducer. The specificity of the biosensor will depend on the 
binding abilities of the biorecognition element; the sensitivity on the transducer used for the  
detection of binding.42 
 
                                                 
40 Eltzov E., Marks R. IEEE Instr. Meas. Magazine, 2009, 10-16. 
41 Cooper M. A. Drug Discov.Today, 2006, 11, 1068-1074. 
42 Pohanka J. Appl.Biomed., 2009, 7(3), 121-127. 
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2.1.1 The biorecognition element 
The biorecognition element is chosen according to the target analyte on the report method. Any 
of the possible bioreceptor elements of a biosensor will indicate interaction with the target 
analytes; this capability ensures that the sensor is selective. The biological components of a 
biosensor are not only responsible for the correct recognition of the analyte but also the 
generation of the physico-chemical signal monitored on the transducer and, ultimately, the 
sensitivity of the final device.43  
They can be divided in two categories: catalytic and non-catalytic. The catalytic group include 
enzymes, microorganisms and tissues. Devices incorporating these elements are appropriate for 
monitoring metabolites in the millimolar to micromolar range and can be used for continuous 
monitoring. The non-catalytic or affinity class biological components comprises antibodies (or 
antigen), lectins, receptors and nucleic acids which are more applicable to “single use” disposable 
devices for measuring hormones, steroids, drugs, microbial toxins, cancer markers and viruses to 
concentration in the micromolar to picomolar range.44 
 From an analytical point of view, the most important class of enzymes are oxidoreductases, 
which catalyses oxidations using oxygen or NAD, and the hydrolases, which catalyse the 
hydrolyse.45 Most successful biosensors exploit enzymes as the biological recognition/response 
system because of the range of transducible components such as protons, ions, heat, light, 
electrons and mass that can be exchanged as part of their catalytic mechanism.46 This catalytic 
activity is controlled by pH, ionic strength, temperature and the presence of cofactors. Enzyme 
stability is usually the deciding factor in determining the lifetimes of enzyme based biosensors, 
typically between one day and one or two months.47 
In many case organelles, whole cells or tissue section have been used directly as biocatalytic 
element since they contain, together with numerous enzymes, all the other necessary components 
needed to convert substrates into products in an environment which has been optimized by 
evolution. The appropriate use of enzyme inhibitors, activators and stabilizing agent can be used 
to enhance the selectivity and lifetimes of tissue based biosensors.45 
 Naturally occurring receptors are non-catalytic proteins that span cell membranes, 
extending into both the extracellular and intracellular spaces; they are involved in the chemical 
senses such as olfaction and taste as well as in metabolic and neural biochemical pathways. 
Within the organism they act as links in cell-cell communication and they are also the binding site 
for many drugs and toxins.  
                                                 
43 Eltzov E., Kushmaro A., Marks R. Biosensor and Related Techniques for Endocrine Disruptors, Endocrine Disrupting Chemicals in Food, 
2008, ed. I. Snow, Cambridge, U.K. 
44 a)D’Orazio Clin. Chim. Acta, 2003, 334(1-2), 41-69. b) Griffiths D., Hall G. Trends. Biotechnol., 2003, 11, 122-130.  
45 Li H., Liu S., Dai Z., Bao J., Yang X. Sensors, 2009, 9(11), 8547-8561. 
46 Lowe C.R. Phil. Trans. R. Soc. Lond., 1989, B324, 487-496.  
47 D’Auria S., Lacowikz J.R. Curr. Opin. Biotech., 2001, 15, 201-218. 
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Two methods have been defined by which binding of a transmitter molecule to the extracellular 
side of the receptor leads to modification of intracellular processes. The first method is by 
opening a transmembrane ion channel and the second method is by activation or inhibition of 
membrane enzyme that generate secondary messenger compounds.48 All three processes involved 
in this situation (binding specificity, ion channel opening and enzyme activation) provide possible 
opportunities for receptor utilization in biosensors. Attempts at using neuroreceptors as the 
recognition elements in biosensors have largely been restricted to the nicotine acetylcholine 
receptor which can be isolated from the electric organ or electric eel or ray in relatively large 
quantities. The unavailability of other receptors for biosensors use is no doubt a reflection of the 
fact that they are normally present in small amount in tissues and are unstable once removed 
from their natural lipid membrane environment.49 
 Antibodies are a molecules produced by animals in response to the antigen and which bind 
to the latter specifically. Antibody to smaller molecular weight environmental contaminants such 
as pesticides, herbicides, microbial toxins or industrial chemicals can be made attaching the latter 
to carrier proteins like BSA (Bovine Serum Albumin) or KLH (Keyhole Limpet 
Haemocyanine)50: the small molecular component of the resultant conjugate is known as hapten.  
Direct measurements of the resultant change in mass can be made with acoustic devices51 and of 
the change in refractive index with surface plasmon resonance.52 Binding can also be detected at 
the surface of optical fibres by conjugating the antigen or antibody to a fluorescent label,53 or 
with electrochemical devices by the use of an enzyme label.54 
 The ability of a single-stranded nucleic acid molecule to recognize and bind to its 
complementary partner is known like DNA-hybridization and has been used in genetic analyses 
and can also be used in a biosensor. Over the last decade there has been a movement away from 
radiometric methods towards the application of electrochemical, microgravimetric, and optical 
transduction system for the measurement of nucleic acid binding reactions.55 Microgravimetric 
methods have been reported to identify the increase in mass due to the hybridization of double 
single stranded DNA and its complementary strand in a sample56 and the measurement of surface 
                                                 
48 Cooper M.A. J. Rec. Signal Transd., 2009, 29 (3-4), 224-233. 
49 Spisak S., Tulassay Z., Molnar B., Guttman A. Electrophoresis, 2007, 28(23), 4261-4273. 
50 a) Harrison R.O., Goodrow M.H., Gee S.J., Hammock B.D. Immunoassay for Trace Chemical Analysis, 1991, ed. Houghton. b) 
Vandeerlan S.H., Stanker B.E., Watkins D.W., Roberts M., 2000, American Chemical Society Symposium Series, 451, 14-27. c) Harris 
J.R., Markl J. Micron, 1999, 64, 79A-88A. 
51 Ferreira G.N.M., da-Silva A.C., Tomè B. Trends in Biotech., 2009, 27(12), 689-697. 
52 Mc Loughlin M., Collins D. J. of Chromat. B, 2009, 878(2), 149-153. 
53 a) Anis A.N., Wright J., Rogers K.R., Valdes J.J. Anal. Lett., 2002, 25, 627-635. b) Gauglitz G. Anal. Bioanal. Chem., 2005, 381(1), 
141-155. 
54 a) Aizawa M. Phil. Trans. R. Soc. Lond., 1997, B316, 121-134. b) Lee W.E., Thompson H.G., Hall J.G., Fulton R.F., Wong J.P. J. 
Immunol. Meth., 1993b, 166, 123-131 c) Ogert R.A., Burans J., Liegler F.S. Proc. SPIE Int. Soc. Opt. Eng., 1994, 2068, 151-158. 
55 Miranda Castro R. Miranda-Ordieres A.J. Electroanalysis, 2009, 21(19), 2077-2090.  
56 Luppa P.B., Sokoll L.J., Chan D.W. Clin. Chim. Acta, 2001, 314(1-2), 1-26. 
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plasmon resonance at a liquid-metal film interface has also been used to detect the hybridization 
of bound DNA.57 
 
2.1.2 The secondary transducer              
Biosensors can also be classified into four different basic groups on the basis of signal 
transduction: electrochemical, optical, mass sensitive and thermal sensor. Most of the biosensors 
described in the literature are electrochemical biosensors. Electrochemistry offers high sensitivity, 
compatibility with modern microfabrication technologies, portability, low cost and minimal 
power requirements.58 
Optical biosensor are the most common after amperometric and potentiometric biosensors. The 
various types of optical transducer exploit properties such as light absorption, fluorescence or 
phosphorescence, bio-chemiluminescence, reflectance, Raman scattering and refractive index. 
There are other some example of optical techniques usually utilised in biosensors like fibre optic, 
optical waveguide structures and surface plasmon resonance (SPR).59 
Within mass-sensitive biosensors, acoustic wave biosensors operate on the basis of an 
oscillating crystal that resonates at a fundamental frequency. The crystal element is coated with a 
layer containing the biorecognition element designed to interact selectively with the target analyte. 
A measurable change in the resonance frequency occurs after the binding of the analyte on the 
sensing surface according to the mass change of the crystal. Most of these biosensors utilise 
piezoelectric materials as the signal transducers51 and it provides real-time data of binding events 
but, as the sensitivity is lower than SPR, this method has been used less frequently.60 An emerging 
group of mass-sensitive biosensors are the so-called cantilever biosensors, which are based on the 
bending of microfabricated silicon cantilevers. The mass change, originating from the adsorption 
of target molecules on the microcantilever surface causes a differential surface stress change, and 
therefore a bending or deflection of the cantilever; the deflection of a few nanometres can be 
detected by an electric or optical methods.61 
Microcantilever biosensor offer various advantages due to their microscopic dimensions (in the 
range of 10-3 mm2): only small quantities of receptor and analyte are necessary and limits of 
detection achieved are often lower than those obtained by classical methods.62 
Thermometric biosensors, finally, exploit the absorption or evolution of heat in biological 
reactions This is reflected as a change in the temperature within the reaction medium and is 
                                                 
57 Scarano S., Mascini M., Minunni M. Biosens. Bioelect., 2009, 25(5), 957-966. 
58 Wang J. Anal. Chim. Acta., 2002, 469, 63-71. 
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transducer by a change in the resistance of a thermistor, which acts as a temperature transducer. 
Thermistor-based calorimetric biosensors have mainly been applied to clinical and industrial 
process monitoring; in the environmental field, only a few applications have been described up to 
now: several pesticides, for example, have been measured by thermometric biosensors.63 
 
2.1.3 Immobilisation of biorecognition element 
Immobilisation is one of the key steps in the development of biosensors. It not only helps to 
achieve the required close proximity between the biomaterial and the transducer, but also to 
stabilise the biomaterial for reuse.64 The most generally employed immobilisation procedures are 
adsorption, cross-linking, covalent binding, entrapment, sol-gel entrapment, self-assembled 
biomembranes and immobilisation based on bulk modification. 
Physical adsorption of the biocomponent, based on hydrophobic, electrostatic and van der Waals 
attractive forces, is the oldest and simplest immobilisation method. It does not require chemical 
modification of the biological components and allows the regeneration of the matrix membrane. 
In spite of its simplicity, this immobilisation method is clearly restricted to a limited number of 
applications because of its long-term unstability. Loss of adsorbed biological components is 
possible if changes in pH, ionic strenght or temperature occur during measurements. 65  
The cross-linking method is based on the formation of covalent binding between molecules of an 
inert bed and the functional reagents. Cross-linking procedures have been attractive due to their 
simplicity and to the strong chemical binding achieved for the biomolecules; the main drawback 
is the possibility of activity losses due to the distortion of the active enzyme conformation during 
the cross-linking. Cells66 and enzymes67 have been successfully immobilised by cross-linking 
method. 
The entrapment of cells in polymer structures may create diffusion barriers, which could hinder 
the transport of analytes and result in prolonged washing, equilibration and measuring steps.68 
The other common approach is to retain an enzyme solution, a suspension of cells or a slice of 
tissue in close proximity to the transducer surface, confined by analyte semi-permeable 
membranes such as dialysis membranes or ultrafiltration membranes, which permit the free 
passage of the substrate and product but retain the sensing element.  
Sol-gel entrapment is based on inorganic material that is able to give physical rigidity, chemical 
inertness and high photochemical and thermal stability at the final biosensor structure.69 Solids 
prepared by sol-gel chemistry shrink around hosted reagents, thereby blocking them from 
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66 D’Souza S.F. Biosens. Bioelectron., 2001, 16, 337-353. 
67 Tyagi R., Batra R., Gupta M.N. Enzy. Microb. Technol., 1999, 24, 348-354. 
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leaching into the sample solution, but possess a porous structure that provides access to small 
analyte. Sol-gel chemistry yields a matrix that retains the protein’s native conformation and 
reactivity and avoids the denaturation of proteins during the immobilization. 70 
Biomembranes are self-organised structures consisting of amphiphilic lipid molecules. In water 
solution thermodynamics drive these molecules to assemble into structures such as self-
assembled monolayer membranes (SAMs) and self-assembled bilayer membranes (BLMs). SAMs 
offer promising possibilities in the control over the orientation of the molecule immobilised71 and 
BLMs have recently been used in various experimental biosensors as models of actual living cell 
membranes. Molecular self-assembly occours in nature and produces nanosystem far more 
advanced than man-made system. Inspired by the nature those nanostructures are applied to the 
development of biosensors.72 Nanotechnology is generating new ideas not only for 
immobilisation purposes but also in the design of nanostructures with particular optical 
properties. 
At the end, a biocatalyst can be incorporated within the bulk of entire electrode material: a 
carbon composite matrix or graphite epoxy resin. These modified biosensors offer several 
advantages such as the close proximity of the biocatalytical and sensing sites, possibility to 
incorporate other components (cofactors), easy renewing of the surface, economy of fabrication 
and high stability of the incorporated biocatalysts. Biosensors with these features can be the 
carbon paste electrodes, screen-printed biosensors and solid binding matrices of defined 
molecular structure.73 
  
2.2 Microarrays 
Microarray, sometimes referred to as a chips or arrayed libraries, can be classified into two 
general types: biochips (biomicroarray) and chemical microarray.74 Biochips are usually generated 
from biochemical or biological components, such as protein (including enzymes and antibodies), 
DNA, cells75 and tissues;76 chemical microarrays consist of arrays of organic compounds 
including small organic molecules, peptides and sugars.77 
In recent years microarrays have become an unvaluable research tool for life scientists and 
their use in diagnostic has emerged as a great promise of medicine. Microarrays consist of 
immobilized biomolecules spatially addressed on substrates such as planar surfaces (typically 
coated microscope glass slide), microwells or array of beads. Immobilized biomolecules, here 
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referred as probes, usually include oligonucleotides, PCR products, proteins, peptides, 
carbohydrates and other small molecules. 
Generally a protein or peptide microarray are made by a large set of this biological molecule 
arrayed on a solid support; after washing and blocking surface unreacted site the array is probed 
with a sample containing, among a variety of unrelated molecules, the counterparts of the 
molecular recognition events under study. If the interaction occurs, a signal is revealed on the 
surface by a variety of detection techniques; or with label-free methods like mass spectromerty 
(MS), surface plasmon resonance (SPR), atomic force microscopy (AFM), quartz crystal 
microbalance (QCM), or directly with a labelled probe. 
The aim of peptide and protein microarrays is the study of molecular interactions occurring 
between two partners: one contained in a liquid sample and one immobilized on a solid support. 
The key requirements of the surface hosting a protein microarray assay are: 
1. Provision of an optimal binding capacity of capture ligands (probes), 
2. Retaining of biological activity of capture ligand, in order to allow internal hydrophobic side 
chains to for hydrophobic bonds with the solid surface,78 
3. Accessibility of the ligand by the interaction partner (protein-substrate interaction reduce the 
accessibility of target, possibly leading to false negative results). This issue is particularly 
important for peptide microarrays due to the small molecular mass of capture ligands. 
4. Low degree of aspecific interaction; the achievement of a low degree of aspecific binding is 
extremely difficult when the sample is a complex mixture of thousand of molecules such a 
serum.79 
One of the most important point in the microarray development is the binding of protein or 
peptide over the solid surface. The simplest way for binding a protein is through surface 
adsorption. This approach has been used in standard ELISA and Western blot for many years 
and is based on adsorption of the macromolecules either by electrostatic forces on charged 
surfaces (poly-Lysine coated slides)80 or by hydrophobic interactions (nitrocellulose or 
polyvinyldene fluoride membranes).81 
The covalent binding of proteins and peptides on the substrate represent a more robust 
approach. Considerable effort has been made in the last years to improve immobilization of 
protein on modified glass surface using a number of different strategies which recently have been 
compared systematically.82 The covalent mechanism of attachment requires the presence of 
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reactive support such as epoxides,83 aldehydes,84 succinimidyl esters or isothiocyanate 
functionalities85 able to react with nucleophilic groups (amino, thiol, hydroxyl) on the ligand 
molecules. 
The use of a matrix that embeds the protein in a structured environment is an alternative way to 
immobilize proteins. This mechanism does not involve the cross linking of the capture molecules 
with the surface, but is based on the physical entrapment of proteins in gel such as 
polyacrylamide86 or agarose.87 The three-dimansional structure of these substrates generally 
increases the loading capacity and does not disturb the potential functional sites or regulatory 
domains of the protein; moreover the aqueous environment of the gel reduces protein or peptide 
denaturation. However, the gel structure can represent a barrier to the diffusion and the 
molecular recognition events may require long incubation times. A mixed approach, based on 
nanoengineered 3D polyelectrolyte thin films (PET) deposited on glass slide by consecutive 
adsorption of polyelectrolyte via self-assembled technique, has been reported.88 Proteins were 
immobilized in the PET-coated glass slides by electrostatic adsorption and entrapment on porous 
structure on the 3D polymer film. 
In addition to non-specific methods, probe molecules can be tagged and immobilized by a 
specific non-covalent interaction between the tag and an immobilized capturing molecules. The 
attachment to the surface is typically mediated by a molecular recognition event such as biotin-
avidin interaction, by interaction between nickel coated slides and His-tagged proteins or 
glutathione and GST tags. An innovative affinity-based protein immobilization strategy was 
developed based on the combined use of the carbohydrate binding module (CBM) and its natural 
three-dimensional substrate such as cellulose.89 CBM fused antibodies or peptide were produced, 
immobilized on cellulose surfaces and used for serodiagnosis of human immunodeficiency virus 
patients. 
 Besides the attachment mechanism (adsorption, physical entrapment into gels, covalent 
binding or oriented molecular recognition), also the molecular architecture of the coating plays an 
essential role and must be considered. Proteins or peptides, regardless of the attachment 
mechanism, can be directly in contact with the activated surface on a one dimensional coating; 
alternatively the probe can be inserted in a simple monolayer architecture such as in SEM or poly 
ethylen glycol (PEG)90 or in a more complex three-dimensional structure like a dendrimeric 
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polymer or a random co-polymer91 like a co-polimer of N,N-dimethylacrylamide, N-
acryloyloxysuccinimide, and 3-(trimethoxysilyl)propyl methacrylate.92 A covalently attach 
biomolecules on glass slides was firstly reported for the preparation of low-density DNA 
microarrays and the innovative aspect in this approach relies in the fact that the polymer self-
adsorbs onto the glass surface very quickly, simply immersing glass slides in a diluted aqueous 
solution of the polymer and without time consuming glass pretreatments.  
Supramolecular structures are generally considered favorable in retaining protein activity 
recognition. In addition, due to the decreased reaction rate constant in close vicinity to the 
surface, recognition of small molecules, such as peptides, is often hindered. The polymeric 
coating on the surface acts as a linker and moves the bound probe away from the surface 
resulting in a much faster and efficient interaction with the target. This issue is very important 
when dealing with small molecule microarrays as peptide arrays. 
 
2.2.1 Ligand detection 
Current detection strategies for protein microarrays are generally classified as:93 
1. Label free methods, including mass spectrometry (MS), surface plasmon resonance (SPR) and 
grating-coupled surface plasmon resonance (GC-SPR), atomic force microscopy (AFM), micro-
electromechanical systems (MEMS) cantilevers and quartz-crystal microbalance analysis (QCM); 
2. Labelled probe methods, including fluorescence, chemiluminescence, 
electrochemiluminescence and radioactivity detection. 
 
SPR spectroscopy is a well-know technique to study the kinetics of protein-protein 
interactions in real-time57 and it is the leading technology in the field of label-free detection of 
molecule interactions.94 In conventional SPR spectroscopy, the capture ligand is immobilized on 
a thin metal film (gold or silver) and the target is added. The change in the reflection angle of the 
incident light indicates the amount of target molecule captured on the surface. SPR is a versatile 
tool but it allows the analysis of only a few channels for a single experiment.  
Grating-coupled surface plasmon resonance is a method for the assessment of analyte in a 
multiplexed format. In GC-SPR the analyte is flowed across specific probes that have been 
immobilized on a sensor chip. The chip surface is illuminated with p-polarized light that couples 
to the gold surface’s electrons to for a surface plasmon. At a specific angle of incidence, called 
the GC-SPR angle, the maximum amount of coupling occurs, thus reducing the intensity of 
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reflected light. Since regions of the chip can be independently analyzed, this system can assess 
400 interactions between analyte and receptor on a single chip.95 
AFM reveals the change in height of an immobilized protein upon binding with its cognate 
molecule. It has been introduced for detection at the singular molecular level in protein 
nanoarrays96 but is currently widely used for surface characterization in protein microarrays. 
Microcantilevers for biosensing are silicon strips attached at one end, with the capture molecule 
(antibody or protein) buond to the surface. When an analyte binds onto the microcantilever, its 
bending as a result of surface stress is measured by the deflection of an optical beam or by a 
change of electrical resistance in a piezoelectric thin film on the cantilever. Alternatively, a change 
in its mechanical resonant frequency is measured.97 
All label-free detection methods are promising tools to characterize binding events on surface. 
They do not require labelling of molecules that may affect protein activity. However, they are 
generally based on sophisticated equipment not easily available in all types of laboratories.  
 Labelled probe methods have directly evolved from clinical immunoassays, 
radioimmunoassays or ELISA protocols where they are widely used. They can be distinguished 
in: 
 
1. Direct; when a mixture of protein is immobilized and the detection is performed using 
labelled binding molecules such as antibodies, 
2. Indirect; when immobilized antibodies are used as capture ligands and probed by labelled 
proteins, 
3. Sandwich; when a first immobilized antibody acts as a capture agent for the assayed protein 
which is revealed by a recognition with a secondary labelled antibody. 
Labelled probe detection methods rely on fluorescence, chromogenic, chemiluminescence, 
electrochemiluminescence or radioactive labelling strategies. Detection methods developed for 
microarrays, due to the miniaturized format, are required to provide high sensitivity and high 
throughput. The use of fluorescent probes and signal amplification techniques with chromogenic 
or fluorescent probes usually leads to performances that meet such criteria. 
The fluorescence sensing system coupled with antibodies represents the simplest and most 
versatile strategy for an highly specific and sensitive analysis.98 Even though the requirement of 
two antibodies severely constrains the array design, the sandwich method, increases the 
specificity of antibody arrays and is widely used especially in microimmunoassays on array 
format.  
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Chromogenic detection is based on the use of chromogens. They are substrates for an enzymatic 
reaction that generates an unsoluble coloured product. Commonly used enzymes for 
chromogenic reactions on microarrays are alkaline phosphatase and horseradish peroxidase. 
These enzymes act on colourless chemical substrates generating stable coloured product; for 
example the blue spots generated by 5-bromo-4-chloro-3-indolyl phosphate/nitro blue 
tetrazolium and alkaline phosphatase system has been used for proteomic profiling of cancer cells 
on nitrocellulose coated slides;99 tetramethylbenzidine (TMB) and diaminobenzidine (DAB) are 
widely used substrate for peroxidase.100 
 
2.2.2 Peptide array 
 An important difference between petide arrays and the oligonucleotide arrays is found in 
the range of applications they can be used to address. DNA-arrays are used almost entirely to 
profile mRNA populations in cells and rely exclusively on hybridization of sample DNA with the 
immobilized DNA. Peptide arrays, by contrast, can be used to screen diverse interactions, 
including the binding of proteins, the action of enzymes, the adhesion of cells, the binding of 
metals and many others.101 Further issues that have made peptides arrays more challenging to 
implement include the expense of preparing large numbers of peptides, the development of 
chemistries and supports that give good control in presenting immobilized peptides, the 
prevention of non-specific interactions at the surface and the development of analytical methods 
to detect activities on the chips. 
 How can we prepare a peptide array? There are several methods that can be classified by 
the assembly of peptide on the surface, typical in situ peptide synthesis and immobilization of 
functionalized peptides onto chips,102 and by the properties of the support. 
The in situ synthetic approaches have the primary benefit that they avoid conventional synthesis 
of each of the peptide sequences that are present in the array. The expense and time required to 
prepare hundreds of peptides, including purification before immobilization, prohibit routine 
applications. These considerations have motivated the development of the in situ approaches, 
which benefit from using small amounts of reagents and avoiding purification and 
immobilization of peptides.  
The two general approaches for in situ peptides synthesis are photolithographic synthesis and 
SPOT synthesis. The photolithographic approach was first reported by Fodour et al. in 1991.102 
This group translated solid phase methods for peptides synthesis directly on the array support by 
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developing photolabile protecting groups that would allow synthesis to proceed only at regions of 
the surface that are illuminated. Since this first report, several improved photolithographic 
synthesis methods have been reported, including the use of photoresist films and development of 
maskless array synthesis by Singh-Gasson et al. in 1999.103 This later development was exciting 
because the use of a micro-mirror array served as a virtual mask for the photolithografhic 
exposures, leading to lower expense, faster throughput and higher densities in array preparation. 
The second technique used for in situ peptide synthesis is the SPOT method, first reported by 
Frank in 1992.104 In the SPOT synthesis, peptides are synthesized by sequential spotting of 
microliter volumes of activated amino acids to a porous membrane, like the same chemistry used 
in conventional solid-phase synthesis. SPOT synthesis is one player on the array technology field 
and fullfils the main characteristics of array technology, at the same time it is able to makes 
peptides as capture molecules. Those are synthesized in a stepwise and parallel manner directlt on 
cellulose support; the basic principle of SPOT technology involves the positionally addressed 
delivery of small volumes of activated amino acid directly onto a cellulose membrane sheet. The 
areas wetted by the resulting droplets can be considered microreactors, provided that a non-
volatile solvent system is used; the physical properties of the membrane surface, the solvent 
system and the applied volumes define the size of the resulting spots. Both immobilised and 
soluble peptides can be prepared by SPOT technology. Generally small-scaled spots are tipically 
used for an immobilised synthesis; in contrast, large-scaled spots are used for preparation of 
soluble peptides.105 
 The alternative method to in situ peptide synthesis relies on immobilization of peptide that 
have been previously synthesized by chemical or recombinant methods. This strategy is 
important when small number of peptides will be used to prepare large numbers of identically 
arrays, situation that can justify the expense of peptide synthesis and purification. 
In a way, the peptide microarray is nothing more than a library of immobilized peptides that are 
spatially addressable, highly miniaturized and therefore requiring only a minimal amount of 
analytes for analysis. Using various screening techniques, we can identify peptide or peptides with 
a specific biological, chemical or physical property and isolate them for structural determination. 
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Chapter 3: Target molecules 
 
The development of new biorecognition elements for organic molecules is the aim of this 
project. In our case, target analyte were represented by three molecules: caffeine and 
theophylline, that are two smalls organic xanthines and own similar chemical properties, and 
palytoxin that is a dangerous algal toxin with very different properties compared with the first 
two molecules. 
Palytoxin is an very large molecule and its structure allow to identify different strategic functional 
groups useful for chemical modifications or conjugations at proteins; in contrast, caffeine and 
theophylline are small organic molecules with less number of chemical groups available to a 
chemical modification.  
  
3.1 Palytoxin 
Palytoxin is one of the most potent and complex marine toxins. Though first isolated from the 
zoanthid Palythoa toxica, its biogenetic origin was questioned because of marked seasonal and 
regional variations, but the question was never pursued. Sporadic occurrence of palytoxin in an 
alga, crabs and herbivorous fish also suggested that the toxin might be produced by a 
microorganism and trasmitted to the marine food chain, as is the case with ciguatera, where the 
epiphytic dinoflagellate Gambierdiscus toxicus produces ciguatoxins and maitotoxin that are isolated 
from fish.106 
The letal marine toxin palytoxin, first extracted from the polyps of soft-bodies zoanthids of the 
genus Palythoa is a potentially useful tool for elucidating the molecular reactions by which the 
Na/K-ATPase stoichiometrically transports Na and K ions in opposite directions across the cell 
surface membrane: Palytoxin was found to depolarize mammalian cells by causing small-
conductance relatively nonselective cation channels to appear in their surface membranes.107 
Although the palytoxin-containing zoanthid organisms are located in tropical waters, the 
dinoflagellate of the genus Ostreopsis have a worldwide distribution and toxin producing species 
have been described not only in tropical and subtropical waters, but also in the Mediterranean 
Sea. Humans show symptoms of intoxication by palytoxin following ingestion of contaminated 
seafood or exposue to seawater aerosol in bathing areas. Oral poisoning can induce among other 
symptom vomiting, diarrhea, paresthesia of the extremities, myalgia, respiratory distress and 
death; exposure to the toxin by aerosol induces rhinorrhea, cough, fever and 
broncoconstriction.108 
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Palytoxin is regarded as one of the most potent toxins so far known; the LD50s 24 hours after 
intravenous injection vary from 0.025 μg/kg in rabbits and about the same in dogs, to 0.45 
μg/kg in mice, with monkeys, rats and guinea pigs around 0.9 μg/kg. 
Chemically, palytoxin is a very large and complicated structure (Figure 3.1):  
 
O
H2N OH
O
O
OH
OH
O
HO
OH
OH
Me
OH
HO
OH
OH
OH
OH
OH
O
OH
OH
OH
OH
HO
O
OH
OH
HO
OH
OH
Me
OH
O
OH
OH
O
O
Me
Me Me OH
OH
OH
HO
OH
O
OH
OH
MeMe
OH
OH
N
H
O
HO OH
OH
HO OH
OH
O
N
H
HO
1
115
74
75 76
77
83
84
85
86
 
Figure 3.1: palytoxin structure. In red hydroxy groups, in blue diene motifs, in green terminal amino group. 
 
It is a hydrophilic molecule, with 115 carbons atoms and 64 of these stereogenic centers; it is 
similar to a carbohydrate structure because of the presence of hydroxy groups (42 groups). The 
molecular weight of the toxin is 2678.5 g/mol; most of the functional groups presents in the 
molecule are secondary hydroxy groups; unsatured and hydrophobic moieties are found in diene 
motifs: the first is found at C74-C77 position and the second between C83 and C86. The most 
reactive group is the primary amino group at C115. This nucleophylic functionality could be used 
to modify the original structure of palytoxin in order to generate new different conjugate of this 
molecule with biomolecules as proteins and enzymes, or with other organic molecules. 
The structure of palitoxyn has been elucidated by two different groups separately with NMR 
nuclear Overhauser effects (NOE) in order to define the absolute stereochemistry of all 64 chiral 
centers;109 total synthesis of palytoxin have been achieved by Kishi et al. in about 20 years.110 A 
convergent strategy was adopted by Kishi, after the identification of eight key building blocks. 
Coupling reactions between all the key building blocks allow to obtain final complete palytoxin 
structure; generally, the coupling reactions involve the carbon-carbon bond formation and the 
most used reactions are, for examples, Wittig reaction for the C22-C23 and C75-C76 bond followed 
by hydrogenation, Ni(II)/Cr(II) reaction to obtain only trans stereoisomer for the carbon-carbon 
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bond contiguous to a double bond and Suzuki coupling for the diene structure formation (Figure 
3.2).111 
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Figure 3.2 
 
 
3.2 Theophylline and caffeine 
The xanthine alkaloids caffeine (1) and theophylline (2) (Figure 3.3) are closely related 
compounds found in a variety of plants indigenous to several continents. They are not true 
alkaloids, as they are only weakly basic, and possess some acidic properties. Their structure  
include a purine ring, as found in the adenine and guanine nucleotides. The occurreance of N-
methyl groups determines the specific pharmacological profile of each compound. The xanthines 
are not of great current importance as medicinals, but their history and cultural significance 
makes them of continuing interest.112 
 
N
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N N
N
O
O
1 2  
Figure 3.3: caffeine and theophylline structure. 
 
Theophylline, also known as dimethylxanthine, is a methylxanthine drug used in therapy for 
respiratory diseas such as asthma under a variety of brand names. It is present in tea, although in 
                                                 
111 Uenishi J. C., Beau J.M., Armstrong R.W., Kishi Y. J. Am. Chem. Soc., 1987, 109, 4756-4758.  
112 Franco R. Atencion Primaria, 2009, 41(10), 578-581. 
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trace amounts (about 1 mg/L), significantly less than therapeutic doses; it is found also in cocoa 
beans and in Criollo cocoa beans in amounts as high as 3.7 mg/g.113 
Theophylline, first isolated in 1888 from tea extract, was discovered much later than the other 
xanthines, presumably because its presence was masked by the relatively large amount of caffeine 
contained in tea. 
Theophylline and its bronchodilator action has been of greatest importance in modern medicine. 
This xanthine infact relaxes airway smooth muscle, thus exergting a therapeutic effect in asthma. 
The mechanisn of action is based on o non-selective inhibition of cyclic nucleotide 
phosphodiesterases (PDEs), preventing breakdown of cyclic AMP and cyclic GMP.114 
Another important action is theophylline’s competitive antagonism at adenosine receptors which 
prevents bronchoconstriction in asthmatics patients. Theophylline also inhibits synthesis and 
secretion of inflammatory mediators from various type of cells; it has been proposed, but not yet 
proven, that this anti-inflammatory effect may be relevant to the drug’s therapeutic action. The 
terapeutic range for theophylline bronchodilator action has been established at 10-20 mg/L. 
Above this value, toxic effects may occur, including tachycardia, severe restlessness, agitation, 
emesis and occasionally seizures; desired plasma concentrations are obtained by careful dose 
adjustment and periodic blood testing. 
 Caffeine is a bitter, white crystalline xanthine alkaloid that acts as a psychoactive stimulant 
drug. Caffeine was discovered by a German chemist in 1819 and he coined the term “kaffein”, a 
chemical compound in coffee. Caffeine molecule is found in varying quantities in the beans, 
leaves and fruit of some plants, where it acts as a natural pesticide that paralizes and kill certain 
insects feeding on the plants. It is most commonly consumed by humans in infusions extracted 
from the cherries of the coffee plant and the leaves of the tea bush, as well as from various food 
and drinks containing products derived from the yerba mate, guaranà berries and Yaupon 
Holly.115 
 Caffeine’s most prominent pharmacologic action is to stimulate the central nervous system 
(CNS), increasing arousal and vigilance, reducing fatigue and decreasing motorial reaction time 
for some tasks. It may interfere with sleep and it tends to decrease cerebral blood flow. As to 
cardiovascular effects, the drug induces a 5-10 mm increase in blood pressure via peripheral 
vasoconstriction, a slight decrease in heart rate and to cause the systemic release of epinephrine, 
norepinephrine and renin. Gastric secretion of acid and pepsin is also stimulated by caffeine and 
may contribute to acid reflux symptoms by decreasing the lower esophageal sphincter pressure. 
Other effects include caffeine’s ability to increase metabolic rate and circulating concentrations of 
                                                 
113 Montuschi P., Pagliari G., Fuso L. Ther. Adv. Resp. Dis., 2009, 3(4), 175-191. 
114 Simpson J.L., Gibson P.G. Pharmacol. Ther., 2009, 124(1), 86-95.  
115 Myslobodsky M. Curr. Drug Target, 2009, 10(10), 1009-1020.  
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free fatty acids, cortisol and glucose.116 Caffeine has long been used as an adjuvant in analgesic 
products, where it is believed to enhance gastrointestinal absorption of the analgesic and 
potentiate their activity. It was a component of an analgesic-antipyretic tablet containing aspirin, 
phenacetin and caffeine first marketed by Burroughs Wellcome as Empirin Compound; caffeine 
is also used for the treatment of apnea in newborns. Both caffeine and theophylline are 
comparably effective in regularizing the breathing, but caffeine is easier to administer, has a wider 
therapeutic index, and produces fewer peripheral effects.117  
The interest of our research group in the development of primary transducer towards xanthines 
dates back to year 2005 as a consequence of a joint research plan between the Dept. of Chemistry 
of our University and Biosensor Technologies Ltd, a small enterprise based in Trieste, whose 
core activity was represented by the development of peptide libraries towards molecules of 
interest for the coffee and flavour industry. More recently a similar collaboration was started with 
T&B associates, another SME, and a joint research project coordinated by our Dept. and T&B, 
the Dept. of Life Sciences, the group of Statistical Mechanics and Biophysics at SISSA, the group 
of Virology at ICEGB.   
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
116 Geleijnse J.M. Vasc Health Risk Manag., 2008, 4(5), 963-970. 
117 Jankiewickz K., Czuczwar S.J. Oncogene, 2007, 26(56), 7816-7824.  
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AIM OF RESEARCH 
 
Our research group has been recently involved in a research project, granted by the regional 
government of “Regione Autonoma Friuli-Venezia Giulia” focused on the development of a 
biosensor for the detection of palytoxin in sea water and sea food. 
Due to the afflorance of Ostreopsis blooms in the Trieste gulf area, monitoring of such toxin has 
become of high interest for the seafood industry. 
Among the different strategies outlined within the project to obtain primary transducers 
(including mono- and polyclonal antibodies towards palytoxin) and the development of libraries 
of antibody fragments. We have also planned to obtain peptides that could be interact with the 
whole molecule, or with fragment of the toxin as well.   
The interest of our research group is also oriented in the development of primary transducer 
towards xanthines, as a consequence of a joint research plan between the Dept. of Chemistry of 
our University and Biosensor Technologies Ltd, a small enterprise based in Trieste, whose core 
activity was represented by the development of peptide libraries towards molecules of interest for 
the coffee and flavour industry. More recently a similar collaboration was started with T&B 
associates, another SME, and a joint research project coordinated by our Dept. and T&B, the 
Dept. of Life Sciences at the University of Trieste, the group of Statistical Mechanics and 
Biophysics at SISSA, Trieste, the group of Virology at ICEGB, Trieste.   
 
 
 
 
 
 
 
 
 
 
 
 
 37
RESULTS AND DISCUSSION 
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Chapter 4: Modified target molecules 
 
4.1 Caffeine and theophylline  
In order to fish out binders towards small organic molecules from biological libraries of 
receptors, several modified versions of the target molecules are required, that could allow 
immobilization and eventually bioconjugation. 
Immobilization is thus one of the most important step in the identification and isolation of 
receptors or bioreceptors having affinity to the target analyte. The immobilization of small 
molecules must allow the full exposure of all the functional groups of the organic compound in 
order to allow optimal interactions with the receptor macromolecule. In order to avoid masking 
effect between target molecule and the solid surface used for the immobilization,118 generally a 
spacer is introduced (Scheme 4.1): 
 
TARGET
SPACER REACTIVE
GROUP
 
Scheme 4.1 
 
Linker spacer in this case plays a foundamental role for the selection; it must not interfere with 
the binding between target molecule and receptor macromolecules but only avoid non-specific 
interactions between solid support and reactive groups of target compound. This conditions is 
very difficult to obtain, since even very simple linker moieties, as a hydrocarbon chain, are able to 
interact with some members of the receptor library, via, for example, non specific hydrophobic 
interactions. Many often this leads to the selection of a rather high number of false positives or to 
the selection of true binders towards the target, but showing high affinity only in the presence of 
the linker and thus unable to be used as competition elements between the free and immobilized 
target 119. In order to minimize the occurrence of such false positivity phenomena, we have 
planned to introduce diversity inside the spacer structure by changing its lenght, its polarity and 
the final reactive group as well. 
                                                 
118 a)Lin C., Shen J., Chan W., Wang H. J. Med. Biol. Engin., 2009, 29(6), 276-283. b)Barbas A.S., White R.R. Curr. Opin. Investig. 
Drugs, 2009, 10(6), 572-578. c) Bailon P., Won C.Y. Exp. Opin. Drug Del., 2009, 6(1), 1-16.  
119 Christensen D.J., Gottlin E.B., Hamilton P.T. Drug. Disc. Tod., 2001, 6(14), 721-727. 
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The spacer must be introduced on the analyte at carefully selected positions, in order to avoid the 
modification of reactive groups present in the original structure. When possible, linker is placed 
at an unreactive site of the molecule, leaving free the other reactive groups.  
The first step of this work was thus represented by the synthesis of different typologies of 
modified caffeine and theophylline in order to introduce in their structure a spacer linker. The 
structure of caffeine and theophylline does not allow easy modification without lost of potential 
important interaction groups of this small aromatic compound; in order to avoid chemical 
modification of carbonyl or nitrogen positions, the only point available for a chemical 
modification is represented by position 8 (Scheme 4.2):   
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Scheme 4.2: theophylline and caffeine structure with modification site 
 
According to this, a first set of two different modified molecules 8, 9 (Figure 4.1) has been 
synthesized, having caffeine and teophylline linked to biotin as the final reactive group120 (a high 
affinity streptavidin binder). The biotin-avidin complex has been used in numerous bioanalytical 
and biotechnological applications because of its high affinity constant, which leads to stable 
biomolecular construct. The stability of the avidin-biotin complex was first reported by Launer 
and Fraenkel-Conrat based on dyalisis equilibrium measurements and they found that the 
dissociation constant is 2.4 * 10-10M at 25°C.121 
This allows target-biotin conjugates to be immobilized to a solid surface previously coated with 
streptavidin. 
The overall structure of the first set of conjugates is reported in Figure 4.1. A relatively highly 
hydrophobic ten atoms linker, containing two hydrogen-bond capable group was introduced. 
Such linker has been used in the past during the production of a monoclonal antibody towards 
caffeine with good results122.  
 
                                                 
120 Oh C., Kim J., Kearns B., Cheng A., Dobashi T. Clin .Chim .Acta, 1993, 218(1), 59-71. 
121 Launer L.J., Fraenkel-Conrat H. FASEB, 1994, 8(6), 452-453. 
122 Del Carlo M., Mascini M. Field Anal. Chem. Tech., 1999, 3(3), 179-184.  
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Figure 4.1: structure of caffeine/theophylline-biotin conjugates. 
 
We have also considered a set of amino-modified xanthines 10, 11, 13, 15 (Scheme 4.3): 
 
NH2
n
n =10 (10, 11)
   =4 (13, 15)
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  = CH3 (11, 15)
 
Scheme 4.3 
 
This different linker is shorter than the other in the biotin derivatives and its amino terminal 
allows both non covalent immobilization to several commercially available dedicated matrics such 
as Amino-Nunc ©123, and immobilization by acetylation to carboxy-functionalized surfaces or 
carrier proteins. 
Finally we have also planned a set of modified xanthines bearing a polar and charged linker 20 
(Scheme 4.4) in order to introduce a high degree of polarity diversity among the available linkers. 
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Scheme 4.4 
 
 
                                                 
123 Robin K., Benisty H. Biosens. Bioelect., 2009, 24(6), 1585-1591. 
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4.1.1 The synthesis of caffeine/theophylline-biotin conjugates (8, 9). 
When synthesizing a modified version of the target molecule, one could start from the original 
structure and introduce a bond to the linker by direct modification. However, in our case this is 
not easy, due to the scarce reactivity of xanthines at position 8. We have thus decided to 
synthesize de novo a xanthine scaffold with a built-in linker at position 8. 
The first synthesis steps for theophylline and caffeine modification are thus outlined in Scheme 
4.5: 
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Scheme 4.5 
a)NaOH/DMF/75°C; b)SOCl2/MeOH/reflux; c)CH3I/NaH/THF; d)LiOH/H2O-THF 
 
The synthesis started from 4,5-diamino-1,3-dimethyl-uracil hydrate that was reacted with glutaric 
anhydride under basic conditions;124 in this step glutaric anhydride undergoes a condensation with 
one of the uracyl amino groups, in the second step sodium hydroxide solution was added in 
order to allow the cyclization and theophylline-8-butanoic acid 1 was obtained in 50% yield. 
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Scheme 4.5b 
 
The caffeine derivative was obtained from this theophylline derivative by methylation. The acid 1 
was first protected as methyl ester using thionyl chloride in methanol to give compound 2 in 
excelent 98% yield. Alkylation of the xanthine nitrogen at position 9 was carried on under 
anhydrous conditions with methyl iodide and sodium hydride as base in tetrahydrofuran; 
compound 3 was obtained in 70% yield. Finally, caffeine-8-butanoic acid 4 was obtained from 
                                                 
124 Kim H., Ji X., Melman N., Olah M., Jacobson A. J. Med. Chem., 1994, 37, 3373-3382. 
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ester 3 by base hydrolysis of the methyl ester moiety with litium hydoxide acqueuos solution 
using a mixture of water/THF=50/50 as solvent (65% yield). 
At the same time, the synthesis of a biotin-cadaverine derivative was carried out (Scheme 
4.6): 
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Scheme 4.6 
a)Boc2O/DCM/0°C; b)Biotin/HOBT/NMM/EDC-Cl/CH3CN; c)TFA/DCM 
 
1,5-diaminopropane (cadaverine) was monoprotected at one of its two amino groups as t-
butoxycarbonyl carbamate (Boc) using Boc anhydride and dichloromethane as solvent at 0°C; 
compound 5 was obtained in 45% yield and then used directly for the synthesis of amide 6. The 
reaction of  monoprotected cadaverine with biotin under anhydrous conditions using 1-
hydroxybenzotriazole (HOBT) to optimize the condensation, N-methylmorpholine (NMM) as 
base and ethyl-carbodiimide (EDC-Cl) as activator, gave compound 6 in 64% yield. Removal of 
Boc-protection with 50% trifluoroacetic acid (TFA)/DCM gave the final product 7 in 98% yield. 
 Compound 7 was finally reacted with theophylline-8-butanoic acid (1) or caffeine-8-
butanoic acid (4) under the same conditions previously described for the coupling of 
monoprotected cadaverine with biotin. Final conjugates 8 and 9 were obtained in 54% and 65% 
yields respectively.   (Scheme 4.7): 
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Scheme 4.7 
a) 1/HOBT/NMM/EDC-Cl/DMF; b) 4/HOBT/NMM/EDC-Cl/DMF 
 
4.1.2 The synthesis of  caffeine/theophylline amino derivatives 10, 11, 13, 15 
Another important modification for caffeine and thephylline was obtained with the introduction 
of a free amino group at the end of linker. The linker is shorter than that used in the biotin 
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conjugates and this should allow a reduction of linker-binding false positives occurrence by 
sequential multiple selection rounds. The longer amino linker of compounds 10 and 11 (Figure 
4.2) was simply obtained from the coupling of 1 and 4 with monoprotected cadaverine 5 under 
the same conditions previous described, with HOBT, NMM and EDC-Cl. Removal of Boc 
protection from the free amino group gave the final products with excellent total yields (80%) 
(Figure 4.2). 
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Figure 4.2 
 
 
Beside these conjugates, the shorter structures 13 and 15 have been synthesized (Scheme 4.8): 
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Scheme 4.8 
a)NaOH/DMF/75°C; b)(PhO)2PON3/NEt3/benzyl alcohol/toluene; c)Pd(C)/H2/MeOH 
 
This synthesis starts also from theophylline-8-butanoic acid (1) but afetr having obtained the 
xanthine system, in the second step Curtius rearrangement125 was used in order to convert the 
carboxy group into an amino group, protected as benzyloxycarbonyl carbamates (Cbz). 
Theophylline-8-butanoic acid was thus dissolved in dry toluene and under anhydrous conditions 
and diphenylphosphoryl azide was added. When the solution was heated, the acid was quickly 
converted in to an acyl azide intermediate, that rearranges to isocyanate giving finally, in the 
presence of benzyl alcohol, the Cbz-protected amine (Scheme 4.9): 
 
                                                 
125 a)Curtius T.H. Chem. Ber., 1890, 23, 3023. b)Ma B., Lee W.C. Tetrahedron, 2010, 51(2), 385-386.   
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Scheme 4.9: Curtius rearrangement mechanism 
 
The N-Cbz protected derivative 13 was thus obtained from theophylline 8-butanoic acid in 56% 
yield. 
In a similar way the amino linker caffeine derivative 15 was synthesized starting from caffeine-8-
butanoic acid 4 (Scheme 4.10): 
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Scheme 4.10  
 
4.1.3 Synthesis of polar-linker xanthines 
In order to increase the polarity of linker, a new family of conjugates was generated in which a 
central amino group was introduced; Depending on the environmental pH, such a derivative can 
be used during the library selection either as a cationic molecule or as a hydrogen-bond acceptor 
highly polar selection tool. As in the previous modification, at the end of linker a free amino 
group was introduced to allow binding with suitable groups on the solid surface used for the 
immobilization (Scheme 4.11): 
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Scheme 4.11 
a) Compound 5/HOBT/NMM/EDC-Cl/CH3CN; b)BH3-DMS/THF; c)TFA/CH2Cl2; d) Compound 
1/HOBT/NMM/EDC-Cl/CH3CN; e)Pd(C)/H2/MeOH  
 
  
γ-aminobutyric acid was protected as Cbz at the free amino group (15) and it was reacted with 
compound 5 in the normal conditions for the aminoacids coupling using acetonitrile as solvent to 
give the corresponding amide 16. Compound 16 was reducted with BH3-DMS in THF as solvent; 
in these conditions the reduction takes place only on the amide carbonyl group and not on the 
Boc or Cbz carbonyl group126. Removing Boc protection with TFA in dichloromethane the free 
amino molecule 18 was obtained and after reaction with theophylline-8-butanoic acid (1) and 
removing of the Cbz protection, final conjugate 20 could be used directly for the immobilization 
(66%). 
 
4.1.4 Xanthine-protein conjugates. 
The target molecules caffeine and theophylline have also been labeled with two proteins: 
Horseradish peroxidase (HRP) and Albumin from chicken egg white (OVA). These conjugates 
have been synthesized only as reagents for the ELISA tests and not for the immobilization of 
organic molecules on solid surface, as the previous cases. 
Enzyme-linked immunosorbent assay, also called ELISA, is a biochemical technique used mainly 
in immunology to detect the presence of an antibody or an antigen in a sample. The ELISA has 
been used as a diagnostic tool in medicine as well as quality control check in various industries. In 
simple terms, in ELISA an unknown amount of antigen or other molecules are affixed to a 
surface, and the a specific receptor is incubated over to the surface so that it can bind to the 
analyte. The receptor is linked to an enzyme, and in the final step a substrate is added that the 
enzyme can convert to give some detectable signal.  
                                                 
126 Felluga F., Gombac V., Pitacco G., Valentin E. Tetrahedron: Asymmetry, 2004, 15, 3323-3327. 
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In many cases the enzyme used as label is the Horseradish Peroxidase (HRP) that can react with 
an appropriate substrate namely 3,3’,5,5’-tetramethylbenzidine (TMB) causing a change in color, 
which is used as a signal. 
Horseradish peroxidase is a 44 kDa glycoprotein with four lysine residue suitable for conjugation 
to a labelled molecules. It produces a colour, fluorimetric or luminescent derivative of the 
labelled molecule allowing it to be detected and quantified. 
HRP is a oxidoreductase that transfers hydrogen from donator molecule to hydrogen peroxide. 
In ELISA test in acid conditions, TMB was oxidazed from HRP to obtain a final blu radical 
compound that can be converted in a yellow compound (λmax=450 nm) with high absorbance, by 
pH decreasing127 (Scheme 4.12):  
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Scheme 4.12 
 
Albumin from chicken egg white (OVA) makes up 75% of the total protein in egg whites. The 
protein contains 20 lysine residues and 14 aspartic acid and 33 glutamic acid groups. This gives a 
total of 20 ε-amines, 1 N-terminal amine, 47 side-chain carboxylates, and 1 C-terminal 
carboxylate for conjugation reactions. The majority of acid groups gives the protein a pI of 4.63. 
OVA is sensitive to temperature (above 56°C), electric fields and vigorous mixing. Care should 
be taken in handling the protein to prevent denaturation and subsequent precipitation.  
The conjugation of theophylline and caffeine to HRP and OVA was carried out starting from 
free acids 1 and 4 which were used to acylate the primary amino groups of lysines present on the 
protein (Scheme 4.13):  
                                                 
127 Tijssen P. Pratice and Theory of Enzyme Immunoassay, 1988, cap. 12, Elsevier Amsterdam. 
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Scheme 4.13 
a) Compound 1/EDC-Cl/MES(pH=4.5)-DMSO/MES(pH=4.5)-DMF; b) Compound 4/EDC-Cl/MES(pH=4.5)-
DMSO/MES(pH=4.5)-DMF 
 
 
Both the conjugates were purified by dialysis against phosphate buffer for HRP conjugates or 
water for OVA, and the degree of protein modification was estimated by UV spectroscopy. 
The modification index for the two conjugates was calculated in a spectrophotometrical way at 
λ=401.4 nm for HRP; λ=283.2 for OVA and λ=275.4 for the two xanthines.  
By this way it was possible to estimate the concentration of protein and hapten in solution after 
dyalisis according to the Lambert-Beer law (Scheme 4.14): 
 
1)HRP-theophylline conjugate: [HRP]f=2.27 μM; [theophylline]f=26.2 μM 
IM=11 
2)HRP-caffeine: [HRP]f=6.72 μM; [caffeine]f=228 μM 
IM=33 
3)OVA-thephylline : [OVA]f=19.5 μM; [theophylline]=916.3 μM 
IM=47 
Scheme 4.14 
 
Assuming that after dialysis all the hapten presence is bound to the protein, and the ratio 
[hapten]/[protein] represent the modification index (IM) for the two conjugates, as the number 
of molecules of hapten bound per molecule of protein. 
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4.2 A menthone-biotin conjugate 
Caffeine and theophylline are closely similar aromatic molecules, and the only difference is given 
by the nitrogen at 7 position that is methylated in caffeine and is not methylated in the 
theophylline. 
Beside these xanthines, another small organic molecule, menthone, has been chosen with 
different characteristics in order to evaluate the selectivity of the anti-xanthine selected peptides. 
Menthone is a small non aromatic terpene and it has two stereocenter (Figure 4.3).  
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23  
Figure 4.3 
 
Biotinylation of menthone is necessary in order to immobilize this molecule on solid surface; 
thus a the menthone-biotin conjugate 26 was synthesized, within a similar frame to the 
theophyline and caffeine-biotin conjugates (Figure 4.4): 
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Figure 4.4: the structure of menthone-biotin conjugate 
   
The synthesis of this conjugate are reported in Scheme 4.15: 
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Scheme 4.15 
a)Et2AlCN/(CH3)COHCN/toluene; b)H2SO4:H2O=1:1; c) compound 7/HOBT/NMM/EDC-Cl/DMF 
 
The synthesis starts from (+)-pulegone that was converted in to cyanoketone 24 by the addition 
of diethylaluminium cyanide in presence of acetone cyanohydrin with toluene as solvent.128  
The cyanoketone was obtained as a 3:1 mixture od diasteroisomers, since protonation of the 
addition intermediate (scheme 1.16) by acetone cyanohydrin is some what diastereo selective due 
to the stereocontrol by the stereocenter in position 1 of pulegone: 
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In our case we heve obtained the ratio sin/anti = 3/1. For the further steps we have not separated 
the two diasteroisomers because ti was not an objective of our purposes. 
Product 24 was oxidized in acqueous sulphuric acid to give the free acid 25 (75%) that was 
converted into the final conjugate 26 by the coupling with compound 7 in the standard 
conditions for coupling of amino acids in 66% yield.  
 
 
 
 
                                                 
128 Benedetti F., Berti F., Norbedo S. Tetrahedron Lett., 1999, 40, 1041-1044. 
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4.3 Palytoxin 
Beside theophylline and caffeine, the other target molecules studied and considered for chemical 
modifications is palyotxin, an extremely complex organic molecule. 
Along its backbone are found 40 secondary hydroxy groups, two diene motifs, a conjugate 
acrilamide-enamide system, three unsaturations, two hydrophobic hydrocarbon chains, cyclic 
ether system byciclic acetal, and a primary amino group at the end of carbon sequence (Figure 
4.5): 
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Figure 4.5: palytoxin structure with examples of secondary hydroxy groups (red); diene motifs (blu); free amino 
group (green). 
 
 
The primary amino group is essential for both the conformation adopted by the molecule in 
solution and for its toxicity. 
Very recent X-ray scattering and NMR studies suggest that palytoxin exists as a dimer in aqueous 
environment, while acetylation of the amino group leads to a monomeric structure in 
solution.129Although most of the dimerization interface is hydrophobic and made by the diene 
and hydrocarbon regions, protonation of the amino group is essential to shift the equilibrium 
towards the dimer. 
As the amino group is likely to be essential, we have decided on one side to attempt the synthesis 
of a fragment of palytoxin containing this region towards this “epitope”. On the other side, on 
carrying out bioconjugations of palytoxin, the use of this amino group for conjugations, is almost 
mandatory. 
                                                 
129 Inuzuka T., Uemura D., Arimoto H. Tetrahedron, 2008, 64(33), 7718-7723. 
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As to the synthesis of a small fragment of palytoxin, we have considered the C101-C115 fragment 
where the most reactive primary amino group is present (Figure 4.6): 
 
O
H2N OH
O
O
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C101C115
 
Figure 4.6 
 
 
4.3.1 Retrosynthetic analysis for the C101-C115 synthesis. 
Fragment C101-C115 can be considered as the union of other two smaller fragment: one is given by 
C110-C115 fragment and one is C101-C109 fragment as reported in the retrosynthesis scheme (Scheme 
4.17): 
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Scheme 4.17: retrosynthetis of C101-C115 fragment 
 
where the C109-C110 carbon bond is obtained by a Wittig reaction between the aldheyde 29 and the 
triphenyl phosphonium ylide 28, followed by hydrogen reduction of double bond. 
The ylide 28 is easily obtained from the primary alcohol 30 by a nuchleophylic substitution and 
the other partner aldehyde 29, is obtained by oxidation of protected alcohol 31. 
Synthesis of compounds 30 and 31 has been perfomed by Kishi130 during his total synthesis of 
palytoxin. We have followed the approach proposed by Kishi for the synthesis of 30  as reported 
in Scheme 4.18a: 
  
                                                 
130 Kishi Y., Leder J., Fujioka H. Tetrahedron Lett., 1983, 24(14), 1463-1466. 
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Scheme 4.18a 
a)EtSH/ZnCl2/HCl; b)I2/acetone; c)tert-BuOK/THF:DMSO=3:1; d)LiAlH4/THF. 
 
D-xylose was protected at the aldehyde group as tioether by treatment with ethanethiol (EtSH), 
zinc chloride (ZnCl2) and cloridric acid to give the corresponding ethyl mercaptane 32 with good 
70% yield. Protection of hydoxy groups was carried on with I2 and acetone in order to obtain the 
diacetonide 33 that was converted into the unsaturated compound 34 by  potassium tert-butoxide 
(tert-BuOK) in THF/DMSO as solvent via acetone elimination. 
Reduction of double bond with LiAlH4 in anhydrous conditions gave the product 34 that can be 
converted in further five steps into the final product in about 60% overall yield from compound 
34. 
The synthetic approach for the fragment 31 is described in the Scheme 4.18b and 4.18c: 
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Scheme 4.18b 
a)P(Ph)3/toluene; b)NaOH/water; c)compound38/THF/80°C; d)(Ph)2Si(t-Bu)Cl/DIMAP/pyridine/DCM/0°C; 
e)tert-BuOK (0.3 eq.; 1 M in tert-BuOH)/toluene/50°C 
 
Methyl-4-bromocrotonate was converted into the phosphonium bromide 37 by treatment with 
triphenylphosphine (P(Ph)3) in toluene, and then ylide 38 was obtained directly from 37 by base 
treatment with sodium hydoxide in water solution. Ylide 38 was reacted with 2-deoxy-D-ribose in 
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a Wittig reaction, to obtain the diene ester 39 that was protected selectively at the primary 
hydroxyl group as tert-butyldiphenylsilil ether (40). 
Compoud 40 was then treated with potassium tert-butoxide under carefully controlled conditions 
to give the desired bicyclic ester 41 in addition to a mixture of four monocyclic esters 42a,b and 
43a,b (Figure 4.7): 
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Figure 4.7: equilibrium of the four monocyclic ester 
 
An equilibrium between species 41, 42 and 43 was established via the precursor diene ester 40, 
and the composition of the equilibrium mixture depends on the base and solvent used; the best 
conditions were found to be 0.3 equivalents of tert-BuOK in a mixture of tert-BuOH and toluene. 
We have followed the same synthetic way described by Kishi, and we have obtained compound 
41 in an overall 21% yield from D-xylose. In order to accumulate enough material to reach the 
end of the synthesis, we have repeated the whole preparation of 41 seven times, thus 
accumulating 2.3 g of this compound. The synthetic work is still in progress, and further steps 
(Scheme 4.18c): 
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Scheme 4.18c: a)DIBAL-H/DCM/-78°C; b)(CH2OH)2/p-TSA/toluene(reflux); c)(COCl)2/DMSO/Net3/DCM. 
 
The reduction of 41 with diisobutyl alluminiumhydride (DIBAL-H) in order to obtain the 
aldehyde 42 that will be protected as cyclic acetals 43 using ethylene glycol, p-toluensulfonic acid 
and toluene as solvent. 
Final Swern oxidation allows to obtain fragment 31. 
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4.3.2 Bioconjugation of palytoxin. 
The conjugation of palytoxin to proteins as KLH, BSA, OVA, HRP was performed in order to 
use the bioconjuagtes as immunogens or as coating antigens for immunoassay development, or as 
an enzyme marker for competition ELISA. All the bioconjugations were carried out by modifyng 
palytoxin at its amino terminal. Proteins were binded via a maleimido-linker that was bound to 
palytoxin by acylation (Scheme 4.19): 
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Scheme 4.19: palytoxin modification 
 
Treatment of palytoxin with commercially available bifunctional linker succinimidyl-4-(N-
maleimidomethyl)-cyclo-hexane-1-carboxylate (SMCC) yielded the corresponding amide 
derivative 44 (PTX-MCC). The reaction was carried out in DMF/buffer phosphate on a 1 mg 
scale and the modified palytoxin 44 was not purified. 
At the same time, a modification of the lysine primary amino groups of proteins was necessary in 
order to convert them into thiol groups. Three different proteins and one enzyme have been 
thiolated using 2-iminothiolane (2-IMT); the three proteins were albumin from bovine serum 
(BSA), keyhole limpet hemocyanin (KLH) and albumin from chicken egg white (OVA); the 
enzyme was horseradish peroxidase (HRP). BSA, OVA and KLH are proteins frequently used 
for immunization treatment as carrier for differents aptens; HRP is typical enzyme used in 
immunoassay (Scheme 4.20): 
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44a: BSA-SH
44b: KLH-SH
44c: OVA-SH
44d: HRP-SH  
Scheme 4.20: protein modification 
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The reactions were carried out in borate buffer (pH=9.0) and the modified proteins was not 
purified. 
PTX-MCC 42 can react with protein thiol residues to form thioether bond to give final thioether 
conjugates (Scheme 4.21): 
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Scheme 4.21 
 
The resulting cojugates were purified by dialysis against buffer phosphate. UV spectroscopy was 
used as previously described for the caffeine/theophylline conjugates to obtain the modification 
index of the BSA and KLH conjugates. These conjugates are infact used to immunize animals, 
and thus in function is necessary in order to evaluate the amount of conjugate to be administred 
(Table 4.1): 
 
Conjugate n PTX / n protein
PTX-BSA 34
PTX-KLH 133
Table 4.1 
 
The value n PTX /n protein is the index of modification (IM) and represents the number of PTX 
molecules bound at one molecole of protein. 
The IM value is high in both the PTX-BSA and KLH-PTX and the conjugates can be used for 
the immunization runs.  
 
4.3.3 Biotinylation of palytoxin. 
An other important modification of palytoxin was introduced by biotinylation of its amino 
terminal; palytoxin-biotin conjugate can be used for the immobilization of toxin on a solid system 
exploiting streptavidin 
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Likewise the other palytoxin modification, synthesis of palytoxin-biotin involves a modification 
on the primary amino group of toxin (Scheme 4.22): 
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Scheme 4.22: palytoxin biotinilation 
 
Reaction was carried out on a 1 mg scale directly between palytoxin and commercial biotin N-
hydroxysuccinimide ester using water as solvent. The product  was well characterized by mass 
spectroscpoy and the mass spectrum is reported in Figure 4.8: 
 
Figure 4.8 
 
As this spectrum clearly shows the presence of [M+Na]+ molar ion of byotinilated-palytoxin plus 
Na+ and there are no other products. The conjugate has been used without further purification. 
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Chapter 5 : The E/K coiled-coil peptide 
 
Coiled-coils have been used in numerous applications, including affinity purification, direct 
assembly of extracellular receptor domains, creation of miniaturized antibodies, microarray and 
peptide libraries.131 The small size and defined structure of the coiled-coil make it an extremely 
used motif for a growing number of de novo design, protein engineering and biotechnological 
application. 
 
5.1 The E/K structure 
Based on typical coiled-coil features described in the “chapter 1”, in 1998 Hodges et al. 
characterized the E/K coiled-coil, a de novo designed heterodimeric parallel coiled-coil domain, 
for biosensor-based affinity and chromatographic applications.132 They analyzed the structure of 
several natural coiled-coils, and some requirements were established to permit the correct folding 
of the new protein (see Figure 2.1) 
1-  to select amino acids that are non-destructive for the helical structure; 
2- the placement of non-polar residues at a and d positions for tighten packing in the 
hydrophobic core;133 
3- to chose appropriately polar or charged residues at e and g positions that will promote the helix 
associations in a heterodimeric form;134 
4- the inclusion of polar or charged residues at position f, to permit the protein solubilization in 
aqueous solution;135 
5- the polar or charged residue at position f must be opposite charge respect to aminoacids in e 
and g position, in order to balance the total charge on individual α-helix; 
6- to select an optimal lenght of α-helix to permit the protein production with synthetic means, 
and to avoid alteration of structure or stability of the coiled-coil; 
7- balance between stability of hydrophobic core that permit heterodimer folding and 
electrostatic repulsion that prevent the assembly of homodimers.136 
                                                 
131a)Mc Farlane A. A., Orriss G., Stetefeld J. Eur. J. Pharmac., 2009, 625, 101-107. b)Lupas, A. Trends Biochem. Sci., 1996, 21, 375-
382. 
132 Chao H., Bautista D. L., Litowky J., Irvin T. R., Hodges R. S. J. Chromatogr B. Biomed. Sci. Appl., 1996, 715(1), 307-329. 
133a)O’Shea E.K., Albert T., Kim P.S. Science, 1991, 254, 539. b)Woofson D.V., Alber T. Protein Sci., 1996, 4, 1596. c)Hodges R.S., 
Zhu B.Y., Zhou C.M. J. Biol. Chem., 1984, 259, 13253. d)Hodges R.S., Sodek J., Smillie L.B., Jurasek L. Proc. Natl. Acad. Sci USA, 
1972, 69, 3800. 
134a)Hodges R.S., Kohn W.D., Kay C.M. J. Mol. Biol., 1997, 267, 1039. b)Hodges R.S., Kay C.M., Zhou N.E. Protein Eng., 1994, 7, 
13655. c)Krylov D., Mikhailenko I. EMBO J., 1994, 13, 2849. d)Lumb K.J., Kim P.S. Science, 1995, 268, 436. 
135 Lyu P.C., Gans P.J., Kallenback N.R. J. Mol. Biol., 1992, 223, 343-351. 
136 Lavigne P., Kondejewski L.H., Houston M.E., Sonnichsen F.D., Lix B., Sykes B.D., Hodges R.S. Kay C.M. J. Mol. Biol., 1995, 
254, 505-517. 
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Based on the statements given above, the E/K coiled-coil developed by Hodges et al. results in 
the couple of sequences reported in Figure 5.1: 
 
 
Figure 5.1: helical wheel representation of E/K coiled-coil system viewed from N-terminus. 
 
The E/K coiled-coil is made of two distinct chains namely the E and K peptides. Each peptide is 
composed by five repeats of a single heptad ; in the E peptide, the heptad sequence is E-V-S-A-
L-E-K (g-a-b-c-d-e-f) and in the K peptide the sequence is K-V-S-A-L-K-E (g-a-b-c-d-e-f).  
The hydrophobic core is made by valine in a position and leucine in d position; these 
aminoacids are common in the natural and synthetic coiled-coils. Valine is often replaced by  
isoleucine in order to generate a leucine-isoleucine core but the choice of Hodges et al. tends to 
favour the dimeric parallel association.137 
Complementary lysine and glutamate residues at e and g position were placed in order to 
favour electrostatic interchain attractions; these aminoacids are also frequently present in natural 
coiled-coil motifs. In addition, at neutral pH values, the repulsive interactions between the 
charged side-chains prevent formation of homodimeric E/E and K/K coiled-coils, allowing the 
formation of E/K heterodimeric coiled-coil.138 
The c position was assigned to alanine, because of its particular ability to stabilize helical 
structure; serine in b position increases coiled-coil solubility in a polar solvent and glutamate on 
the K-peptide and lysine on the E-peptide in the f  positions were used to balance the total charge 
of coiled-coil. 
                                                 
137 Harbury P.B., Zhang T., Kim P.S. Alber T. Science, 1993, 262, 1401-1403. 
138 a)Kohn W.D., Kay C.M., Hodges R.S. Protein Sci., 1995, 4, 237. b)Yu Y., Monera O.D., Hodges R.S., Privalov P.L. Biophys 
Chem., 1996, 59, 299. 
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E and K associate in a heterodimeric protein of 70 aminoacids with a molecular weight of 7682 
Da. Each peptide is amidated and acetylated in order to increase the helix formation and to 
reduce the likelihood of proteolysis. 
 
5.1.1 Physical characterization of the E/K coiled-coil 
The EK peptide prefers to form a heterodimeric coiled-coil at moderate protein 
concentrations.139 The CD spectra of E- or K-peptides alone shown a largely random coil 
character; in contrast, a solution containing both peptides displays a CD profile that is 
characteristic of a helical structure, with spectral minima near 208 and 222 nm 132 (Figure 5.2). 
The ratio of molar ellipticities at 222 nm ([θ]222) over 208 nm ([θ]208) is 1.07, a typical value for 
coiled coils, indicating the presence of interacting helices in a coiled-coil conformation (a ratio of 
0.85-0.95 is conversely expected for single α-helices).140  
 
Figure 5.2: CD spectra of the E peptide (▼), K peptide (●) and the E/K coiled-coil (■) recorded at 20°C. 
taken from reference 10. 
 
The stability of E/K coiled-coil was also studied by both chemical and temperature denaturation 
experiments as monitored by CD spectroscopy.132 The E/K coiled coil is resistant to heat 
denaturation up to 85°C or urea denaturation. Guanidinium HCl (GdnHCl) was the only agent 
which could denaturate the E/K coiled-coil completely 132 (Figure 5.3): 
 
                                                 
139 Chao H., Houston Jr., Grothe S., Kay C.M., Irvin R.J., Hodges R.S. Biochemistry, 1996, 35, 12175.  
140 Litowski J., Hodges R. S. J. Chem. Biol., 2002, 277(40), 37272-37279. 
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Figure 5.3: Urea (○), GdnHCl (●), heat denaturation (▲) of the E/K coiled-coil taken from refernce 10 . 
 
This high association strenght is highlighted by the dissociation constant for this dimer that is 63 
pM.141  
High stability and affinity of dimerizzation make E and K peptides as good candidates for 
biosensor applications in which the biorecognition element must demonstrate capacity of binding 
with analyte and particular resistance to enviromental stress. 
 
5.2 The C-EKinv.-C scaffold, a first library project 
Starting from the E/K coiled-coil, the aim of this part of the project was to generate libraries of 
modified E and K peptides with the following features: 
1- ability to bind our small target molecules caffeine and theophylline; 
2- short lenght, in order to allow both chemical synthesis and biological expression; 
3- good stability, under different pH or temperature conditions; 
4- small size of the binding site, constituted by a small number of aminoacids to allow rational 
affinity improvement after a first selection round. 
As a first version of an E/K-based artificial receptor, we have chosen to adopt a scaffold 
design that could in principle allow a maximun stability due to a cirular structure. In order to 
acheive this kind of stability we have introducted a flexible linker that joins E and K peptide 
chains, consisting of eight aminoacids: a threonine and seven glycine that assure high flexibility 
and low steric hindrance. This kind of Thr/Gly linker is commonly used in molecular biology 
technique in order to build up proteins constructs arising from the fusion of different domains.142 
                                                 
141 De Crescenzo G., Litowski J.R., Hodges R.S. O’Connor-Mc Court M.D. Biochemistry, 2003, 42(6), 1754-1763. 
142 Zoldak G., Aumuller T., Lucke C., Hritz J., Schmid F.X. Biochemistry, 2009, 48(43), 10423-10426. 
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Reverting the K sequence (Kinv.) in order to keep the E/K, we have planned coiled-coil 
association even if the coil is shifted from a parallel to antiparallel orientation. 
Finally, we have planned the introduction of two cysteines as amino and carboxy terminals in the 
hope of generating a intramolecule disulfide bond.  
As to the α-helical domains, both the two α-helices were constitued by a repeat five times of a 
single heptad; in the E domain the heptad sequence is the same of the original coiled-coil: E-V-S-
A-L-E-K (positions g-a-b-c-d-e-f); in the Kinv. domain the new sequence is E-K-L-A-S-V-K 
(positions: f’-e’-d’-c’-b’-a’-g’). The new scaffold was thus dubbed C-EKinv.-C (Figure 5.4-5.5): 
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Figure 5.5: helical wheel representation and linear structure of EKinv. peptide 
 
With the flexible linker connecting the helical domains, and the disulfide bond at the terminal, 
the scaffold C-EKinv.-C can in principle adopt a circular closed tertiary structure (Figure 5.6): 
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Figure 5.6: EKinv. scaffold closed in double way. Flexible linker was curved in order to make a loop for E and Kinv. 
chains assembly. Disulfide bond blocks final structure.  
 
 
5.2.1 Preliminary study on the EKinv. folding 
Having thus designed the overall structure of C-EKinv.-C, we have started several preliminary 
studies aimed at determining its conformation in water. 
A theoretical model of the coiled-coil was built first by homology modeling. The NMR structure 
of the C-Jun homodimer, one of the few available in the Protein Data Bank (Pdb id: 1JUN) was 
chosen as the starting topology.143 
The C-Jun homodimer is a six heptad parallel homodimeric coiled-coil consisting of a non 
repeating sequence (Table 5.1-entry 1): 
 
1. C-Jun G R I A R L E E K V K T L K A Q N S E L A S T A N M L R E Q V A Q L K Q K V M N Y
2. Mut1  R V A R L E E K V K T L K A Q V S E L A S T V N M L R E Q V A Q L K Q      
3. Mut2  E V A R L E K E V K T L E K E V S E L E K E V N M L E K E V A Q L E K      
  K V A R L K E K V K T L K E K V S E L K E K V N M L K E K V A Q L K E      
4. E/K  E V S A L E K E V S A L E K E V S A L E K E V S A L E K E V S A L E K      
  K V S A L K E K V S A L K E K V S A L K E K V S A L K E K V S A L K E      
Table 5.1 
The initial C-Ju homodimeric structure was relaxed first into a periodic box of TIP water 
molecules by a 100 ns molecular dynamics run in the NTV ensemble, carried out with the 
AMBER force field as implented in Sybyl 8.2 in iTS cornell version.144 The relaxed structure was 
then gradually mutated to that of the E/K parallel heterodimer, by first replacing all the residues 
at position a and d with valine and leucine respectively, in both the chains (Table 5.1, entry 2, 
mut1). The charged residues at positions g, e, f, where then mutated into E, K, E in one chain and 
into K, E, K in the other, as in the E/K heterodimer (Table 5.1, entry 3, mut2). Finally, also 
                                                 
143 Jomins F.K., O’Donoghe S.I., Nilges M., Weiss A.S., King G.F. J.Biol.Chem., 1996, 271, 13663-13667. 
144 Cornell W.D., Gelpack P., Bayly C.I., Gould I.R., Merz K.M.S., Ferguson D.M., Sjellmeyer D.C., Fox T., Caldwell J.W. 
Kollman P.A. J. Am. Chem. Soc., 1995, 117, 5179. 
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positions b and c were mutated to S and A in both the chains, giving by this way a model of the 
E/K heterodimer. Full MD relaxation was allowed at each stage, to verify the stability of the 
mutated models. The final model adopts the typical superhelical conformation of a coiled-coil  
 
Figure 5.6 
  
Further mutation to the E/Kinv. model required a more complex approach, and the K chains was 
temporarily broken at each heptad end, and each heptade was separately inverted and relaxed. 
Finally, the heptades were joined again and the whole model was submitted to 300 ns MD run. 
The resulting antiparallel dimer (Figure 5.6) resulted stable and no unfolding or separation of the 
two chains were detected during this very long molecular dynamics symulation. 
 The number of hydrophobic contacts at the coil interface is conserved, and also the buried 
hydrophobic surface is similar in the E/K and in the antiparallel EKinv. models (Table 5.2). 
 
 EK EKinv. 
Buried hydrofobic surface (Ǻ2) 1290 1253 
Hydrofobic contacts 30 28 
Table 5.2 
 
Starting from this favourable theoretical prediction, we have synthesized the E3Kinv.3 peptide on a 
10 mg scale, as a reduced model of the full C-EKinv.-C scaffold (Figure 5.7). 
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Figure 5.7: linear structure of EKinv. synthesized 
 
Due to its synthetic cost, E3Kinv.3 is shorter than the full scaffold and the absence of final cysteine 
can influence the real peptide behaviour; however, it can mimic with a certain reliability the 
behaviour of EKinv and a preliminary study of its folding has been carried out. 
The folding of previous peptide was studied by CD spectroscopy. 
Circular dichroism (CD) is one of the most used technique to investigate secondary structure of 
proteins or peptides, as CD spectra can be readily used to estimate the fraction of α-helix, β-
sheet or random-coil conformation. 
Protein or peptide secondary structure can be determined by CD spectroscopy in the far-UV 
spectral region (190-250 nm), where the chromophore is the peptide bond and the CD signal 
arises when the bord interest with the chiral enviroment of the folded peptide. The lowest energy 
transition in the peptide chromophore is an n→π* transition observed at 210-220 nm, and the 
highest energy process is the π→π* transition that gives rise to a band at 120 nm. The ellipticity 
associated to such transition depends on the local conformation of the peptide chain and α-
helices, β-sheets and random-coils each gives rise to a characteristic shape and magnitude CD 
spectrum145 (Figure 5.8). 
                                                 
145 Kelly S.M., Jess T.J., Price N.C. Biochim. Biophys. Acta, 2005, 1751, 119-139. 
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Figure 5.8: CD spectra of various types of secondary structures. Solid line, α-helix; long dashed line, antiparallel β-sheet; dotted 
line, type I β-turn; cross dashed line, extended 31-helix or poly(Pro) II helix; short-dashed line, irregular structure. 
Data taken from ref. 145 . 
 
The circular dichroism spectrum of a freshly prepared 5 μM peptide solution in water is shown in 
Figure 5.9: 
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Figure 5.9 
 
In our case the previous spectrum is typical for a random-coil conformation due to the presence 
of a minimum  202 nm, and to the lack of Cotton effect inversion along the whole spectral 
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range.146 A fraction of folded peptide can be responsible for the shoulder around 220 nm spectra. 
A new spectrum was registered after four days (Figure 5.10): 
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Figure 5.10 
 
Major changes are observed after this time, and now the spectrum is typical for a folded 
structure. 
The α-helix content of this structure has been calculated according to the empirical equation 
2.1147 
 
fα=([θ]222-[θ]R)/([θ]α-[θ]R) eq.5.1 
 
which is commonly used for short peptides, where fα is the fractional α-helix content, [θ]R is the 
ellipticity at 222 nm for a disordered chain and [θ]α is the ellipticity at 222 nm for a 100% α-helix 
n long peptide. [θ]α is obtained from this equation(4.2):146  
 
[θ]α=[θ]∞ (1-k/n) eq. 5.2 
 
where [θ]∞ is the molar ellipticity per residue for a chain of infinite lenght with maximal α-helix 
content and k is an empirically determined factor interpreted as the average number of peptide 
bonds in the chain that cannot participate in α-helix formation. There is general agreement for an 
[θ]∞ value of 40000 deg dmol-1cm2 but the k value remains in dispute. Estimated value of k have 
                                                 
146 Fasman G.D. Circular dichroism and the conformational analysis of biomolecules, New York U.S.A.; Plenum Publishing Corp.  
147 Ahmad B., Ahmed Zulfazal M., Haq S., Hasan Khan R. Biochim. Biophys. Acta, 2005, 1750, 93-102.  
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ranged from 2.5148 to 4.3148, and even up to 6.3149; for our work we have used the commonly value 
of 4146; for the [θ]R value we have used the estimate 0 deg dmol-1cm2. 
A 40% helix content was obtained from eq. 2.1 for our case. This value is not in agreement with 
the expected α-helical character of E3Kinv.3 if it were correctly folded.  
Conversely, the [θ]222/[θ]208 ratio is consistent with the presence of a single α-helix rather than 
with a coiled-coil, or, more likely, the coiled-coil is too short to induce the superhelical 
deformation to the α-helix which are responsible for the enhandement in 208 nm helipticity that 
is observed in longer coils.140 
The folding process of E3Kinv.3 is apparently extremely slow. This point is perhaps remarkable, 
and would require a more detailed study. Unfortunately, due the small amout of available peptide, 
we were able to obtaining a single very preliminar kinetic run by monitoring at differents times 
the molar ellipticity change at 222 nm (Figure 5.11). The resulting sigmoidal behaviour is 
consistent with a cooperative process with a very long histeresis followed by an autocatalytic 
phase. 
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Figure 5.11: kinetic folding of EKinv. peptide.  
 
Although very unusual, this behaviour is not unprecedented. 
The four-helix bundle Rop, also known as Rom, is a homodimer of two helix-loop-helix 
monomers, each of which is 63 aminoacid long and its folding time after guanidinium 
denaturation, is in the order of days.150 The mistery of Rop folding was addressed by many 
authors, and several theoretical explanations have been proposed. In a recent, general study on 
the molecular basis of coiled-coil formations, Steinnetz, Kammerer and colleagues have 
                                                 
148 Chen Y. H., Chau K.H. Biochemistry, 1974, 13, 3350-3359.  
149 Ozdemir A., Lednev I.K., Asher S.A. Biochemistry, 2002, 41, 1893-1896. 
150 Monson M., O’Beein R., Startevant J.M., Regan L. Protein Sci., 1994, 3, 2015-2022.  
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suggested that , in order to allow a correct folding of a coiled-coil, a trigger sequence must be 
present.151 However, the E/K sequence in the native heterodimer leads to very usual and fast 
folding kinetics152 and the unusual folding of E3Kinv.3 seems rather connected with the presence of 
the loop. The presence of a trapping minimun in the protein energy landscape has been proposed 
for the Rop dimer, and viewed in a series of Rop mutants, as a sin association of the two 
monomer instead of the correct anti topology, or in other cases as a molten globule.153In an 
attempt to generate crystals for an X-ray analysis of E3Kinv.3 structure, we have also submitted the 
peptide to a GPC analysis, that revealed the existence of three fractions, at molecular weight 
corresponding to a monomer, a trimer and an octamer respectively. The octamer appears as the 
predominant fraction. Again, the CD spectrum of a freshly isolated octamer fraction, reveals a 
largely unfolded population and again the CD slowly changes and after 48 hours the folded 
structure is observed, thus supporting the possibility that the octameric form could represent the 
free energy trap that makes slow the folding of E3Kinv.3. 
 
5.2.2 Binding site design 
In order to create a specific binding site for our target molecules, a further modification at the 
EKinv. scaffold was introduced: sequence randomization of a single heptad of both E and Kinv. 
domain could in principle allow to generate a pocket in which random aminoacids can interact 
with our xanthine targets and bind them 
We have chosen to generate the binding site in the central heptads of the C-EKinv.-C: the central 
heptades of E and Kinv. were randomly mutagenized by substituting each residue with any natural 
aminoacid; the remainis heptads were kept unchanged (EWT and Kinv.WT) (Figure 5.12). 
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151 Steinmetz M.O., Selesorov I., Matanjek W.M., Honnappa S., Janka W., Missimer J.H., Frank S., Alexandrescu A., Kammerer 
R.A. PNAS, 2007, 104(17), 7062-7067. 
152 Salwiczek M., Koksch B. ChemBioChem, 2009, 10, 2867-2870. 
153 Leuy Y., Cho S., Shen T., Onuchic J.N. Wolynas P.G. PNAS, 2005, 102(7) 
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Chapter 6: C-EKinv.-C libraries 
 
After having designed the topology of the C-EKinv.-C peptide receptor, we have started the 
development of a library of receptors. 
The libraries were developed by phage-display technique in collaboration with the group of prof. 
Marzari at the Dept. of Life Sciences of our University; using this biomolecular tecnhique a large 
collection of cloned peptides was obtained and selected against immobilized theophylline-botin 
(8) and caffeine-biotin (9) by ELISA-tests in order to identify and characterize the best binders. 
Further characterization of several binders was obtained by sequencing the peptides, by them in 
proper expression system or by expressing. Dot blot experiments, in which peptide receptors 
were immobilized on a nitrocellulose membrane and the binding with target analytes was identify 
using theophylline-HRP (21a) and caffeine-HRP (22a) and the peroxidase catalyzed 
chemiluminescent reactions. 
 
6.1 Phage-library construction. 
Randomized peptide libraries were obtained by phage-display technique. In principle by  
randomizing a the central heptad of both E and K domain, one could obtain 1,63 * 1018 different 
peptides receptors, and of course any available technique while allow to obtain only an extremely 
small fraction of such a chemical space. 
The starting point for library construction is represented by the primer design. In our case the 
randomization of central heptades was obtained separately for E and K peptides, by PCR 
(Polimerase Chain Reaction) using Ewt and Kwt as template (Figure 6.1): 
 
 
Figure 6.1: representation of amplification in PCR strategy. K chain needs of 2 cycling  and E chain 3. In green, randomized 
primers were introduce in the central heptad; in red, common portion in the final product of each chain. 
 
 
 
Primers used for randomization are made by a region for the pairing with Ewt and Kwt and a 
randomized region; in the first PCR reaction, a “random sense” primer and a reverse primer were 
used in order to introduce the random region with the first and to allow the pairing at the last 
non randomized heptad of the chain with the second primer. 
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The random sense primer was introduced in the third heptad of each chain and its random region 
contains the triplet NNK (N=A,T,C,G; K=G,T) in order to generate any aminoacid code and 
increase the variety of random region. 
After having synthesized the two chain separately, the E and K random domain were assembled 
in the common region of the linker which was previously inserted in both the strains, in the 
absence of the external primers. After nine PCR cycles, external primers are added in order to 
allow the amplification of the whole construct, which is 300 bp long. Assembling was obtained 
by a PCR carried out in the presence of a mixture of a 1:1 E and K randomized chains. 
 
For the generation of the random library, a phagemidic vector (pB vector) was used (Figure 
6.2)154. It is composed by 7 different parts: 
1- a plasmidic replication origin (ORI), 
2- a cloning site before phage gene III, 
3- a lacZ promoter for the expression of the construct, 
4- phage gene III which codes for protein 3 on the phage capsid, 
5- the leader sequence for the secretion of scaffold in the periplasmatic region,  
6- the gene for β-lactamase which carries ampicillin resistance to the infected bacteria, 
7- the sequence of C-EKinv.-C. 
   
 
Figure 6.2: schematic representation of pB vector used for library construction. 
 
 
 
                                                 
154 Chang C.Y., Kemp P., Molineux I.J. Virology, 2010, 398(2), 176-186. 
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In the last step of library construction, about 320 ng of the fragment obtained through PCR 
reaction were purified and then cloned in to the purified pB vector using T4 DNA ligase as 
enzyme for the ligation step. 
This final library was composed by 2 * 108 elements and such a numerousity was considered 
satisfactory. 
The library was checked first for the proper length of C-EKinv.-C. 23 clones were randomly 
selected, amplified and composed by agarose electrophoresis run. 18 out of 23 clones were 
expressing a correct length fragment. The library diversity was also evaluated by random selection 
of 16 clones that were sequenced (Table 6.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6.1 
 
Five clones resulted as correctly randomized in E domain, but not in K, while all the other clones 
were randomized in both domains. The presence of non randomized K domains is likely due to a 
contamination from KWT that has been used as template. However, since also peptides 
randomized of the E domain only are in principle capable of generating binding areas for our 
small molecules, we have decided to keep the whole library and to begin selection runs towards 
xanthine. 
 
6.2 Selection of xanthine-binding clones. 
This library was thus selected towards immobilized target molecules caffeine and theophylline. 
The selections were carried out using both the caffeine/theophylline-biotin conjugates (8, 9) and 
the immobilization was obtained using the biotin-streptavidin system. 
clone 
K 
Central heptade 
E 
Central heptade
K E 
1 WT R E K L A S V K V L T W W P L
2 R R L L L G R R S L R N S R Y Y 
3 R R P G G L R R W R A F P S I R 
4 WT R E K L A S V K S F L Y V F W 
6 R R F L T L A R I S W K S Y V Y 
7 WT R E K L A S V K C W Q A C F F
9 R R L L I C L G G A V V W V S E
10 WT R E K L A S V K R S G M K L K
11 R R S L V G G N W Q C G V F V F
12 R R P S S V G F C C V V K M V F
13 WT R E K L A S V K F I L F A L F 
14 R R C F R W M V F D L L G G I I 
15 R R V L L F D M R F V C F G T W
16 R R V F Q C V L G R A C S L V C 
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Generally, phages can show a certain background reactivity against streptavidin or other reagents 
used for the selection test, and give a high level of false positivity during the selection runs. In 
order to reduce the occurrence of such false-positives, non specifics phages were eliminated via a 
pre-selection step (Figure 6.3) over free streptavidin beads. The fraction of unreactive phages was 
then used to select binders.  
 
 
Figure 6.3: Initial pre-selection. Phages were incubated on streptavidin only and the other reagents used in the experiment; 
unblocked phages were recovered for the selection, while blocked phage was eliminated. 
  
The selection of phages was performed using streptavidin-coated magnetic beads155; beads were 
incubated with biotin analyte in the first step and then with the phages. The phages blocked on 
the beads surface are able to recognize and bind the analyte and can be separated from the other 
non specific phage through the use of a magnetic rod (Figure 6.4). 
 
 
Figure 6.4: selection of phages with magnetic beads covered of streptavidin and biotinilated analyte. 
 
Final eluition with unbiotinylated caffeine allows to recover phages and to sequence cloned 
peptides in order to obtain the primary sequence of binders. In our case, four cycle of selection 
have been made; at the end of fourth cycle, 86 clones were isolated and tested against biotinilated 
analytes (8, 9) and free amino modified xanthines (10, 11, 13) in different ELISA experiments. 
                                                 
155 Shlyapnikov Y.M., Shlyapnikova E.M., Morozov V.M. Anal. Biochem., 2010, 50(2), 235-239. 
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The selection required an initial amount of 1012 phages in 250 μL of phosphate buffer. 
Preselection was achieved also towards defatted milk in order to remove most of non specific 
protein reactivity. The phage suspension was then incubate over 10 ng/mL immobilized 
xanthine. After repeated washing cycles, binders were eluted with a 100 ng/mL caffeine solution, 
and the eluted phages were then used to infect DH5αF’ bacterial strains. Bacteria were then 
grown up over plates and recovered to start a new selection cycle. Four selection cycle were 
carried out, and at the end of fourth cycle, 86 clones were selected. 
 
6.2.1 The ELISA tests. 
Enzyme-linked immunosorbent assay, also called ELISA, is a widely used156 immunochemical 
technique to detect the presence of a receptor towards a target molecule. The target molecule 
caffeine or theophylline in our case is immobilized over a solid surface, and a solution of the 
potential receptor/binder (an antibody, a membrane protein, a whole phage displaying a binder 
on its surface as in our case) is incubated. After washing, a secondary enzyme-labelled reagent is 
added (typically an antibody, in phage display an antibody towards one of the phage proteins, 
labelled with horseradish peroxidase). Finally a substrate for an enzyme-catalyzed colorimetric 
reaction is added.   
In our case, phage-ELISA test was used for a first screening with the 86 isolated clones. 
Polystyrene microtiter plate were coated with streptavidin;  caffeine-biotin (9) was immobilized 
on solid surface exploiting streptavidin-biotin system and a solution of each selected phage clone 
displaying randomized peptides was added. 
After washing, the concentration of bound phage in a single well was determinated with an 
antidoby specific for an external protein of phage (Figure 6.5). 
 
 
Figure 6.5: schematic representation of phage-ELISA test.  
 
Six out the 86 tested clones demonstrated a good affinity to caffeine, although with a rather high 
cross-reactivity towards streptavidin (Figure 6.6). Figure 6.6 reports a typical ELISA result 
                                                 
156 Nielsen U.B., Geierstanger B.H. J. Immunol. Meth., 2004, 290(1-2), 107-120. 
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obtained towards biotin/avidin immobilized caffeine. The same concentration of phage was used 
in all cases; the negative control is represented by the Wild-Type non mutated C-EKinv.-C 
scaffold, while the positive control is given by a caffeine-binding peptide obtained in previous 
studies.157 Despite the occurence of a significant amount of reactivity towards streptavidin alone, 
specific caffeine binding can be observed. 
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Figure 6.6 
 
In parallel, clones were tested also in another phage-ELISA system using immobilized caffeine-
biotin (9), menthone-biotin (26) and linker-biotin (7) (Scheme 6.1) in order to analyse the cross-
reactivity of clones against unrelated molecules and against the linker alone (Figure 6.7): 
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157 A. Savoini, It. Pat. Appl. RM2006 A000707. 
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Figure 6.7: comparison of three different phage-ELISA using caffeine-biotin, menthone-biotin and linker-biotin as target 
analytes. 
 
All the six clones show a partial cross-reactivity towards menthone but the interaction with 
menthone leads to signals that are comparable to there obtained with the linker alone, and thus it 
can be considered negligible. This is an important information, as it means a potentially good 
selectivity of our peptides in favour of aromatic xanthines; however, clones show cross-reactivity 
also against linker-biotin that represents a portion of the overall conjugates. 
Such a level of interfering interaction with the linker used to immobilized target molecules, is a 
very common phenomenon which is observed many times also during the selection of antibodies 
from phage display libraries, and more generally during any kind of generation of biological 
binders that require immobilization or bioconjugation of the target.158 
In order to clean out this cross-reactivity toward linker, the clones were tested again against 
caffeine derivatives with different linker having a free terminal amino group (10, 11, 13). 
                                                 
158 a)de Villiers S.H.L., Lindblan N., Kalayanov G., Gordon S., Boraznekok I., Malmarfelt A., Marcus M.M., Svesson T.H. Vaccine, 
2010, 23(7), 34-37. b)Stanberg J., El Ayed M., Wisztorski M., Day R., Fournier I., Salzet M. Anal. Chem., 2009, 81(22), 9512-9521. 
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In this case modified caffeine and theophylline were directly linked onto a properly activated 
solid surface under (Scheme 6.2). In a first run, the clones were tested towards the caffeine-
cadaverine derivative 11 (Figure 6.8): 
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Scheme 6.2 
 
As expected, under the new ELISA conditions the clones show a clean recognition of caffeine 
with a high difference over the background signal given by Tween, the surfactant used to saturate 
the solid plane in the ELISA test. This means more safely that the observed signals are due to 
specific recognition only for the aromatic target compound (Figure 6.8): 
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Figure 6.8: new phage-ELISA obtained from amino conjugate. Cntl+ and cntl- were the same used in the previoud ELISA 
experiment. 
 
In order to further reduce any linker effect, another phage-ELISA was developed towards 
compound 13 (Scheme 6.3); in this case linker dimensions were reduced from eleven atoms to 
four and  the clones tested were only bE1 and bE8, the best isolated receptors from the previous 
experiment, with a good affinity toward caffeine and with very low background (Figure 6.9): 
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This test was carried out using a theophylline derivative instead of a caffeine use, in order to join 
insight also on the caffeine/theophylline cross-reactivity. 
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Figure 6.9: comparison results between ELISA test. 
 
Recognition of xanthines by E1 and E8 is thus not affected by the linker length, no by the methyl 
group at position 3 of the xanthine ring. 
 
6.2.2 Measurement of the dissociation constant of the peptide/caffeine complexes 
After having selected the E1 and E8 binders, we have measured the dissociation constant of their 
caffeine complexes, using an ELISA methodology described by Loomans and colleagues.159 
The dissociation constant is measured by coating a series of ELISA plates with different 
concentrations of caffeine (namely 2, 5, 5, 10 and 20 μg/mL) and then by incubating different 
concentrations of peptides over any concentration of immobilized caffeine. A peptide 
                                                 
159 Loomans E.E., Roelen A.J. J. Immunol. Meth., 1995, 184(2), 207-217. 
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concentration/response plot is obtained at any caffeine concentration (Figure 6.10: the series of 
curves given by E1, Figure 6.11: the response obtained with E8): 
 
 
 Figure 6.10                                 Figure 6.11 
 
The experimental points are then submitted to a nonlinear regression analysis that yield 
hyperbolic fittings and OD50 calculated values. A series of Kd values is then obtained by 
submitting any possible couple of peptide concentrations corresponding to the calculated OD50 
values, to equation 6.1: 
  
Kd=(n-1)/2(n[B]-[A]) eq. 6.1 
 
where [B] and [A] are the peptide concentrations giving the OD50 signal at two different caffeine 
concentrations, and n is their ratio. The average of such calculated Kd values gives finally a Kd of 
0.70±0.12 nM and of 6.90±0.17 nM for E8 and E1 caffeine complexes, respectively. 
A remarkable affinity towards immobilized caffeine is thus measured by the ELISA experiments, 
and the nanomolar dissociation constants are comparable with these usually observed in 
antibody-hapten complexes. 
With this series of phage-ELISA experiments we have identified two new potential peptides 
receptors for caffeine and theophylline molecules.  
 
 
6.2.3 Characterization of bE1 and bE8 sequence. 
By PCR amplification and sequencing of the DNA strands contained into the phage expressing 
E1 and E8, their aminoacid sequence was obtained (Table 6.2): 
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 E random Kinv. random 
E1 F L R R R I R E K L A S V K 
E8 Q S R R L K R E K L A S V K 
Table 6.2 
 
In both the peptides the Kinv. random sequence correspond to that of the wild-type scaffold, and 
the whole of diversity is found into the E randomized heptad only. The sequence of E1 and E8 
at this level are nevertheless similar and very acidic: four arginine residues are found in E1, three 
arginine and one lysine residue are found in E8. The presence of such a high number of arginines 
is rather surprising. However, an analysis of xanthine binding motives inside enzyme binding sites 
reveals that strong interactions between arginine and xanthine carbonyls are often found. This is 
the case of xanthine oxidase, where Arg 880 plays a key role in orientating xanthine and 
stabilizing its complex with the catalytic molibdenum ion of the enzyme.160 
Also in xanthine dehydrogenase from Rhodobacter Capsulata, arginine 310 is essential, and its 
mutation to methionine leads to a 103 reduction in both the thermodynamic and kinetic 
parameters for a series of purine substrate161; arginine is essential also in caffeine inhibition of 
ionotropic glycine receptors.162 With the sequence of E1 and E8 in hand, we have tried to build 
up also a model of the two caffeine complexes.  
A Predict-Protein163 sequence analysis carried out on the two peptides yields a random-coil 
secondary structure prediction at the mutated E sequences in both the peptides, while α-helix 
conformation is confirmed as highly probable along the remaining sequence. This allow to take 
as a starting hypotesis the possible creation of a small binding pocket onto a largely conserved 
coiled-coil skeleton. As the starting geometry for the coiled-coil scaffold, we have chosen the 
homology model described in chapter 5 page 58. The linker chain, the terminal cysteines and 
their disulfide bridge were added first, and the topology was submitted again to a relaxation MD 
cycle as we have previously described. The sequence were then mutated to obtain the first models 
of E1 and E8. The models were submitted again to a final-multistage relaxation session164, and 
then docking of caffeine was performed using a GRID-flexible docking protocol.165 We have also 
docked the linker-modified caffeine and thephylline into the peptide binding site, in order to 
evaluate also the interaction s towards the linker, and its cooperation in recognizing immobilized 
xanthines. 
                                                 
160 Pauff J.M., Zhang J., Bell C.E. Hille R. J.Biol.Chem., 2008, 283(8), 4818-4824. 
161 Pauff J.M., Heman C.F., Junemann N., Leimkubler S., Hille R. J.Biol.Chem, 2007, 282(17), 12785-12790. 
162 Duan L., Yang J., Slaughther M.M. J. Physiol., 2009, 587(16), 4063-4075. 
163 Rost B., Yachdav J. Nucl. Acids Res., 2004, 32, W321-W326. 
164 Berti F., Forzato C. Tetrahedron Asymmetry, 2005, 16, 1091-1102. 
165 Goodford P.J. J. Med. Chem., 1985, 28, 849-857.  
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The more stable docking solution obtained after clustering of the docking poses were then 
optimized again in a periodic box of water molecules to obtain the final models. The final 
geometry of the E8-linker-caffeine complex is reported as an example in Figure 6.12: 
 
 
Figure 6.12: E8 and caffeine-biotin complex. 
 
A rather deep caffeine-binding site is observed. Caffeine is buried to a deeper extent at its 
imidazole system and at methyl in position 7. Carbonyl 2 and partly methyl group 1 and 3 are 
conversely exposed to the solvent.. The site is contigous to a hydrophobic cleft that corresponds 
to the zipper interface hosting the hydrocarbon chain of the linker. 
A detailed view of the caffeine interactions is given in Figure 6.13 for E1 and in Figure 6.14 for 
E8 complexes. 
  
 
          Figure 6.13: Detail of E1 peptide and caffeine interaction.   Figue 6.14: Detail of E8 peptide and caffeine interaction.   
 
In the E1 complex, hydrophobic contacts are established between caffeine and the hydrocarbon 
chains of Lys 61, Val 65, Lys 68, Leu, 13, Leu 17, Arg 20. Phenylalanine 16 is at π-methyl 
distance to caffeine methyl 1 while Arg 20 is at hydrogen bond distance to carbonyl 2. 
In the E8 complex the side chains of Val 61, Leu 62, Leu 20, Lys 61, Lys 21, Ser 17 are at 
hydrophobic  contact distance with caffeine, while the distances between caffeine carbonyl 2, the 
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hydroxy group of Ser 17 and the cationic head of Lys 21 are consistent with an hydrogen bond 
network. 
We have calculated complexation energy values, obtained by adding a solvation energy term 
(obtained from a discrete water model) to the conformational, non bonded and electrostatic 
energy terms arising from the AMBER force field (equation 6.2) 
 
ΔEcompl.= ΔEconf.+ ΔEelast.+ ΔEnb+ΔΔEsol (equation 6.2) 
 
The complexation energy are reported in Table 3.2, relatively to the calculated complexation 
energy for the E1/caffeine complex. 
 
 E1 ΔEcompl / Kcal mol-1
E8 
ΔEcompl / Kcal mol-1
Caffeine-linker -44.4 -62.3 
Caffeine 0 8.5 
Teophylline 3.9 7.1 
Table 3.3 
 
In the lack of a calibration set of experimental data, such complexation energies can not be used 
to predict binding constants; however, the model predicts a better interaction for the E1 
complexes, with a very large gain in binding energy for the linker-modified target molecules. 
 
6.3 Expression of E1 and E8 in E. Coli 
After the first ELISA characterization of E1 and E8, the peptides have been expressed also in a 
soluble form suitable for large scale bacterial production and for simpler purification protocols. 
According to commonly adopted techniques, the peptides were produced in fusion with the E. 
Coli maltose binding protein, which is a part of maltose/maltodextrin system of Escherichia Coli. 
Maltose binding protein is a part of maltose/maltodextrin system of Escherichia Coli. As different,  
MBP has an approximate molecular weight of 42.5 kDa, and it widely used to increase the 
solubility of recombinants proteins expressed in E. Coli.166 When the protein of interest is 
expressed as a MBP-fusion protein its solubility is often enhanced, and by this way, relatively high 
concentration of peptide can be found in the bacterial colture supernatant. In addition, MBP 
itself can be used as an affinity tag for purification of recombinant proteins. The fusion protein 
binds to amylose columns while other proteins flow through; the MBP-protein fusion can be 
                                                 
166 Chater K.F., Birò S., Palmer T., Schrempf H. FEMS, 2010, 34(2), 171-198. 
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purified by eluting the column with maltose. Once the fusion protein is obtained in purified 
form, the protein of interest is often cleaved from MBP with a specific protease.167 
Cloning of the peptides at MBP was performed with a pMAL vector (Figure 6.15), E1 and E8 
fragment were produced by PCR reactions and then transfered in pMAL vector using T4 DNA 
ligase.168 
 
 
Figure 6.15: E1, E8 in pMAL vector 
 
The MBP-E1 and MBP-E8 fusion proteins were than produced in NM522 E.Coli coltures and  
purified by affinity chromatography, followed by dialysis in order to eliminate the maltose used 
for the elution; the purified MBP-peptides were then tested in two different systems to evaluate 
the reactivity towards caffeine and theophylline. 
 
6.3.1 Dot-Blot  
Dot Bolt is a molecular biology techique used to detect binding between biomolecules.169 In a 
Dot Blot experiment the biomolecule to be detected is applied directly on a membrane as a dot. 
This step is followed by incubation with a labelled binding partner.  
In our case, a small amount of MBP-E1 and MBP-E8 (about 2 μg of protein) was immobilized 
over a nitrocellulose membrane and then incubated with caffeine-HRP and theophylline-HRP, 
the conjugates of xanthine with horseradish peroxidase described in the previous sections. After a 
washing step, membranes were incubated with an enhanced chemiluminescence system (ECL) in 
which horeradish peroxidase oxidizes luminol to 3-aminophtalate in the presence of several 
                                                 
167 Malhotra A. Meth.Enzym., 2009, 463(C), 239-258. 
168 Riggs P. Molecular Biotech., 2000, 15, 51-63.  
169 a)Vincitelli R., Cambillau C. Bio Tech International, 2005, 6, 14-16. b)Andoh A., Benno Y., Kanauchi O., Fujiyama Y. Curr. Pharm. 
Design, 2009, 15(18), 2066-2073. 
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cofactors.170 The oxidation of luminol is accompanied by emission of low intensity light at 428 
nm; this emission is then boosted up to 1000-fold by the cofactor, making the light easier to 
detect and increasing the sensitivity of the reaction. 
 
 
Figure 6.16: E1-MBP and E8-MBP clones tested with HRP labeled analyte. EKinv. wild-type was used as Cntl-. 
 
Figure 6.16 reports a typical Dot-Blot output, obtained by impression of photographic paper by 
the emitted light. A clean interaction between E1 and E8 peptides and xanthines analytes is 
detected with the appearance of a blu spot; EKinv. wild-type, used as negative control (Cntl-), does 
not bind caffeine or theophylline. 
With this important result, we have confirmed that interaction between E1 and E8 peptides and 
caffeine or theophylline is not affected by the expression system of the binders peptides. 
 
 
6.3.2 E1 and E8 as affinity chromatography stationary phases 
The high affinity of E1 and E8 towards caffeine, lead us to the idea of testing their ability as 
stationary phases in an affinity chromatography system for the purification/removal of caffeine 
from solution. 
The MBP expression system provides an ideal way to set up a stationary phase, due to the ease of 
immobilization of MBP constructs over amylose beads. We have thus exploited the affinity of 
MBP for amylose in order to block the MBP-E1 and MBP-E8 on a amylose resin in a 
chromatography column. In order to generate an analytical instrument for caffeine and 
theophylline detection, water solutions of these xanthine were flowed through the column and 
the xanthine column retention after washing was estimated in different ways (Figure 6.17). 
 
 
                                                 
170 Newmann G.R., Jasani B. J. Pathology, 1998, 186(2), 119-125. 
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Figure 6.17: schematic representation of affinity column. Resin of amylose was coated on surface of column (a), MBP-peptides 
was blocked through amylose-MBP interaction (b) and a solution with  our analyte (red) was flowed under the column. E1 and 
E8 bound the analyte in the randomized region (c) and at the end MBP-peptides-analyte was removed from the column using 
maltose solution (d). 
 
 
In a first series of experiments, the theophylline-HRP conjugate was used as analyte; without 
taking care, in this stage, of proper elution conditions for caffeine (i.e. of conditions allowing the 
breakup of the peptide –caffeine complex without destroying the stationary phase) we have 
initially simply eluted the whole MBP-peptide-caffeine-HRP complex by adding maltose to the 
mobile phase after a proper washing volume, and then we have measured peroxidase activity in 
any fraction by a colorimetric test, using 3’,3’,5’,5’ tetramethylbenzidine (TMB) as substrate. The 
resulting chromatograms are reported in Figure  6.18: 
 
Figure 6.18 
 
The result are excellent, with a release of caffeine well over the background given by the MBP-
WT peptide in both cases. We have also tested the effect of a pH shock on the E8 column, and 
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we have observed that lowering of the pH down to 3 with glycine buffer does not affects the 
stability of the system, and no caffeine is eluted under these conditions. 
The loading capacity  of the E8-MBP system was also evaluated by measuring with a reference 
HPLC methodology.171 The amount of bound caffeine over one ml of amylose resins loaded with 
50 μg of the MBP-E8 protein. 8.42 μg of caffeine were dissolved in TRIS buffer and the solution 
was then elluted over the MBP-E8 column. The column was then extensively washed and the 
amount of recovered caffeine was measured in any fraction. 8.04 μg of caffeine were present in 
the eluted fraction. A control experiment carried out on a resin loaded with the wild type MBP 
construct gave 8.16 μg of caffeine recovery. A specific loading capacity of 0.12 μg caffeine per 50 
μg of MBP-E8 can thus be estimated. This corresponds roughly to a realistic ratio of 0.6 moles 
of caffeine per mole of binder peptides.    
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
171 Novakova L., Vlckova H. Anal. Chim. Acta, 2009, 656(1-2), 8-35. 
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Chapter 7: K library, towards a simplified system. 
 
The development of C-EKinv.-C library has represented the first step for the achievement of small 
receptor peptides able to identify caffeine and theophylline. E1 and E8 peptides are promising 
structures; the affinity for our two target analytes were tested in different way and in all cases a 
relevant interaction takes place. However, based on stataments on usage facility  and structure 
stability given in Chapter 2, we have considered the possibility of further reduction of C-EKinv.-C 
scaffold to a very simplified and short structure.  
In order to reduce as more as possible the scaffold lenght and with the intention to keep 
nevertheless the α-helix as principal motif, we have decided to use as scaffold only the K chain of 
the EK coil. Although nor E neither K wild type chain are reported to be able of organized 
folding alone (see chapter 2), and indeed they have been designed in order to avoid self-
organization and homodimerization, we have reasoned that the energy balance between homo- 
and hetero-organization in coiled-coils, is generally very subtle, and for this reasons, mutations in 
the central heptade of one of the two chains could in principle lead to self-organizing structures, 
including folded monomers, dimers or even more complicated aggregates (Figure 7.1): 
 
 
Figure 7.1 
 
 
Following an approach similar to that used for C-EKinv.-C randomized library, we have chosen to 
generate a library of K randomized chains using the phage-display technique. The K chain  was 
chosen instead of the E chain because, on carrying out several synthetic trials on automated 
peptide synthesizers, we have always encountered huge difficulties in the synthesis of the E chain, 
while the KWT chain resulted relatively easy to be prepared. Randomization was generated only in 
the central heptad of K chain, again in order to identify a region of overall randomized peptide 
able to bind caffeine or theophylline. 
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K random peptides were tested against the same modified targets and conjugates used for the 
first library: namely theophylline-biotin 8, caffeine-biotin 9 for phage-ELISA experiment and 
ELISA test with K random chains expressed in fusion with MBP. 
 
7.1 K library construction. 
The starting point for library construction was again represented by the choice of primers. As  in 
the C-EKinv.-C library, the randomization of Kwt was achieved via PCR using Kwt sequence as 
template. Two primers  were used: the first to allow pairing at one end of K chain and the second 
to allow pairing at the central heptad of K. The fragment obtained by PCR reaction was purified 
and cloned into the pBIOS 1 phagemidic vector using T4 DNA ligase for the reaction of 
inesrtion; pBIOS 1 allows to express peptide in fusion with protein 3 of phage capsid (Figure 
7.2):172 
 
 
Figure 7.2 
 
Randomization of the K central heptad lead to a 1.1 * 108 members library. 
The selection of specific phages against caffeine was carried on in three rounds, again using 
streptavidin coated beads with caffeine-biotin as target. 96 clones were isolated from the library 
and tested by phage-ELISA experiments in order to check their reactivity against caffeine and 
theophylline. 
In this case, analyte was immobilized in the ELISA wells exploiting streptavidin-biotin system 
using modificated molecules 8, 9 and 26 (Scheme 7.1): 
 
                                                 
172 Chassagne S., Laffly E., Thullier P. Mol. Immunol, 2004, 41(5), 539-546. 
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Scheme 7.1 
 
The performance of the best four clones with a good affinity toward caffeine and theophylline is 
reported in Figure 7.3 and compared with the background given by KWT: 
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Figure 7.3 
 
Clones named KE1 and KB4 have demonstrated a high and specific reactivity towards caffeine and 
theophylline and a reduced cross-reactivity towards menthone and biotin-linker; on the contrary 
KE12 lacks of specificity, as well as KG2. 
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The four clones were then sequenced (Table 7.1): 
 
Clone name Aminoacidic sequence 
KE12 (KVSALKE)2SERRCQQ(KVSALKE)2
KG2 (KVSALKE)2RYFRCQS(KVSALKE)2
KE1 (KVSALKE)2QFLCLMF(KVSALKE)2
KB4 (KVSALKE)2QFLCLMF(KVSALKE)2
Table 7.1: randomized central heptad is marked in yellow 
 
The best performing peptides KE1 and KB4 resulted to be identical clones of the same sequence. 
KE1 was thus the only peptide submitted to further characterization.  
Clone KE1, KWT and also EWT were thus expressed in fusion with MBP, as it was done for E1 and 
E8 in the previous library. 
A cysteine is present in the KE1 sequence as the fourth aminoacid in the randomized sequence 
(position 18). In order to reduce the occourence of high background due to disulfide bond 
between this cysteine and other cysteine that could be present on the phage capsid on exèression 
protein, we have chosen to mutate the cysteine into a methionine; the new peptide sequence 
(scheme 7.2) was for this reason expressed in fusion with MBP in E.Coli. 
 
(KVSALKE)2QFLMLMF(KVSALKE)2 
Scheme 7.2 
 
After purification on amylose column, the peptide was tested for its ability to bind caffeine 
(Figure 7.4): 
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Figure 7.4 
 
There is no difference between the reactivity of KE1 and its C18M mutant. Based on this finding, 
the original sequence of KE1 was abandoned, and any further characterization was carried out on 
the C18M mutant. 
 
7.2 Synthesis and chemical characterization of KE1 
According to the design of the K library, the short lenght of KE1 allows its full chemical synthesis: 
the peptide was synthesized on a 40 mg scale, and this allowed a more detailed characterization of 
its chemical and binding properties; we have thus obtained informations on the peptide folding 
and on the crystal structure of the peptide that were unavailable for the members of the C-EKinv.-
C library. 
Currently, peptide synthesis includes a wide range of techniques and protocols that enable the 
preparation of materials ranging from small peptides to large proteins. The pioneering work of 
Bruce Merrifield who introduced solid phase synthesis (SPPS)173, dramatically changed the 
strategy of peptide synthesis and simplified the step of purification associated with solution phase 
synthesis. Moreover, solid phase peptide synthesis also permitted the development of automation 
and the extensive range of robotic instrumentation now available. After defining a synthesis 
strategy and programming the amino acid sequence of peptides, machines can automatically 
perform all the synthesis steps required to prepare multiple peptide sample.174 
                                                 
173 Merrifield R.B. J. Am. Chem. Soc., 1963, 85, 2149-2154. 
174 a)Sabatino G., Papini A.M. Cuur. Opin. Drug Develop., 2008, 11(6), 762-770. b)Lam K.S., Renil M. Curr. Opin. Chem. Biol., 2002, 
6(3), 353-358.  
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Solid support synthesis has obviuos advantages. Large excess of reagents at high concentration 
can drive coupling reactions to completion. Excess reagents and side products can be separated 
from the growing insoluble peptide simply by filtration and washings and all the synthesis steps 
can be performed in the same vessel without any transfer of material. In the SPPS approach, the 
N-protected C-terminal amino acid residue is anchored via its carboxyl group to a hydroxy, 
chloro, or amino resin to yield respectively an ester or amide linked peptide. After loading the 
first amino acid, the desired peptide sequence is assembled in a linear fashion from the C-
terminus to the N-terminus by repetitive cycles of Nα deprotection and amino acid coupling 
reactions. Side chain functional groups of amino acids must be masked with permanent 
protecting groups (Pn) that are stable in the reaction conditions used during peptide elongation. 
After coupling, the excess of reactants is removed by filtration and washings. Temporary N-
terminal protecting group is removed allowing the addition of the next N-urethane protected 
amino acid residue by activation ot its carboxylic acid. This process of deprotection and coupling 
is repeated until the desired sequece is obtained. In a final step, the peptide is released from the 
resin and the side chain protecting groups conomitantly removed. 
In SPPS, two strategies of protection are commonly used: the Boc/Bzl and the Fmoc/tBu 
approaches for protection of terminal amino group/side chain functional group. 
Fmoc-based SPPS is now the method of choice for the routine synthesis of peptides.175 
 
7.2.1 Solid phase synthesis of KE1 peptide 
The sequence of KE1 was evaluated first with the Peptide Companion software176, that allow to 
predict the ease of synthesinzing a certain sequence, and the resulting yield, based on 
bioinformatics knowledge of the conformational behaviour of sequence motifs, and of their 
tendency to form aggregates. The level of difficulty for the synthesis of the KE1 sequence is 
reported in Figure 7.5: 
                                                 
175 Mizhiriistki M., Shpernat Y., Askinazi B. Chimica Oggi, 2003, 21(6), 22-25. 
176 CSPS Pharmaceuticals, Inc. Copyright© 1994-2004 All. Rights Reserved. 
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Figure 7.5 
 
A high degree of difficulty is predicted for the constant K regions of the peptide, which is infact 
designed in order to form aggregates, and the occurance of such phenomena, that lowens the 
yield by masking the reactive terminals of the growing paptide chains, can not be avoided by the 
presence of side chain protecting groups (for lysine, serine and glutamic acid we have used Boc, 
TMS and t-butyl ester respectively). We have thus considered the use of microwave synthesis to 
overcome this problem, since microwave greatly improve the yield of solid phase reactions.174 
The synthesis of KE1 peptide was thus performed with an automated CEM microwave 
synthesizer on a NovaSyn© TGA resin177 (Figure 7.6) 
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Figure 7.6 
This peg-based solid support is based on Tentagel, a composite of polyethylene oxide grafted 
onto a low cross-linked polystyrene gel-type matrix, which has been amino functionalized and 
derivatized with the TFA-labile 4-hydroxymethylphenoxyacetic acid linker. The 90 μm beads 
have a narrow size distribution, excellent pressure stability and swelling properties, and high 
diffusion rates, making them ideally suited for both batch or continuous flow peptide synthesis. 
In situ carboxy activation was achieved by PyBop activation in N-methyl pyrolidone178. 
                                                 
177 Bouajila J. Raffin G., Waton H., Sanglar C. Polymers and Polymer Composited, 2003, 11(4), 263-276.   
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 Complete peptide synthesis was obtained in 36 hours with 36 cycle of deprotection and coupling 
raction; final treatment with trifluoroacetic acid (TFA), triisopropylsilane (TiPS) and water allow 
to to detach the peptide from the solid support. 40 mg of peptide were by this way obtained in 
high purity as it can see from its mass spectrum (Figure 7.7): 
 
 
Figure 7.7 
 
7.2.2 The solution behaviour of KE1. 
The CD spectrum of a 50 μM solution of KE1 phosphate buffer in reported in Figure 7.8: 
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Figure 7.8 
 
The spectrum is consistent with a higly α-helical structure, with a CD minima at 222 nm and 208 
nm and with positive molar ellipticity near 200 nm. This result is very important; the original K 
                                                                                                                                                                       
178 Coste J., Le Nguyen D., Castro B. Tetrahedron Lett., 1990, 31, 205-208. 
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chain, in fact, in the absence of its complementary E chain, shows a typical random-coil spectra 
and only in the presence of E chain generates an α-helix structure179 (Figure 7.9): 
 
Figure 7.9 from reference 179. 
 
The [θ]222/[θ]208 ratio is 1.4 and this suggests a multimeric aggregate in solution as a dimeric, 
trimeric or higher order coiled coil. 
Using equation 5.1 showed in (Chapter 5) we have calculated a 0.6 fraction of α-helix content for 
KE1, corresponding to about 21 amino acids. This is roughly consistent with a helical arrangement 
conserving a rather high degree of conformational freedom at its terminals and perhaps also at 
the central heptade region. 
The thermal denaturation of KE1 was then studied by measuring the ellipticity value at 222 nm in 
the 0°-80°C temperature range for a 50 μM peptide solution in phosphate buffer (Figure 7.10): 
 
 
Figure 7.10 
                                                 
179 Litowski J.R., Hodges R.S. J. Biol. Chem., 2002, 277(40), 37272-37279. 
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The peptide exhibited a single sigmoidal thermal unfolding curve, with a melting point at 41°C. 
The simple sigmoidal behaviour is consisten with a single two-states unfolding process, with the 
folded structure transforming directly into the final unfolded state without the occurence of 
intermediate structures. A dissociation enthalpy of 95.7 kJ/mol is found for this transition by 
estimating the dissociation constant at any temperature from the [θ]222 value.180 This enthalpy 
magnitude is consistent with that of other trimeric coiled-coil of such lenght.181 KE1 is rather  
stable upon thermal unfolding and the ellipticity value at 80°C is still corresponding to a 10% 
helix fraction. 
If we compare this behaviour with that of the wild-type K sequence, which is unable of any 
folding even at room temperature, we are lead to look at the key role pleyed by the central 
heptade sequence, that strongly cooperates in folding up on an aggregate structure, due to its 
enhanced hydrophobicity. 
 
7.2.3 The crystal structure of KE1 
KE1 peptide was submitted to crystallization trials in collaboration with the group of prof. 
Geremia at the Dept. of Chemistry of our University using an automated screening system for 
crystallization conditions (Tecan robot Technologies); the peptide was finally crystallized at best 
in 0.1 M Hepes buffer, 1.8-2.5 M sodium sulphate and 1.5-3% w/v PEG400. 
X-ray diffraction analysis was carried out using synchrotron radiation light source of ELETTRA 
Trieste; data set was collected with λ=1.0 nm and a resolution of 1.10 Å on a small fragment of a 
non geminated crystals whose cell parameters are reported in Table 7.2: 
  
KE1 Cell Parameters of non twinned crystal 
System Trigonal 
Space 
group 
P 3   (P 3¯ ) 
M.V. 
Solvent 
22192.62Å2 - 1.64 - Single molecule 
24.36% 
a (Å) b (Å) c (Å) a(◦) b(◦) g(◦)Elementary 
cell 22.427 22.427 50.949 90 90 120
Table 7.2 
 
The refined structure allows to individuate a perfect primitive trigonal elementary cell in which 
KE1 is structured as an unusual parallel trimeric coiled-coil (Figure 7.11): 
 
                                                 
180 Chapeaurouge A., Johansson J., Ferreira S.T. J. Biol. Chem., 2002, 277(19), 16478-16483. 
181 Dragan A.I., Potekhin S.A., Sivolob A., Lu M., Privalov P. Biochemistry, 2004, 43(47), 14891-14900. 
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Figure 7.11 
 
The trimer core interface is composed prevelently by hydrophobic residues of valine, leucine and 
phenylalanine; the external side of the bundle is characterized by polar residue of lysines, glutamic 
acid or glutamine (Figure 7.12): 
 
Figure 7.12: the interface of trimer. 
 
A more detailed view of the central heptade shows hydrophobic intrachain contacts  between the 
aromatic side chain of phenylalanine 16 (i) and the hydrocarbon chain of methionine 20 (i+4) and 
an interchain contact between the same Phe 16 and the hydrocarbon chain of glutamine 15 (i-1), 
with consequent stabilization of the coiled-coil bundle via trans rotamer conformation of 
phenylalanine (Figure 7.13): 
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Figure 7.13 
 
An inter cell analysis of trigonal KE1 packing shows a very compact structure. In particular, 
phenylalanine 21 points out the trimeric bundle and interacts with the corresponding residues of 
other two bundles of through π-stacking, and a sulphate ion contributes to structure stability 
through hydrogen bonding and polar interaction with lysine 27 of three differents bundles again 
(Figure 7.14): 
 
 
a)       b) 
Figure 7.14 
 
As a general comment on this structure, we have to note first that a fully parallel homotrimeric 
coiled-coil is a very unusual and rare structure, and to our knowledge there are no examples of 
such an arrangement in the protein databank. In trimeric coiled-coils, one of the chains is usually 
found in an antiparallel orientation with respect to the other two, in order to reduce the very high 
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dipole moment given by the coherent orientation of all the peptide carbonyl groups within any α-
helical strand182 
The strong inter coil interactions between Phe 21 rings and between Lys 27 and sulphate, which 
can clearly occurr only in a full parallel coil, are likely to stabilize this structure in the solid phase. 
This structure might also be different from that adopted by the peptide in solution and upon 
binding of xanthines. It is infact rather difficult to identify a xanthine binding site in the frame of 
such a compact coiled-coil which preserves the helical structure also at the level of the central 
heptade. An attempted crystallization run carried out in the presence of caffeine or theophylline 
gave no results, and the only structure obtained was that of the trimeric coil. However, the 
solution aggregation state of KE1 could be very different not only due to the lack of interactions, 
but also due to the presence of caffeine itself. 
 
7.3 The interaction between KE1 and theophylline 
We have thus started a series of experiments aimed at obtaining a more detailed view of binding 
of xanthines by KE1. As we have seen, binding has been detacted on both the phage display and 
MBP expression version of the peptide. The synthetic peptide, available in high amounts and 
with its high purity, allows more precise measurements, that were carried out again by CD and by 
calorimetry. 
 
7.3.1 Binding of theophylline via circular dichroism 
We have recently developed a CD methodology that allows to detect binding of small organic 
molecules to proteins from the appearence of ligand induced bounds in the CD spectrum.183 
We have thus adopted the same approach to study the binding of theophylline and KE1. The UV 
spectrum of theophylline in the 250-300 nm range is reported in Figure 4.15b and it shows an 
absorption band at 272 nm, in a spectral region that is free from peptide absorption. Both the 
CD spectra of peptide and theophylline alone do not show any CD activity in this region.  
A mixture of peptide solution and theophylline, however, shows an induced band at the same 
wavelenght of theophylline absorption in the UV spectrum due to interaction of the non chiral 
xanthine with the chiral peptide environment, which result in an overall chiral structure (Figure 
7.15): 
 
                                                 
182 Roy L., Core M.A. Chem. Commun., 2009, 192-194. 
183 a)Berti F., Bincoletto S., Donati I., Fontanive G., Fregonese M., Benedetti F. Eur. J. Org. Chem. Submitted. b) Benedetti F., 
Berti F., Donati I., Fregonese M. Chem. Comm., 2002, 8, 828-829. 
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Figure 7.15 
 
The appearance of the CD induced band is again a clean evidence of the recognition of 
theophylline by KE1 in solution. 
The elliptcity of the induced band was found to be proportionally dependent upon the 
concentration of theophylline in solution and thus it can be related to the amount of bound 
ligand at any theophylline concentration. 
By plotting the measured ellipticity versus the total theophylline concentration, a sigmoidal 
behaviour is observed (Figure 7.16):  
  
 
Figure 7.16 
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For the theophylline-KE1 complex, it was possible to estimate a dissociation costant of about 50 
μM. 
The dissociation constant is thus seen by far less favourable than that obtained via ELISA 
techniques for the E1 and E8 peptides (pag 77). However, the value is realistic for a small 
peptides as KE1, and it can be compared with the few data available in the litterature. 
In the mid-1990s, Alber reported the design of a coiled coil with an Ala mutation in each helix at 
the hydrophobic core of the structure.184 This system was found to bind hydrophobic molecules 
such as benzene and cyclohexane as a trimer, but in absence of guest, it was present as a mixture 
of dimers and trimers. More recently, McLendon has simplified the analysis of these coiled-coil 
receptors through metal coordination, thus eliminating equilibration between dimeric and 
trimeric complexes.185 In addition, he demonstrated the use of hexafluorobenzene as a probe to 
measure the competitive binding of several guest small molecules guest. 19F NMR was used to 
measure binding of benzene to the bundle, giving a KD of 110 μM. Using toluene instead of 
hexafluorobenzene, McLendon found a KD of 3 μM; binding affinities appeared to correlate with 
ligand size as well as hydrophobicity, and 1,3,5-trimethylbenzene binds more weakly than toluene 
(KD≈50 μM).  
The KD value found for our equlibrium is comparable with the values found by McLendon for 
aromatic molecules similar to theophylline. 
The relatively low affinity of KE1 for theophylline could also explain the unsuccefull 
cristallyzation trial in the presence of xanthines, since a very delicate balance between inter coil 
stabilization by sulphate and intra coil stabilization by xanthine is likely to occur during crystal 
formation. 
On the other side, the sigmoidal behaviour reported in Figure 4.16 is suggestive for a cooperative 
binding process, requiring a critical concentration of theophylline. This could be explained with a 
shift in the aggregation state similar to that observed by Mc Lendon. Unfortunately, the peptide 
region of the CD spectrum is entirely masked by very strong theophylline bands, and nothing can 
be said about changes in peptide conformations upon theophylline binding. 
 
7.3.2 Binding of theophylline via calorimetry. 
In order to evaluate enthaplic contributions in the KE1 theophylline interaction, calorimetric 
studies have also been performed, during a visit at the laboratory of prof. Ksenija Kogej, in the 
dept. of Physical Chemistry of the University of Lubljana. 
                                                 
184 Gonzales L., Plecs J.J., Alber T. Nat. Struct. Biol., 1996, 3, 510-515. 
185 Doer A.J., Case M.A., Pelczer I., McLendon G.L. J. Am. Chem. Soc., 2004, 126, 4192-4198. 
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We have thus carried out an isothermal titration calorimetry (ITC) run. ITC is a methodology to 
measure the heat change in a reaction at costant temperature.186 In ITC analysis, the measurement 
of heat is made at a given temperature, which allows direct determination of binding constant 
(K), reaction stoichiometry (n), enthalpy change (ΔH), free energy change (ΔG) and entropy 
change (ΔS). In addition, varying the temperature of the experiment allows the detrmination of 
the heat capacity (ΔCP) for the reaction, thereby providing a complete thermodynamic profile of 
the molecular interaction. 
ITC is mostly used to measure strenghts of interaction between proteins and ligands on either 
small molecules like drugs, or large ones such as nucleic acids or other proteins.187 
A typical isothermal titration calorimeter is composed of two identical cells (a reference and a 
sample cell) made of highly efficient thermal conducting material surrounded by an adiabatic 
jacket. Sensitive thermopile/thermocouple circuits are used to detect temperature differences 
between the reference cell (filled with buffer or water) and the sample cell containing the 
macromolecule. Known concentrations of degassed sample are taken in the injector and sample 
cell. Prior to the injection of the tritrant, a costant power (<1 mW) is applied to the reference 
cell. This signal directs the feedback circuit to activate the heater located on the sample cell and 
this represents the baseline signal. During the experiment the titrant is added into the sample cell 
in precisely known aliquots, causing heat to be either taken up or evolved. For an exothermic 
reaction, the temperature in the sample cell will increase, and the feedback power will be 
deactivated to maintain equal temperatures between the two cells; for the endothermic reactions 
the reverse will occur and the feedback circuit will increase power to the sample cell to maintain 
the temperature (Figure 7.17). 
                                                 
186 Peljhan S., Zagar E., Cerkovnik J., Kogej K. J. Phys. Chem. B, 2009, 113(8), 2300-2309. 
187 a)Bertini I., Calderone V., Fragai M., Giachetti A. J. Am. Chem. Soc., 2007, 127, 2466-2475. b)Haq I. Arch. Biochem. Biophys., 
2002, 403, 115. c)Chatterjec A., Moulik S.P., Sanyal S.K. Biophys. Chem., 2002, 98, 313-327. d)Houtmann J.C., Brown P.H. Protein 
Sci., 2007, 16, 30-42. 
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Figure 7.17: schematic representation of ITC calorimeter 
 
The raw data for an experiment consists of a series of heat peaks, with every peak corresponding 
to a ligand injection. These heat flow peaks are integrated with respect to time, giving the total 
heat effect per injection. This heat released or absorbed is in direct proportion to the amount of 
binding that occurs. Additionally, a volume correction is also performed due to dilution in the 
sample cell due to each injection. 
The pattern of these heat effects as a function of the molar ratio [ligand]/[macromolecule] can 
then be derived to give the thermodynamic parameters. They are derived as follows (eq. 7.1): 
 
ΔG=ΔH-TΔS=ΔG0+RTlnKa  (eq. 7.1) 
At the equilibrium ΔG=0, so (eq.7.2): 
 
ΔG0=-RTlnKa=ΔH0--TΔS0  (eq. 7.2) 
where ΔG, ΔG0, ΔH0, ΔS0 and Ka are free energy change, standard free energy change, standard 
enthalpy change, standard entropy change and affinity constant, respectively. Ka is derived from 
isotherm study. As ΔH is dependent on concentration and is not considered as standard state, the 
ΔH value is directly measured by ITC analysis. 
Titration of a 53 μM KE1 solution with increasing amounts of theophylline from a 23 mM mother 
solution, allowed to obtain important informations (Figure 7.18). The first was that, in agreement 
with circular dichroism measures, the free molecules KE1 and theophylline in solution do interact, 
with an endhotermic process (ΔH=27.5 kcal*mol-1) and a calorimetryc costant for the association 
process of about 2*105 L * mol-1 that for the inverse process becomes KD= 5*10-6 mol * L-1. 
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Figure 7.18 
 
7.4 Towards an electrochemical-sensor: F16H-KE1 
After having characterized the binding of xanthines by KE1, we have also designed a further 
mutant version of the peptide that could be useful for electrochemical sensoring of xanthines. 
The X-ray structure of the peptide lead us to the idea of creating a metal-binding site in the 
middle of the bundle by mutating phenylalanine 16 to histidine, (Figure 7.19): 
 
(KVSALKE)2QFLMLMF(KVSALKE)2  KE1 sequence 
        (KVSALKE)2QHLMLMF(KVSALKE)2  F16-KE1 sequence 
Figure 7.19 
 
The histidine side chain with its imidazole moiety is a key binding site for a number of metals 
ions including Cu2+; Zn2+ and Ni2+. The metal ion coordination generally takes place via N(1) or 
N(3) atoms of imidazole as is found in a great variety of nickel, zinc or copper proteins including 
carbonic anhydrase, carboxypeptidase and blue copper proteins.188 The metal complexes of 
peptides containing two or more imidazole residues are also frequently used to mimic the 
structural and catalytic features of the active sites of metalloproteins. Our idea was thus to mutate 
phenylalanine 16 with histidine in order to generate a binding site for a metal and to use this 
structure as an immobilized receptor on glassycarbon electrodes for a biosensor system for 
theophylline (Figure 7.20a); such a system could infact provide a metal electrochemical signal that 
could be modulated by binding of xanthines occurring in close proximity. 
 
                                                 
188 Bertini I, Cavallaro G., Mc Greevy K.S. Coord. Chem. Rew., 2010, 254(5-6), 506-524.  
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a)      b) 
Figure 7.20: a)model structure of mutated KE1peptide with metal ion coordination and b)the metal bindin site of the catalytic site 
of carbonic anhydrase.189 
 
The synthesis of F16-KE1 peptide was performed of KE1; the complete synthesis was obtained in 
40 hours with 40 cycle of deprotection and coupling reaction and by this way, 30 mg of peptide 
were obtained. 
Circular dichroism analysis of the mutant peptide shows that (Figure 7.21). The peptide adopts an 
α-helix conformation, but the ratio [θ]222/[θ]208 is less than 1 and this is consistent with the 
presence of a single α-helix rather than with a coiled-coil.  
 
 
nm
200 210 220 230 240 250
C
D
 (m
de
g)
-50
-40
-30
-20
-10
0
10
20
30
 
Figure 7.21 
 
                                                 
189 Alterio V., Hilvo M., Di Fiore A., Supuran C.T., Pan P., Parkkila S., Scaloni A., De Simone G. PNAS, 2009, 106(38), 16233-
16238. 
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F16H-KE1 was studied also as a theophylline receptor in solution, using again circular dichroism. 
The experimental conditions were the same used as described for KE1-theophylline and also the 
mutant peptide results able of interaction with the xanthine. The concentration-dependent 
theophylline CD induced band is reported in Figure 7.22. 
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Figure 7.22: titration of peptide KE1-His with increasing amount of theophylline. 
 
We are currently carried out a series of preliminary studies on the metal coordinating ability of 
F16H-KE1, and once optimal complexation conditions will be found, we are planning to develop 
a F16H-KE1 coated glassycarbon electrode. 
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Chapter 8: Antibodies library 
 
In this last chapter we report briefly a series of preliminary results obtained using the palytoxin 
conjugates that have been prepared as described in Chapter 3. 
As we have outlined, the palytoxin project is very ambitious, including the devlopment of 
bioreceptors towards palytoxin by many different approaches, ranging from conventional to 
highly innovative methodologies, on one side, and the preparation of several sensing devices 
ranging from standard ELISAs, to stick “on the field” rapid analysis systems, to electrochemical 
sensor based on carbon nanotubes. 
Among the primary transducers, were planned: 
-conventional polyclonal antisera and monoclonal antibodies raised against palytoxin 
bioconjugates with immunogenic carrier proteins, 
-phage display single-chain Fv antibodies from both immune and nonimmune populations of T-
lympocites selected towards the whole palytoxin molecule and its fragment, 
-phage display libraries of peptide receptors. 
Up to date, polyclonal and a monoclonal antibody have been obtained and used to set up a 
reference sandwich ELISA. 
 
 
8.1 Immunization strategy 
Monoclonal antibodies (mAb) are monospecific antibodies pool that are identical because as they 
are the progenies of a unique parent lymph cell.190  
Monoclonal antibodies are typically made by fusing myeloma cells with the spleen cells from a 
mouse that has been immunized with the desired antigen. Polyethylene glycol is used to fuse 
adjacent plasma membranes, but the success rate is low and a selctive medium is used in which 
only fused cell can grow. In the myeloma cell line the hypoxanthine-guanine-phosphoribosyl 
transferase (HGPRT) activity has been depleted. 
Unfused myeloma cells cannot survive as they lack HGPRT while unfused spleen cells are also 
unable to survive indefinitely because of their limited life span. Only fused hybrid cells, refereed 
to as hybridomas, are able to grow indefinitely in the media because the spleen cell partner 
supplies HGRPT. The mixture of cells is then diluted and clones are grown from single parent 
cells on microtitre wells. The antibody secreted by the different clones are then assayed for their 
ability to bind the antigen bya test such ELISA or immuno-Dot Blot. The most productive and 
stable clones is then selected are future use. 
                                                 
190 Tonegawa S., Hozumi N., Matthyssens G., Schuller R. Cold Spring Harbor Symp. Quant. Biol. 41, 877-889. 
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Polyclonal antibodies (or antisera) are antibodies mixture that are obtained from different B-cells. 
They are a combination of immunoglobulin molecules raised against a specific antigen, each 
identifying a different epitope. These antibodies are typically produced by immunization of a 
suitable mammal, such as mouse, rabbit or goat.  
Using mono- and polyclonal antibodies in analytical systems represents one of the most 
established methodologies of biotechnologies; typically antibodies are used in ELISA test and 
widely used in the “sandwich” ELISA. (Figure 8.1):191 
 
 
Figure 8.1: a general scheme of sandwich ELISA. 
 
In this type of ELISA test, a solid phase is coated with capture antibody (1), the sample is added 
and tha antigen binds to the capture antibody (2). An enzyme linked capture antibody, used as 
detecting antibody is added, and binds again to the antigen via another epitope (3); substrate is 
finally added and is converted by the enzyme to a detectable product (4). 
The ELISA test we are focusing on, alongs to this class of immunoenzimatic systems (Figure 
8.2). In our case, a mouse monoclonal antibody was used as capture antibody and a rabbit 
polyclonal antibody is the second detecting antibody. Binding between palytoxin and the 
detecting antibody was determined by a secondary goat antirabbit antibody-HRP conjugate. 
 
Figure 8.2 
 
                                                 
191 Velusamy V., Arshak K., Korostynska O., Oliwa K., Adley C. Biotech. Adv., 2010, 28(2), 232-254. 
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8.1.1 Production of polyclonal antibodies from rabbits. 
The monoclonal antibody required as capture antibody was provided by Hawaii Biotechnology 
Group, Inc.; the polyclonal antibody was producted by the group prof. Marzari at the Dept. of 
Life Science by immunization of two New Zealand rabbits using the PTX-BSA  conjugate as 
immunogenic antibodies production. 
Generally the first immunization causes a weak response in the immune system of the animal 
(primary response); subsequent expositions to the same antigen, however, induce a more intense 
response and consequently a more intense production of antibodies in the serum. 
For these reasons, the two rabbits were treated respectively with ten and seven subcutaneous 
inocules of 200 μg of PTX-BSA. 
A pool of high reactivity bleedings of the two rabbits was recovered and tested in ELISA against 
a coating of PTX-BSA conjugate, BSA, PTX-OVA and OVA, in dilution of pool bleedings 
(Figure 8.3): 
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Figure 8.3 
The anti serum shows a good reactivity against the conjugate molecules and a low reactivity 
against the proteins. For this reason it can be used as detection antibody in the  sandwich ELISA. 
 
8.1.2 The “sandwich” ELISA. 
The development of any ELISA analytical system requires a careful and time-consuming 
optimization of the most important parameters that can influence sensitivity, accuracy and 
precision of the methodology, with the aim of obtaing the maximun sensitivity, intra assay 
precision in the order of 5%, inter assay precision around 10%, accuracy within ± 10% in the 
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whole dynamic range, that must be as wider as possible, and also with the aim of reducing the 
time required for the whole procedure at best. Among the most important variables, are often 
found the temperature and time required for the immobilization of the capture antibody on the 
solid surface, the conditions for the susequent saturation step, the time, pH, ionic strenght, 
temperature for the binding of the analyte to tha capture antibody, the binding of the second and 
third antibody, the number of washing cycle. 
In our case, the ELISA sandwich for free palytoxin was optimized under the following 
conditions: 
1- coating of monoclonal antibody anti-PTX (mAb-antiPTX) at 4°C, overnight in phosphate 
buffer, 
2- saturation with defatted milk at room temperature for one hour, 
3- incubation with free palytoxin in phosphate buffer at different dilution; 
4- washing for three times with phosphate buffer, 
5- incubation with 1:4000 dilution of the polyclonal antiserum in defatted milk for 1h at room 
temperature; 
6- washing for three times with phosphate buffer and three time with phosphate buffer and 
tween, 
7- incubation with antirabbit-HRP conjugate for 45 minutes at room temperature in defatted 
milk, 
Under these conditions it was possible to generate the calibration curve for standard palytoxin 
samples reported in Figure 8.4:  
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Figure 8.4 
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As expected, the calibration curve obeyes to a sigmoidal behaviour. The interassay precision is 
10.4%: this satisfactory level of variability allows to identify the dynamic range of the test 
between 0.25 (LOD) and 2.5 ng/100μL. Although this range is rather narrow, it is none the less 
sufficient to begin the further steps in the development of the ELISA system, which will include 
the determination of the accuracy from the recovery of spiked sample at LOD, medium and high 
concentrations of palytoxin, the comparison with a reference LC-MS analytical method. 
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EXPERIMENTAL SECTION 
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Moisture sensitive reactions were carried out in oven-dried vessels under a positive argon 
pressure. THF was pre-dried over KOH, fractioned and redistilled from sodiun benzophenone 
before use. Dichloromethane was dried over calcium chloride and fractioned . 
Flash column chromatography was performed on silica gel 60 (230-400 mesh); silica gel 60F254 
coated plastics shhets were used for TLC and developed with I2 or with an aqueous solution of 
KMO4 and H2SO4. 
Melting point were determined in an open capillary apparatus and are uncorrected. 
IR spectra was obtained with ATAVAR 320 FT/IR spectrophotometer dispersing the sample in 
Nujol. 
CD spectra was obtained with JASCO J-710 spectrometer under nitrogen flux. 
Mass spectra ESI was obtained with a API 1 Perkin-Elmer SICIEX spectrometer. 
1H-NMR spectra and 13C NMR spectra was recorded with Jeol EX400 (400 MHz) and 
VARIANT 500 (500 MHz) spectrometer. CDCl3 solvent solution contain Me4Si as an internal 
standard. 
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4-(2,3,6,7-tetrahydro-1,3-dimethyl-2,6dioxo-1H-purin-8-yl)butanoic acid (1) 
5 g of 5,6-diamino-1,3-dimethyl uracil (29.38 mmol) were dissolved under anhydrous atmosphere 
in dry dimethylformamide (50 mL). 5.02 g of glutarric anhydride were added (44.07 mmol). The 
mixture was stirred at room temperature for 17 hours. After this time the solvent was eliminated 
by distillation at reduced pressure and the solid residue was dissolved into 80 mL of 2N NaOH; 
the mixture was heated at 75°C for 2 hours. 
HCl 6N was added until pH=5, the volume was reduced by evaporation and the red precipitate 
was filtered, washed with water (3 times) and dried under vacuum fore 12 hours to obtain 5.61 g 
(71%) of compound 1. 
1H NMR (δ-DMSO-d6): 1.89 (quint., 2H, CH2CH2CH2COOH, J=7.4 Hz), 2.25 (t, 2H, 
CH2CH2CH2COOH, J=7.2 Hz), 2.69 (t, 2H, CH2CH2CH2COOH, J=7.2 Hz), 3.19 (s, 3H, 
CON(CH3)CO), 3.40 (s, 3H, N(CH3)CO), 8.40 (s, 1H, COOH). 
13C NMR (δ-DMSO-d6): 23.40 (CH2CH2CH2COOH), 28.01 (CH2CH2CH2COOH), 28.28 
(N(CH3)CO), 31.56 (CON(CH3)CO), 33.87 (CH2CH2CH2COOH), 106.64 (NHC=CN), 148.53 
(NHC=CN), 151.71 (N(CH3)CON(CH3)), 154.12 (C=N), 154.53 (N(CH3)CO), 174.55 (COOH). 
MS m/z: 267.1 [M+H]+; 289.1 [M+Na]+; 305.2 [M+K]+. 
IR (cm-1): 3025 (NH); 1715 (C=O). 
m.p.: 78-80 °C. 
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Methyl 4-(2,3,6,7-tetrahydro-1,3-dimethyl-2,6-dioxo-1H purin-8-yl)butanoate (2) 
3 g of compound 1 (11.42 mmol) were dissolved in 100 mL of methanol and cooled in a ice bath. 
1.66 mL of thionyl chloride (2 g, d=1.638, 22.84 mmol) were added dropwise; the solution was 
stirred for 10 minutes and then heated under reflux for 24 hours. 
The solvent was than eliminated by distillation at reduced pressure to give 3.2 g (99%) of  ester 2. 
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 1H NMR (δ-DMSO-d6): 1.93 (quint., 2H, CH2CH2CH2COOH, J=7.5 Hz), 2.36 (t, 2H, 
CH2CH2CH2COOH, J=7.4 Hz), 2.72 (t, 2H, CH2CH2CH2COOH, J=7.4 Hz), 3.20 (s, 3H, 
CON(CH3)CO), 3.40 (s, 3H, N(CH3)CO), 3.56 (s, 3H, COOCH3). 
13C NMR (δ-DMSO-d6): 25.20 (CH2CH2CH2COOH), 30.30 (CONH(CH3)CO), 31.40 
(CH2CH2CH2COOH), 32.30 (CON(CH3)C=C), 33.20 (CH2COOCH3), 51.91 (COOCH3), 108.52 
(COC=CN), 150.06 (CH3NC=CN), 151.38 (CH3NCONCH3), 153.90 (C=N), 158.99 
(CH3NCOC=C), 174.15 (COOCH3). 
MS m/z: 281.1 [M+H]+, 303.3 [M+Na]+. 
IR (cm-1): 3021 (NH); 1732 (C=O). 
m.p.: 92-95 °C. 
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Methyl 4-(2,3,6,7-tetrahydro-1,3,7-trimethyl-2,6-dioxo-1 H purin-8-yl)butanoate (3) 
2.0 g of compound 2 (3.04 mmol) were dissolved under anhydrous atmosphere in 60 mL of 
anhydrous tetrahydrofuran. 1.1 mL of methyl iodide (2.5 g, d=2.28, 17.7 mmol) were added and 
the reaction was stirred for 16 hours. 
After this time 0.57 g of sodium hydride (14.16 mmol) were added and a precipitate appeared 
white. After 45 minutes the precipitate ridissolved; 10% citric acid was then added dropwise until 
pH=5. 
The organic phase was collected, the aqueous phase was extracted with ethyl acetate (3 * 40 mL), 
washed with satured solution of NaHCO3 and with brine. The combined extracts were dried over 
anhydrous sodium sulphate, the solvent was evaporated and the crude product was purified by 
flash cromatography on silica gel using dichloromethane/methanol=6/4 as eluent mixture. 
Final purification give 1.46 g of pure yellow solid product (73%). 
1H NMR (δ-CDCl3): 1.91 (quint., 2H, CH2CH2CH2COOCH3, J=7.1 Hz), 2.26 (t, 3H, 
CH2CH2CH2COOCH3, J=7.1 Hz), 2.59 (t, 3H, CH2CH2CH2COOCH3, J=7.2 Hz), 3.19 (s, 3H, 
CON(CH3)CO), 3.35 (s, 3H, N(CH3)CO), 3.48 (s, 3H, COOCH3), 3.72 (s, 3H CN(CH3)C).  
13C NMR (δ-CDCl3): 22.49 (CH2CH2CH2COOCH3), 25.87 (CH2CH2CH2COOCH3), 27.93 
(N(CH3)CO), 29.77 (CON(CH3)CO), 31.77 (CN(CH3)C), 32.86 (CH2CH2CH2COOCH3), 51.78 
(COOCH3), 107.48 (NHC=CN), 147.95 (NHC=CN), 151.73 (N(CH3)CON(CH3)), 153.32 
(C=N), 155.34 (N(CH3)CO), 173.36 (COOCH3). 
MS m/z: 294.1 [M+H]+, 333.1 [M+K]+. 
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IR (cm-1): 1745 (C=O); 3010 (C-H). 
m.p.: 88-90 °C. 
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4-(2,3,6,7-tetrahydro-1,3,7trimethyl-2,6-dioxo-1H-purin-8-yl)butanoic acid (4) 
0.5 g of compound 3 were mixed in 20 mL of a 3N LiOH checking the pH value (pH=12). 
The solution was stirred for 12 hours until complete dissolution was achieved. 
The solution was than acidified with 3N hydrochloridric acid to pH=2, and extracted with ethyl 
acetate (5 * 20 mL). The combined organic layers were washed with brine and dried over 
anhydrous sodium sulphate. The solvent was evaporated to give 0.4 g (87%) of pure product that 
can be used directly for next step. 
1H NMR (δ-CDCl3): 1.89 (quint., 2H, CH2CH2CH2COOH, J=7.2 Hz), 2.35 (t, 2H, 
CH2CH2CH2COOH, J=7.1 Hz), 2.75 (t, 2H, CH2CH2CH2COOH, J=7.2 Hz), 3.18 (s, 3H, 
CON(CH3)CO), 3.37 (s, 3H, N(CH3)CO), 3.78 (s, 3H, CN(CH3)C), 8.83 (s, 1H, COOH).  
13C NMR (δ-CDCl3): 23.04 (CH2CH2CH2COOH), 26.07 (CH2CH2CH2COOH), 28.10 
(N(CH3)CO), 29.80 (CON(CH3)CO), 31.77 (CN(CH3)C), 33.10 (CH2CH2CH2COOH), 108.44 
(NHC=CN), 147.86 (NHC=CN), 151.82 (N(CH3)CON(CH3)), 154.11 (C=N), 155.42 
(N(CH3)CO), 174.60 (COOH). 
MS m/z: 281.1 [M+H]+, 303.2 [M+Na]+, 319.1 [M+K]+. 
IR (cm-1): 1783 (C=O); 3017 (C-H). 
m.p.: 121-122 °C. 
 
BocHN NH2  
(5). 
1.2 g of di-tert-butyl dicarbonate (5.87 mmol) dissolved in 20 mL of dichloromethane were added 
dropwise to a solution of 3.45 mL of 1,5-diamino propane (3g, d=0.869, 29.36 mmol)  in 40 mL 
of dichloromethane at 0°C. The solution were stirred for 1 hour at 0°C and then for 1 hour again 
at room temperature. After this time the resulting suspension was filtered under vacuum in order 
to remove the white precipitate; the solution was concentrated with distillation at reduce pressure 
to give a yellow oil. The residue was redissolved in ethyl acetate (20 mL) and the organic solution 
was washed with a satured solution of NaHCO3 and brine. 
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The solution was dried on anhydrous sodium sulfate, the solvent was eliminated to give an oil  
product (5.28 g, 89%). 
1H NMR (δ-CDCl3): 1.22-1.40 (m, 6H, CH2CH2CH2CH2CH2), 1.44 (s, 9H, CH3 (Boc)), 2.65-2.68 
(m, 2H, CH2NH2, J3=7.1 Hz, J5=3.1 Hz), 3.10 (m, 2H, CH2NHBoc, J3=6.1 Hz), 4.57 (s, 1H, 
NH). 
13C NMR (δ-CDCl3): 23.83 (CH2CH2CH2CH2CH2), 28.43 (C(CH3) Boc), 29.79 
(CH2CH2CH2CH2CH2), 30.29 (CH2CH2CH2CH2CH2), 40.26 (BocNHCH2), 41.56 (CH2NH2), 
77.54 (C(CH3)3 Boc), 156.17 (CO Boc). 
MS m/z: 203.1 [M+H]+; 241.2 [M+K]+. 
IR (cm-1): 1771 (C=O (Boc)); 3088 (N-H). 
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tert-butyl 5-(5-((3aR,6S,6aS)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-6-
yl)pentanamido pentylcarbamate (6). 
0.3 g of biotin (1.24 mmol) were dissolved under anhydrous atmosphere in 10 mL of dry 
acetonitrile. The solution was cooled to 0°C and then 0.17 g of HOBT (1.24 mmol) were added; 
the pH of solution was adjusted to 8.5 of N-methylmorpholine. 0.25 g of compound 5  (1.24 
mmol) were added, 0.29 g of EDC-Cl (1.49 mmol) were finally added and the mixture was stirred 
for 1 hour at 0°C and then for 16 hours at room temperature. 
After this time the solvent was removed, the solid residue was divided between ethyl acetate and 
water and the organic layer was washed with 10% citri acid, satured NaHCO3 and brine. 
The organic phase was dried with anhydrous sodium sulfate, the solvent was removed and the 
crude product was recristallized from 2-propanol/di-iso-propyl ether to give 0.092 gr (60%) of 
pure brown solid product. 
1H NMR (δ-DMSO-d6): 1.28-1.65 (m, 21H, CH3 
(Boc)+CH2CH2CH2CH2CH2+CH2CH2(CH2CHS), 2.18 (t, 2H, NHCOCH2, J=7.2 Hz), 2.69 (m, 
1H, CHS), 2.91 (m, 1H, CH2S), 3.02 (t, 2H, CH2NHBoc, J3=6.4 Hz), 3.17 (m, 3H, 
CH2S+CH2CH2NHCO), 4.30 (m, 1H, CHCHS), 4.48 (m, 1H, CHCH2S), 6.36 (s, 1H, 
NHCONH), 6.42 (s, 1H, NHCONH), 7.73 (s, 1H, NHBoc), 7.78 (NHCO). 
13C NMR (δ-DMSO-d6): 23.45 (CH2CH2CH2CH2CH2), 24.40 (NHCOCH2CH2CH2CH2CHS), 
24.47 (NHCOCH2CH2CH2CH2CHS), 25.90 (NHCOCH2CH2CH2CH2CHS), 28.60 (CH3 Boc), 
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29.41-29.44 (NHBocCH2CH2CH2CH2CH2NHCO), 31.91 (NHCOCH2), 40.4 (CH2NHCO), 42.9 
(CH2NHBoc), 55.99 (CHS), 59.75 (NHCHCH2S), 60.51 (NHCHCHS), 61.60 (CH2S),  79.5 
(C(CH3)3 Boc), 156.0 (CO Boc), 164.7 (NHCONH), 172.7 (NHCOCH2). 
MS m/z: 429.45 [M+H]+. 
IR (cm-1): 3320 (N-H); 1790 (C=O).  
m.p.: 138-140 °C. 
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N-(5-(4-(2,3,6,9-tetrahydro-1,3-dimethyl-2,6-dioxo-1H-purin-8-yl)butanamido)pentyl)-5-
((3aR,6S,6aS)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-6-yl)pentanamide (8). 
0.31 g of theophylline-8-butanoic acid 1 (1.15 mmol) were dissolved in anhydrous atmosphere in 
10 mL of N,N-dimethylformammide. The solution was cooled at 0°C and then 0.15 g of HOBT 
(1.15 mmol) were added; the pH value of solution was adjusted with N-methylmorpholine at the 
final of 8.5. 
After this, 0.41 of compound 7 were added (1.15 mmol) and then 0.26 g (1.38 mmol) of EDC-Cl. 
The mixture was stirred at room temperature for 18 hours. 
After this time, the solvent was evaporate and the crude oil product was recristallized from 2-
propanol/di-iso-propyl ether to give 0.22 g (33%) of final brown solid product 8. 
1H NMR (δ-DMSO-d6): 1.23-1.75 (m, 12 H, CH2CH2CH2CH2CH2+ 
NHCOCH2CH2CH2CH2CHS), 1.93 (q, 3H, CH2CH2CH2CO, J3=6.6 Hz), 2.08 (m, 4H, 
CH2CONH+NHCOCH2), 2.56 (d, 1H, CHS, J3=6.7 Hz), 2.66 (t, 3H, N=CCH, J3=6.8 Hz), 2.81 
(dd, 1H, CH2S, J2=10.1 Hz, J3=6.6 Hz), 2.99 (m, 4H, NHCOCH2 + CH2NHCO), 3.09 (dd, 1H, 
CH2S, J2=10.1 Hz, J3=6.6 Hz), 3.22 (s, 3H, CON(CH3)C=C), 3.42 (s, 3H, CON(CH3)CO), 4.12 
(m, 1H, NHCHCHS), 4.29 (dd, 1H, NHCHCH2S, J3=6.6 Hz), 6.36 (s, 1H, NHCONH), 6.42 (s, 
1H, NHCONH), 7.76 (s, 2H, NH (linker)), 12.1 (s, 1H, NH (theophylline)). 
13C NMR (δ-DMSO-d6): 23.50 (CH2CH2CH2CH2CH2); 24.53 (NHCOCH2CH2CH2CH2CHS); 
24.98 (NHCOCH2CH2CH2CH2CHS), 26.81 (NHCOCH2CH2CH2CH2CHS), 29.11 (N(CH3), 
30.13 (NH2CH2CH2CH2CH2CH2NHCO), 31.30 (C=NCH2), 32.34 (N(CH3)), 36.82 
(CH2CONH), 40.47 (CH2NHCO), 55.55 (CHS), 57.75 (CH2S), 59.75 (NHCHCH2S), 61.61 
(NHCHCHS), 106.43 (C=CNH), 148.75 (C=CNH), 154.55 (N(CH3)CON(CH3)), 153.67 
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(N=CCH2), 154.55 (N(CH3)COC=C), 163.28 (NHCONH), 171.79 (CH2CONH), 172.36 
(CH2NHCO). 
MS m/z: 577.3 [M+H]+; 599.3 [M+Na]+. 
IR (cm-1): 3338 (N-H); 1820 (C=O). 
m.p.: 178-180 °C.  
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N-(5-(4-(2,3,6,9-tetrahydro-1,3,9-trimethyl-2,6-dioxo-1H-purin-8-yl)butanamido)pentyl)-
5-((3aR,6S,6aS)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-6-yl)pentanamide (9). 
0.17 g of caffeine-8-butanoic acid 4 (0.624 mmol) were dissolved in anhydrous atmosphere in 5 
mL of dry N,N-dimethylformammide. The solution was cooled to 0°C and 0.13 g of HOBT 
(0.624 mmol) were added. N-methyl morpholine was also added until pH=9 was reached  Then, 
0.22 g of compund 7 (0.624 mmol) and 0.18 g of EDC-Cl were added, and the mixture was 
stirred at room temperature for 16 hours. 
After this time the solvent was evaporated and the crude product was recrystallized from 2-
propanol/di-iso-propyl ether to give final compound 9. (0.19 g, 51%).  
1H NMR (δ-DMSO-d6): 1.22-1.48 (m, 12H, CH2CH2CH2CH2CH2+ 
NHCOCH2CH2CH2CH2CHS), 1.90 (quint., 2H, CH2CH2CH2CO, J3=7.3 Hz), 2.08 (m, 4H, 
CH2CONH+ NHCOCH2), 2.54 (m, 1H, CHS), 2.71 (t, 2H, CH2CH2CH2CO, J3=7.4 Hz), 2.81 
(dd, 1H, CH2S, J2=12.0 Hz, J3=6.5 Hz), 3.05 (m, 4H, CONHCH2 +CH2NHCO), 3.14 (dd, 1H, 
CH2S, J2=12.0 Hz, J3=6.5 Hz), 3.21 (s, 3H, CON(CH3)C=C), 3.34 (s, 3H, CON(CH3)CO), 3.81 
(s, 3H, CN(CH3)C), 4.11 (m, 1H, NHCHCHS), 4.32 (d, 1H, NHCHCH2S, J3=6.7 Hz), 6.36 (s, 
1H, NHCONH), 6.42 (s, 1H, NHCONH). 
13C NMR (δ-DMSO-d6): 20.77 (N=CN(CH3)) 23.90 (CH2CH2CH2CH2CH2), 24.61 
(NHCOCH2CH2CH2CH2CHS), 25.02 (NHCOCH2CH2CH2CH2CHS), 26.63 
(NHCOCH2CH2CH2CH2CHS), 29.13 (N(CH3), 30.44 (NH2CH2CH2CH2CH2CH2NHCO), 31.22 
(C=NCH2), 32.41 (N(CH3)), 37.01 (CH2CONH), 40.43 (CH2NHCO), 55.46 (CHS), 57.32 
(CH2S), 59.69 (NHCHCH2S), 61 .69 (NHCHCHS), 106.40 (C=CNH), 148.80 (C=CNH), 155.02 
(N(CH3)COC=C), 164.64 (NHCONH), 171.67 (CH2CONH), 172.41 (CH2NHCO). 
MS m/z: 591 [IM+H]+. 
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IR (cm-1): 3345 (N-H); 1825 (C=O). 
m.p.: 183-185 °C. 
 
O
CN
 
2-methyl-2-((4R)-4-methyl-2-oxocylohexyl)propanenitrile (24). 
2 g of (+)-pulegone (18.39 mmol, d=0.936) were dissolved in anhydrous atmosphere in dry 
toluene. 36.7 mL of 1M diethylaluminium cyanide (in hexane, 36.78 mmol) were added, and 1,56 
g of acetone cyanohydrine (18.39 mmol, d=0.932) were then immediately added. The mixture 
was stirred for 1 hour at room temperature. After, 6 g of NaF (73.56 mmol) and 2.6 mL of water 
(73.56 mmol) were added carefully. The mixture was stirred for 20 minutes again and 6 g of 
anhydrous sodium sulfate were finally added. 
The resulting solid was eliminated by filtration under vacuum, solvent was evaporated and the 
crude product was purified by flash cromatography on silica with diethyl ether/petroleum 
ether=8/2 as eluent mixture obtaining 2.3 g (70%) of final oily pure product. 
1H NMR (δ-CDCl3): 1.06 (d, 3H, CH3, J=7.7 Hz), 1.46 (s, 6H, C(CH3)CN), 1.63-1.88 (m, 4H, 
CHCH2CH2CH), 1.97 (m, 1H, CH3CHCH2), 2.06-2.31 (m, 2H, CHCH2CO), 2.2 (m, 1H, 
CHC(CH3)2CN). 
13C NMR (δ-CDCl3): 22.23 (CH3CH), 24.72 (CH3CCN), 28.90 (CHCH2CH2CH), 32.07 
(C(CH3)2CN) 33.83 (CH3CH), 35.84 (CHCH2CH2CH), 51.24 (CHCH2CO), 56.45 (COCHCH2), 
128.26 (CN), 208.76 (CO). 
MS m/z: 180.1 [M+H]+. 
IR (cm-1): 2251 (CN); 1667 (C=O). 
 
O
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2-methyl-2-((4R)-4-methyl-2-oxocyclohexyl)propanoic acid (25) 
0.1 g of compound 24 were treated with a mixture of water/sulfuric acid=20/1. The solution was 
stirred at room temperature for 48 hours.After this time, 4N NaOH was added until pH=3. The 
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resulting suspension was extracted with ethyl acetate (8 * 15 mL); the combined organic phases 
were washed with brine, dried over anhydrous sodium sulfate and evaporated  to give 0.1 g (83%) 
of pure product that can be directly used for further step. 
1H NMR (δ-CDCl3): 1.08 (d, 3H, CH3, J3=6.9 Hz), 1.43 (s, 6H, C(CH3)COOH), 1.60-1.90 (m, 
4H, CHCH2CH2CH), 1.97 (m, 1H, CH3CHCH2), 2.05-2.31 (m, 2H, CHCH2CO), 2.20 (m, 1H, 
CHC(CH3)2COOH). 
13C NMR (δ-CDCl3): 21.85 (CH3CH), 22.26 (CH3CCOOH), 28.97 (CHCH2CH2CH), 32.62 
(C(CH3)2COOH), 33.79 (CH3CH), 36.01 (CHCH2CH2CH), 46.88 (CHCH2CO), 52.14 
(COCHCH2),  182.96 (COOH), 208.11 (CO).  
              MS m/z: 199.1 [M+H]+; 197.1 [M-H]+. 
IR (cm-1): 3541 (COOH); 1725 (C=O). 
m.p.: 80-82 °C. 
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N-(5-(2-methyl-2-((4R)-4-methyl-2-oxocyclohexyl)propanamido)pentyl)-5-((3aR, 4R, 
6aS)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)pentanamide (26) 
0.5 g of compound 25 (1.22 mmol) were dissolved in anhydrous acetonitrile. 0.12 g of HOBT 
(1.22 mmol) were added with N-metilmorpholine (0.2 mL, 2.44 mmol) until pH=8.5. 0.8 g of 
compound 6 were then added and the mixture was cooled at 0°C. 0.21 g of EDC-Cl were finally 
added. The mixture was stirred under an anhydrous atmosphere in anhydrous for 16 huors. 
After this time, solvent was distillated with distillation at reduce pressure and the final crude 
product was cristallized with acetone/n-hexane, to give 0.81 g (63.2%) of the final pure product.  
13C NMR (δ-DMSO-d6): 20.22 (CH3CH), 21.14 (CH2CHCO), 23.11 (CH3C), 24.03 
(NHCH2CH2CH2CH2CH2NH), 25.37 (NHCOCH2CH2CH2CH2CH), 26.81 (CH2CHS), 30.01 
(NHCH2CH2CH2CH2CH2NH), 32.33 (CH3CHCH2 menthone), 33.91 (CH3CH),  36.55 (NHCOCH2), 
40.47 (NHCH2CH2CH2CH2CH2NH), 40.99 (C(CH3)2CO), 41.03 (NHCH2CH2CH2CH2CH2NH), 
41.12 (CH2S), 49.33 (CH3CHCH2CO menthone), 55.55 (CHS), 60.44 (CHCH2S), 61.21 (COCH 
menthone), 61.75 (CHCHS), 164.70 (NHCONH), 172.70 (CH2NHCOCH2), 178.05 (CCONHCH2), 
211.51 (CH2COCH menthone). 
MS m/z: 509.3 [M+H]+. 
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IR (cm-1): 3334 (N-H); 1713 (C=O). 
m.p.: 165-167 °C. 
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(37) 
To a solution of P(Ph)3 (1.4 g, 5.5 mmol) in 6 mL of toluene, was added bromo-methyl ester (1g, 
5.5 mmol) were added dropwise monitoring the temperature below 40°C. The reaction was 
stirred for 24 hours. At the end of this time a white solid precipitates was collected and  washed 
with toluene and then with petroleum ether to give the final product white salt 37 (2.33 g; 95%). 
1H NMR (δ-CD3OD): 3.66 (s, 3H, COOCH3); 4.74-4.83 (m, 2H, CH2P, JH-P=22.0 Hz, J3=7.1 
Hz); 6.24 (d, 1H, CHCOOCH3, Jtrans=15.4 Hz); 6.80 (m, 1H, CHCH2P); 7.76-7.92 (m, 15H, 
CHaromatic). 
13C NMR (δ-CD3OD): 26.30 (d, CH2P, JC-P=131 Hz); 47.79 (OCH3); 118.12 (PCaromatic JC-P=130 
Hz); 129.43 (CHCOOCH3); 130.46 (CHaromatic); 133.76 (CHCH2P); 135.41 (CHaromatic); 165.27 
(COOCH3). 
MS m/z: 441.1 [M+H]+. 
IR (cm-1): 1762 (C=O); 1425 (P-CH2). 
m.p.: 143-145 °C. 
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(38). 
1 g (2.27 mmol) of the previous compound 37 was dissolved in 40 mL of distilled water. NaOH 
(2.27 mmol) were added under stiring; immediately, a yellow precipitate is found.  
The precipitate was filtered under vacuum and washed with water (3 x 10 mL), dried under 
vacuum and recrystallized from toluene to give 0.74 g (90%) of pure yellow solid product 38. 
1H NMR (δ-CDCl3): 3.56 (s, 3H, COOCH3); 3.75 (m, 1H, PCH, JH-P=17.4 Hz); 5.12 (d, 1H, 
CHCOOMe); 7.25 (m, 1H, CHCHCOOMe); 7.57 (m, 15H, CHaromatic). 
13C NMR (δ-CDCl3): 48.52 (P=CH, JC-P=133 Hz); 90.10 (CHCOOMe); 126.17 (CHaromatic) 133.27 
(CHaromatic); 138.32 (Caromatic); 152.04 (CHCHCOOMe); 170.85 (COOMe). 
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MS m/z: 361.1 [M+H]+. 
IR (cm-1): 1783 (C=O). 
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(2E,4E)-methyl 7,8,9-trihydroxynona-2,4-dienoate (39). 
 
3.10 g (8.60 mmol) compound 38 were dissolved at anhydrous conditions in 20 mL of anhydrous 
tetrahydrofuran, and 1.22 gr of 2-deoxy-D-ribose (9.12 mmol) were quickly added. The 
suspension was heated at 80°C for 6 hours. 
After this time the solvent was removed and the crude solid product was purified by flash 
cromatography (dichlorometane/methanol=9/1) to give triol 39 (0.85 gr, 37.6%). 
1H NMR (δ-CD3OD): 2.33 (m, 1H, He); 2.55 (m, 1H, Hf); 3.45 (m, 1H, Hi); 3.58 (m, 3H, Hg+Hl); 
3.71 (s, 3H, COOCH3); 5.83 (dd, 1H, Hb, Jtrans=14.8 Hz); 6.30 (m, 2H, Hd+Ha); 7.27 (dd, 1H, Hc, 
Jtrans=15.2 Hz ). 
13C NMR (δ-CD3OD): 38.16 (CHe-f); 52.25 (COOCH3); 65.00 (CH2OH); 73.24 (CHg); 76.12 
(CHi); 122.25 (CHb); 132.03 (CHa); 141.83 (CHd); 147.19 (CHc); 169.91 (COOCH3). 
MS m/z: 592.9 [M+H]+; 590.3 [M-H]+. 
IR (cm-1): 3212 (OH); 1775 (C=O). 
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(40). 
0.2 gr of previous compound 39 (1.12 mmol) were dissolved in 300 μL of pyridine and 5 mL of 
dichlorometane at anhydrous conditions. DIMAP (4-dimethyl aminopyridine) was added to the 
reaction (0.01 g, 0.08 mmol) and the suspension was stirred at 0°C for 15 min. After this time, 
0.38 mL of tert-Butyl-diphenylsilylchloride (0.4 gr, 1.46 mmol) were added to the suspension. 
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The reaction was kept under stir at 0°C for 15 minutes and then for 48 hours at room 
temperature. 
After this time 1 M chloridric acid was added until pH 3; the acqueous layer was extracted with 
ethyl acetate (3 x 10 mL)  and the combined organic layers were washed with brine and dried 
over anhydrous sodium sulphate. The solvent was eliminated by distillation at reduce pressure to 
give pure mono-protected alcohol 40. 
1H NMR (δ-CDCl3): 1.07 (s, 9H, SiC(CH3)3); 2.19 (m, 1H, He); 2.21 (m, 2H, Hl); 2.35 (m, 2H, 
Hf); 3.59 (m, 1H, Hi); 3.72 (s, 3H, COOCH3); 3.80-3.82 (m, 3H, Hg+ 2OH); 5.81 (d, 1H, Ha, 
Jtrans=14.8 Hz); 6.13 (m, 1H, Hd); 6.21 (m, 1H, Hc); 7.26 (m, 1H, Hb); 7.39-7.65 (m, 10H, 
CHaromatic). 
13C NMR (δ-CDCl3): 19.07 (CHf); 26.75 (CHl); 36.47 (CHg); 51.49 (COOCH3); 64.65 (CHi); 71.74 
(SiC(CH3)3); 100.56 (CHc); 121.91 (CHd); 128.00 (CHa); 132.73 (CHb); 133.97 (SiCaromatico); 135.63 
(SiCaromatic); 139.72 (CHaromatic); 144.68 (CHaromatic); 167.70 (COOCH3). 
MS m/z: 831.3 [M+H]+; 829.2 [M-H]+. 
IR (cm-1): 3229 (OH); 1754 (C=O). 
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(41). 
0.4 g of compound 40 (0.89 mmol) were dissolved under anhydrous conditions. 0.034 g of 
potassium tert-butoxide (0.26 mmol) were dissolved in 0.55 mL anhydrous tert-butyl alcohol. 
This solution was added to the solution of 40 in toluene and the resulting suspension was heated 
at 50°C for 24 hours. After this time the solvent was eliminated and the final crude product was 
purified an a short flash silica column with a mixture ethyl acetate/petroleum ether = 2/8, to give 
the final pure product (0.089 gr; 22%). 
1H NMR (δ-CDCl3): 1.07 (s, 9H, SiC(CH3)3); 1.40 (m, 1H, Hf’); 1.69 (d, 1H, He, J3=7.7 Hz); 1.83 
(m, 1H, He); 2.51 (m, 2H, Ha+ Ha’); 3.42 (m, 1H, H1); 3.63 (m, 1H, H1’); 3.69 (s, 3H, COOCH3); 
4.37 (m, 1H, Hd); 4.45 (m, 1H, Hb); 4.50 (m, 1H, Hc); 4.58 (m, 1H, Hg); 7.40 (m, 5H, CHaromatic); 
7.63 (m, 5H, CHaromatic). 
13C NMR (δ-CDCl3): 19.28 (SiC(CH3)3); 26.90 (SiC(CH3)3); 38.48 (CHf); 39.26 (CH1); 41.11 
(CHe); 51.84 (COOCH3); 64.72 (CHa); 67.57 (CHd); 73.42 (CHg); 74.34 (CHc); 127.80 (CHb); 
133.26 (CHaromatic); 135.65 (Caromatic); 171.51 (COOCH3). 
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MS m/z: 455.2 [M+H]+. 
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5,5-bis(ethylthio)-2,3,4-trimethylpentane-1,2,3,4-tetraol (32). 
 
5 g of D-(+)-xylose (3.33 mmol) were dissolved in 1.25 mL of ethanthiol (0.78 gr, 3.33 mmol) 
and the mixture was cooled with a ice bath to 0°C. 0.83 gr of zinc chloride were added and, 
carefully, 5 mL of concentrated hydrochloridric acid. The reaction was kept under stirring at 
room temperature for 20 min., then 20 mL of water were added. 
The solution was concentrated and neutralized with 5M NaOH. After this the solvent was 
evaporated to give 0.694 gr of protected sugar 32 (70 %). 
1H NMR (δ-D2O): 1.28 (t, 6H, SCH2CH3); 2.74 (m, 4H, SCH2CH3); 3.71 (m, 2H, CH2OH); 3.85 
(m, 1H, CHCH2OH); 3.91 (t, 1H, CHCHCH2OH, J3=7.3 Hz); 4.02 (t, 1H,CH(SEt)2CH, J3=7.2 
Hz); 4.13 (d, 1H, CH(SEt)2, J3=7.3 Hz). 
13C NMR (δ-D2O): 14.39 (SCH2CH3); 27.39 (SCH2CH3); 53.15 (HC(SEt)2); 65.94 (CH2OH); 
75.28 (CHCH(SEt)2); 78.72 (CHCH2OH); 80.11 (CHCHCH2OH). 
MS m/z: 298.1 [M+H]+; 296.1 [M-H]+. 
IR (cm-1): 3522 (OH); 2548 (C-S). 
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(33). 
300 mg of iodine was dissolved in 50 mL of acetone; 1 g of previous compound 32 was added 
and the solution was kept under stirring for 3 hours at room temperature. After this time the 
mixture was heated over reflux for 20 minutes until the solution turns to brown from initial 
violet. 0.5N NaOH was then added in order to destroy iodine. The mixture was extracted with 
dichloromethane (3 x 20 mL) and the combined organic layer were washed with water (4 x 20 
mL) and dried over anhydrous Na2SO4. 
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The solvent was evaporated to give 1.03 g of acetonide 33 (82%). 
1H NMR (δ-CDCl3): 1.23-1.47 (m, 18H, S(CH2CH3)+ C(CH3)2); 2.64 (m, 4H, S(CH2CH3); 4.05 
(m, 3H, CH2O+CHc); 4.27 (m, 1H, CHb); 4.49 (m, 1H, CHa); 5.99 (m, 1H, CH(SEt)2) 
13C NMR (δ-CDCl3): 14.74 (SCH2CH3); 26.21- 26.23 (C(CH3)2); 26.85 (SCH2CH3); 53.82 
(CH(SEt)2); 71.67 (CH2O); 73.25 (CHc); 84.70 (CHb); 85.75 (CHa); 105.24 (C(CH3)2); 111.79 
(C(CH3)2). 
MS m/z: 337.2 [M+H]+. 
IR (cm-1): 2555 (C-S). 
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(34). 
A solution of  2.0gr (5.95 mmol) of compund 33 in 20 mL of THF was added dropwise at 
anhydrous conditions to a solution of 1.0 gr (8.92 mmol) of potassium tert-butoxide in 
THF/DMSO=3/1 as solvent; the reaction was kept for 1 hour at 23°C. 
After this time the mixture was poured in 25 mL of  ice and extracted (6 x 15 mL) with ethyl 
acetate. The combined organic layers were washed with water (2 x 20 mL) and dried with sodium 
sulfate; the solvent was evaporated to give final 1.02 gr (62%) of pure product 34. 
1H NMR (δ-CDCl3): 1.00-1.37 (m, 12H, S(CH2CH3)2 + C(CH3)2); 2.60-2.84 (m, 4H, 
S(CH2CH3)2); 3.69 (m, 1H, CH2O); 3.88 (m, 1H, CH2O); 4.01 (m, 1H, CHc); 4.68 (m, 1H, CHb); 
5.81 (d, 1H, CHa; J3= 8.2 Hz). 
13C NMR (δ-CDCl3): 14.12 (S(CH2CH3)2); 26.38- 26.70 (C(CH3)2); 27.59 (S(CH2CH3)2); 65.81 
(CH2O); 70.69 (CHb); 78.87 (CHc); 109.80 (C(CH3)2); 132.78 (CHa); 135.94 (C(SCH2CH3)2). 
MS m/z: 279.1 [M+H]+; 277.1 [M-H]+. 
IR (cm-1): 3467 (OH). 
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(35). 
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0.17 g of LiAlH4 (4.68 mmol) were dissolved in 20 mL of anhydrous THF and the solution was 
cooled at -60°C. A solution of 0.32 g (1.17 mmol) of compound 34 in 10 mL of anhydrous THF 
was added dropwise and the reaction was kept at -60°C for 3 hours. After this time the mixture 
was stirred at room temperature for 1 hour. After this were added at the  organic satured 
ammonium chloride until pH=6; the acqueous phase was extracted with ethyl acetate (4 x 20 
mL), the combined organic layers were dried with sodium sulphate and the solvent was 
eliminated to give a crude brown oil that was purified with flash cromatography on silica with the 
eluent mixture petroleum ether/diethyl ether = 1/1 to obtain the desired reduced product (0.174 
gr, 53%). 
1H NMR (δ-CDCl3): 1.22-1.45 (m, 12H, S(CH2CH3)2 + C(CH3)2); 1.73 (m, 1H, CH2CH(SEt)2); 
2.01 (m, 1H, CH2CH(SEt)2); 2.56-2.72 (m, 4H, S(CH2CH3)2); 3.79 (m, 1H, CHOH); 3.88 (s, 1H, 
CH(SEt)2); 4.01 (m, 2H, CH2O); 4.08 (m, 1H, CHO). 
13C NMR (δ-CDCl3): 14.56 (S(CH2CH3)2); 24.44- 25.28 (C(CH3)2); 28.97 (S(CH2CH3)2); 40.47 
(CH2CH(SEt)2); 47.81 (CH(SEt)2); 66.05 (CH2O); 69.70 (CHOH); 78.66 (CHO); 109.62 
(C(CH3)2). 
MS m/z: 281.1 [M+H]+. 
IR (cm-1): 3423 (OH). 
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benzyl 3-(2,3,6,7-tetrahydro-1,3-dimethyl-2,6-dioxo-1H-purin-8-yl)propylcarbamate  (13). 
A solution of 0.36 g of theophylline-8-butanoic acid 1 (1.33 mmol) dissolved in 50 mL of 
anhydrous toluene were added in anhydrous conditions to a solution of 0.15 g of diphenyl 
phosphorylazide (0.11 mL, 1.622 mmol) dissolved in 20 mL of anhydrous toluene. The solution 
was stired at room temperature for 10 minutes and then 0.24 gr of triethylamine (0.23 mL, 1.62 
mmol) was added. The suspension was heated under reflux for 1 hour. 
The solution was then cooled down to room temperature, and then 0.26 gr of benzil alcohol 
(0.28 mL, 2.704 mmol, d=1.042) added. The solution was refluxed again for 12 hours.  
After 12 hours the solvent was eliminated; the crude solid product was dissolved in ethyl acetate 
(20 mL) and the organic layer was washed with satured solution of NaHCO3, brine, and then 
dried on Na2SO4. 
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The solvent was removed and the crude product was purified with flash cromatography on silica 
gel using as eluent mixture ethyl acetate/petroleum ether = 2/8 to give 0.102 gr (61%) of pure oil 
colourless product. 
 1H NMR (δ-DMSO-d6): 2.20 (quint., 2H, CH2CH2CH2NHCbz, J3=7.1 Hz), 2.42 (t, 2H, 
CH2CH2CH2NHCbz, J3=7.2 Hz), 2.94 (t, 2H, CH2CH2CH2NHCbz, J3=7.2 Hz), 3.43 (s, 3H, 
CON(CH3)CO), 3.60 (s, 3H, N(CH3)CO), 5.09 (s, 2H, OCH2Ph), 7.31 (m, 5H, CHaromatic (Cbz)). 
13C NMR (δ-DMSO-d6): 28.70 (CH2CH2CH2NHCbz), 29.10 (CH2CH2CH2NHCbz), 29.82 
(N(CH3)CO), 32.30 (CON(CH3)CO), 41.50 (CH2CH2CH2COOH), 65.90 (OCH2Ph), 114.52 
(NHC=CN), 127.21-129.1 (CHaromatic (Cbz)), 149.91 (NHC=CN), 151.44 (N(CH3)CON(CH3)), 
154.96 (N(CH3)CO), 156.80 (CO (Cbz)), 157.12 (C=N). 
MS m/z: 372.17 [M+H]+; 394.17 [M+Na]+. 
IR: 3067 (NH); 1787 (C=O (Cbz)). 
 
 
N
N N
H
N
O
O NH2
 
8-(3-aminopropyl)-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione
(14). 
80 mg of 10% Pd/C were added to a solution of 0.89 g of previous compound 13 in 70 mL of 
methanol. The suspension was stirred under a hydrogen flux for 24 hours. 
Ater this time the catalyst was removed over Celite, methanol was evaporate to give 0.559 gr 
(98%) of pure solid white product.  
1H NMR (δ-DMSO-d6): 1.87 (m, 2H, CH2CH2CH2NH2), 2.51 (t, 3H, CH2CH2CH2NH2, J3=6.2 
Hz), 2.69 (m, 2H, CH2CH2CH2NH2), 3.19 (s, 3H, CON(CH3)CO), 3.40 (s, 3H, N(CH3)CO). 
13C NMR (δ-DMSO-d6): 28.4 (CH2CH2CH2NH2), 29.20 (CH2CH2CH2NH2), 29.54 (N(CH3)CO), 
30.60 (CON(CH3)CO), 41.77 (CH2NH2), 114.65 (NHC=CN), 150.02 (NHC=CN), 152.05 
(N(CH3)CON(CH3)), 155.21 (N(CH3)CO), 157.38 (C=N). 
MS m/z: 274.1 [M+H]+; 296.1 [M+Na]+. 
m.p.: 100-103 °C 
IR (cm-1): 3106 (N-H); 1715 (C=O). 
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BocHN N
H
O
NHCbz
  
(16). 
0.32 g of γ-aminobutyrric acid (1.173 mmol) dissolved in anhydrous conditions in 40 mL of 
anhydrous CH3CN. 0.16 g of HOBT (1.173 mmol) and 0.258 mL of N-methylmorpholine (1.408 
mmol, d=0.92) checking that the pH value should be 8. 
The mixture was cooled to 0°C and 0.24 g (1.173 mmol) of N-Boc-cadaverine and 0.27 gr (1.235 
mmol) of EDC-Cl  were added. The reaction was stirred at room temperature for 16 hours. After 
of this time the solvent was removed, the solid residue was dissolved with ethyl acetate (20 mL), 
the organic layer was washed 10% citric acid, satured NaHCO3 solution and dried with sodium 
sulphate. 
The solvent was eliminated to give 0.48 gr (58%) of pure solid product.  
1H NMR (δ-CDCl3): 1.25-1.56 (m, 17H, CH3(Boc)+CH2(cadaverine)), 1.79 (quint., 2H, 
CH2CH2CH2NHCbz, J3=6.7 Hz), 2.18 (t, 2H, CH2CO, J3=6.7 Hz), 3.06-3.21 (m, 6H, CH2NH 
(cadaverine)+CH2NHCbz), 4.67 (s, 1H, NH), 5.05 (s, 1H, CH2(Cbz)), 5.29 (s, 1H, NH), 6.26 (s, 
1H, NH), 7.29 (s, 5H, CHaromatic (Cbz)). 
13C NMR (δ-CDCl3): 23.98 (CH2CH2CH2 (cadaverine)), 27.54 (CH2CH2CH2NHCbz), 28.88 (CH3 
(Boc)), 29.71-30.30 (CH2CH2CH2), 33.64 (COCH2CH2CH2NHCbz), 41.45 (CH2NH), 65.31 (CH2 
(Cbz)), 79.37 (C(CH3)3 (Boc)), 127.26 (CHaromatic (Cbz)), 141.28 (Caromatic (Cbz)) 160.01 (CO), 
172.24 (CO). 
MS m/z: 238.2 [M+H]+; 260 [M+Na]+. 
IR: (cm-1): 3111 (N-H); 1762 (C=O). 
m.p.: 87-89 °C. 
 
BocHN N
H
NHCbz
       
(17). 
1 gr of compund 16 (2.374 mmol) was dissolved in 45 mL of anhydrous tetrahydrofuran (THF) 
and cooled at -10°C. 2.48 mL of 2 M solution in THF of borane-dimethylsulphur (BH3-DMS) (5 
mmol) were carefully added and the mixture was stirred at room temperature for 12 hours. 
After this time the solvent was removed, 60 mL of water were added and the acqueous layer was 
extracted with ethyl acetate (6 x 20 mL). 
The combined organic layers were washed with brine and dried over anhydrous sodium sulphate; 
the solvent was then removed to give 0.48 gr (51%) of white solid product. 
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1H NMR (δ-CDCl3): 1.24-1.85 (m, 19H, 
CH3(Boc)+CH2CH2CH2CH2NH+CH2CH2CH2NHCbz), 2.74 (quint., 2H, CH2NHCO, J3=7.7 
Hz), 3.06-3.18 (m, 4H, CH2NHCH2), 3.70 (s, 1H, NH), 4.68 (s, 1H, NH), 5.10 (s, 2H, CH2(Cbz)), 
5.48 (s, 1H, NH) 7.32-7.34 (m, 5H, CHaromatic (Cbz). 
 13C NMR (δ-CDCl3): 24.04 (CH2CH2CH2CH2NH), 27.58 (CH2CH2CH2 NHCbz), 28.91 (CH3 
(Boc)), 29.68 (CH2CH2CH2CH2NH), 30.61 (CH2CH2CH2CH2NH),36.46 (CH2NHBoc) 40.81 
(CH2NHCbz) 41.61 (CH2NHCH2), 50.01 (CH2NH), 65.52 (CH2 (Cbz)), 79.53 (C(CH3)3 (Boc)), 
126.33 (CHaromatici (Cbz)), 142.42 (Caromatic (Cbz)), 162.01 (CO), 170.24 (CO). 
MS m/z: 408.2 [M+H]+; 430.4 [M+Na]+; 446.2 [M+K]+. 
IR: (cm-1): 3120 (N-H); 1765 (C=O). 
m.p.: 106-108 °C 
 
H2N NH
NHCbz
 
(18). 
100 mg of compound 18 was dissolved in 1 mL of a mixture dichloromethane/trifluoroacetic 
acid = 6/4; the solution was stirred at room temperature for 1 hour. After this time of 10 mL of 
dichloromethane were added and the solvent was removed. In order to remove all excess of 
trifluoroacetic acid the resulting oil was coevaporated with dichloromethane (5 * 10 mL) to give 
18 as pure yellow oil (0.074 mg; 99%). 
1H NMR (δ-CDCl3): 1.24-1.87 (m, 10H, CH2(cadaverine)+CH2CH2CH2NHCbz), 2.84-3.40 (m, 
6H, CH2NHCH2+CH2NHCbz), 4.71-5.14 (m, 4H, NH2CH2+CH2(Cbz)), 7.18-7.35 (m, 5H, 
CHaromatic (Cbz)), 7.63 (s, 1H, NH), 8.26 (s, 1H, NH), 9.08 (s, 1H, NH). 
13C NMR (δ-CDCl3): 18.23 (NH2CH2CH2CH2CH2CH2NH), 27.41-27.72 
(CH2CH2CH2CH2NHCbz), 30.34 (NH2CH2CH2CH2CH2CH2NH), 32.59 
(NH2CH2CH2CH2CH2CH2NH), 41.66 (CH2NHCbz), 42.15 (CH2NHCH2), 49.63 (CH2NH2), 
65.41 (CH2 (Cbz)), 127.22-141.23 (CHaromatici (Cbz)), 156.87 (CO (Cbz)). 
MS m/z: 308.4 [M+H]+, 330.4 [M+Na]+. 
IR (cm-1): 3320 (N-H); 1752 (C=O). 
 
N
N N
N
O
H
N
H
N
NHCbz
O
O
H
 
(19). 
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97 mg of theophilline-8-butanoic acid 1 (0.36 mmol) were dissolved in 5 mL of anhydrous 
acetonitrile. Mixture was cooled to 0°C and 0.049 g (0.36 mmol) of HOBT was added to the 
suspension; after removing the ice-bath, 0.08 mL of N-methylmorpholine (0.073 gr, 0.72 mmol, 
d=0.92) were added to the suspension to pH=8. 0.111 g of previous compound 18 (0.36 mmol) 
and 0.083 g of EDC-Cl (0.432 mmol) were added. The mixture was stirred for 16 hours. 
At the end of time, the solvent was eliminated and the oily crude product was redissolved in ethyl 
acetate (15 mL) and washed with 10% citric acid, satured NaHCO3, brine and dried over sodium 
sulphate. 
Solvent was removed to give 0.212 g of crude product that was purified by cristallization 
(acetone/hexane) to obtain 0.096 gr (48%) of pure final solid product.  
1H NMR (δ-CDCl3): 1.46 (m, 4H, NHCH2CH2NH (Gaba)), 1.93 (m, 6H, CH2CH2CH2CH2CH2), 
2.09 (quint., 2H, CH2CH2CH2CO, J3=6.5 Hz), 2.29 (m, 2H, CH2CH2CH2CO), 2.81 (m, 2H, 
CH2CH2CH2CO), 2.97 (m, 4H, CH2NHCH2), 3.14 (m, 2H, CH2NHCbz), 3.32 (m, 5H, 
CONHCH2+CONCH3), 3.54 (s, 3H, CON(CH3)CO), 5.01 (s, 2H, CH2 (Cbz)), 6.70 (s, 1H, NH), 
7.34 (m, 5H, CHaromatici (Cbz)), 9.22 (s, 1H, NH), 11.17 (s, 1H, NH). 
13C NMR (δ-CDCl3): 19.22 (NHCH2CH2CH2CH2CH2NH (cadaverina)), 25,65 
(CH2CH2CH2CO), 28.74-30.08 (CH2CH2CH2CH2 (Gaba)+CH2CH2CH2CO), 29.06 (N(CH3)CO), 
33.52 (NHCH2CH2CH2CH2CH2NH (cadaverina)), 35.00 (NHCH2CH2CH2CH2CH2NH 
(cadaverina)), 36.14 (CH2CONH) 36.54 (CON(CH3)CO), 42.78-43.61 (CH2NHCH2),  55.35 
(CONHCH2), 55.22 (CH2NHCbz), 63.77 (CH2 (Cbz)), 110.75 (NHC=CN), 117.91-141.28 
(CHaromatici (Cbz)), 150.43 (NHC=CN), 151.29 (N(CH3)CON(CH3), 157.82 (C=N), 160.31 
(N(CH3)CO), 162.72 (CO (Cbz)), 165.65 (CONH). 
MS m/z: 556.32 [M+H]+ 
IR (cm-1): 3163 (N-H); 1779 (C=O). 
m.p.: 131-133 °C 
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CD measuerments 
 
1- Folding of EKinv. 
2.3 mg of peptide were dissolved in 5 mL of phosphate buffer (pH=7.3) in order to obtain a 
mother solution of peptide 4.6 * 10-4 * 10-4M. From this, 1.09 mL were diluted to 10 mL with 
buffer phosphate in order to obtain the final solution of work 5 * 10-5M. 
3 mL of this solution were filled in a circular dichroism cell (light path 10 mm) and the data were 
recovered at 25°C in four accumulations, with data pitch of 0.05 nm, with a scanning speed of 
100 nm/min and a band width of 1 mm. 
The kinetic measure was carried out at fixed wavelenght of 222 nm with an identical previous 
peptide solution. The measure was carried on in five days at 25°C with a time measurement of 8 
minutes. 
 
2- Folding of KE1 
8.0 mg of KE1 were dissolved in 10 mL of phosphate buffer in order to obtain a mother solution 
2.053 * 10-4M. From this, 2,43 mL were diluted to 10 mL with buffer phosphate in order to 
obtain a final solution of work 5 * 10-5M. 3 mL of this solution were filled in a circular dichroism 
cell (light path 10 mm) and data were recovered at 25°C in four accumulations, with data pitch of 
0.05 nm, a scanning speed of 50 nm/min and a band width of 1 mm 
 
3- Folding of F16-KE1 
7.60 mg of F16-KE1 were dissolved in 10 mL of phosphate buffer in order to obtain a mother 
solution 1.93 * 10-4 M. From this, 777 μL were diluted to 3 mL in order to obtain a final solution 
of work 5 * 10-5M. 3 mL of final solution were filled in a circular dichroism cell (light path 10 
mm) and data were recovered at 25°C in four accumulations with data pitch of 0.05 nm, a 
scanning speed of 50 nm/min and a band width of 1 mm. 
 
4- Thermal denaturation of KE1 
8.0 mg of KE1 were dissolved in 10 mL of phosphate buffer in order to obtain a mother solution 
2.053 * 10-4M. From this, 2,43 mL were diluted to 10 mL with buffer phosphate in order to 
obtain a final solution of work 5 * 10-5M. 3 mL of this solution were filled in a circular dichroism 
cell (light path 10 mm) and data were recovered between 0 to 80 °C with a solution time of 
stabilization at the new temperature of 20 minutes. 
Spectra was recovered in four accumulation with data pitch of 0.05 nm, a scanning speed of 50 
nm/min and a band width of 1 mm. 
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5- KE1 titolation with theophylline 
73 μL of a mother solution of KE1 (2.053 * 10-4M) in phopsphate buffer were diluted to 3 mL 
with theophylline solution in water and buffer phosphate, in order to obtain a final solution of 
peptide 5 * 10-6M and final concentrations of theophylline solution in the range of 1.0 * 10-4 M 
and 1.0 * 10-5 M. The final solution of peptide and theophylline was kept under stirred for 10 
minutes and then the solution was filled in circular dichroism cell (light path 10 mm). 
The spectrum was recoreved in four accmulation, with a data pitch of 0.05 nm, a scanning speed 
of 100 nm/min and a band width of 1 mm. 
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Theophylline/Caffeine-protein conjugation 
 
1. HRP-Theophylline/Caffeine 
HRP N
H
O
N
N
N
N
H O
O
n  
HRP N
H
O
N
N
N
N
O
O
n  
2.1 mg of theophylline-8-butanoic acid 1 or 3.6 mg of caffeine-8-butanoic acid 4 were dissolved 
in 200 μL of a 1:1 mixture of DMSO and of 100mM MES; NaCl 400mM; EDTA 10mM; 
pH=5.5. 
2.1 or 3.6 mg for haptene 1 and 4 respectively of Horseradish peroxidase (HRP) were dissolved in 
100 μL of mQ water and the hapten solution was added slowly. 4.2 mg of EDC-Cl were added 
and the final solution was stirred at room temperature for 3 hours. After this time the mixtures 
were centrifugated at 4000 RPM for 5 minutes and the resulting supernatants were purified by 
dialysis against 500 mL of buffer phosphate at 0°C with regular changing of buffer every 4 hours 
for 8  times. Sodium azide was added to the dyalized solution at a final concentration of 0.02%. 
 
HRP-Theo: 
200 μL of the solution were diluted 1 times in mQ water to a final volume of 1 mL. The UV 
spectrum of the resulting solution was of 0.55 at 283.2 nm and of 1.22 at 401.4 nm. From these 
data, an apparent protein concentration of 2.27 μM and an apparent hapten concentration of 
26.2 μM were calculated. The modification index was thus 11. 
 
[HRP]f = 2.27 * 10-6M 
[Theophylline]f = 2.62 * 10-5M 
IM = 11 
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HRP-Caffeine: 
250 μL of the solution were diluited in mQ water to a final volume of 1 mL. The UV spectrum 
of the resulting solution was 1.01 at 283.2 nm and of 1.23 at 401.4 nm  From these data, an 
apparent concentration of 6.72 μM and an apparent hapten concentration of 228 μM were 
calculated. The modification index was thus 34. 
 
[HRP]f = 6.72 * 10-6M 
[Caffeine]f= 2.28 * 10-4M 
IM = 34 
 
2. OVA-Theophylline 
N
H
O
N
N
N
N
H O
O
n
OVA
 
10 mg of theophylline-8-butanoic acid  were dissolved in 2 mL of 1:1 mixture of DMF and 
100mM MES; NaCl 900mM; 0.02% NaN3; pH=5.5. 
10 mg of Albumin from chicken egg white (OVA) were dissolved in 1 mL of milliQ water. 
Hapten solution and 10 mg of EDC-Cl were slowly added to the OVA solution. The mixture was 
stirred at room temperature for 2 hours. After this time the mixture was centrifugate at 4000 RPM 
for 5 minutes and the resulting supernatant was purified by dialysis against 500 mL of milliQ 
water with regular changes of water every 6 huors. 
 
OVA-Theophylline 
300 μL of the solution were diluted 1 times in mQ water to a final volume of 600 μL. The 
absorbance in the UV spectrum of the resulting solution was of 0.82 at 275.4 nm and 0.44 at 
255.8 nm From these data an apparent protein concentration of 19.1 μM and an apparent hapten 
concentration of 401μM were calculated. The modification index was thus 21. 
 
[OVA]f = 1.91 * 10-5 
[Theophylline]f = 4.01 * 10-4 
IM = 21. 
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Protein-palytoxin conjugation 
 
1) Palytoxin activation 
 
O
N
H
O
N
O
O  
 
0.125 mg of 4-(N-Maleimidomethyl)-cyclohexane-carboxylic acid N-hydroxy-succinimide ester 
(SMCC) (3.73 * 10-4 mmol) were dissolved in 0.1 mL of N,N-Dimethylformamide (DMF) 
(Solution a). In another flask, 0.2 mg of palytoxin (7.47 * 10-5mmol) were dissolved in 1.7 mL of 
phosphate buffer (Na2HPO4 0.1M; pH=7.5) (Solution b). Solution a was added to solution b and 
the mixture was stirred for 8 hours at room temperature. 
After this the solution was directly used for the next step. 
 
2) Protein-modification  
 
Protein NH
NH2+Cl-
SH
n  
 
BSA-2-IMT: 
2 mg of BSA (Albumin from bovine serum) (3.03 * 10-5 mmol) were dissolved in 0.8 mL of 
borate buffer and 0.21 mg of 2-IMT (1.52 * 10-3 mmol) were added. The reaction was kept for 1 
hour at room temperature and then used for the next step. 
 
OVA-2-IMT: 
1 mg of OVA (Albumin from chicken egg white) (2.27 * 10-5 mmol) were dissolved in 0.4 mL of 
borate buffer and 0.22 mg of 2-IMT (1.14 * 10-3 mmol) were added. The reaction was kept at 
room temperature for 1 hour and then used for the next step. 
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KLH-2-IMT: 
1mg of KLH (Hemocyanin from Megathura Crenulata) (1.25 * 10-7 mmol) was dissolved in 0.4 mL 
of borate buffer and 0.086 mg of 2-IMT (6.25 * 10-5 mmol) was added in the previous solution. 
The reaction was kept at room temperature for 1 hour. 
 
HRP-2-IMT: 
1 mg of HRP (Horseradish peroxidase) (2.27 * 10-5 mmol) was dissolved in 0.4 mL of borate 
buffer at room temperature. 0.22 mg of 2-IMT (1.14 * 10-3 mmol) were added at and the reaction 
was kept under stirring for 1 hour. 
 
3) Protein-palytoxin conjugation 
 
Protein NH
NH2+Cl-
S N
O
O
O O
 
General procedure 
Activated palytoxin was added in 5 fold-molar excess to the activated protein dissolved in 
phosphate buffer (Na2HPO4 0.1M; EDTA 1mM; pH=6.6). The solution was stirred for 1 hour at 
room temperature and then purified by dialysis against 500 mL of phosphate buffer  (NaCl 
0.14M; KCl 2.7 * 10-3M; Na2HPO4 0.01M; KH2PO4 1.76 * 10-3M; pH=7.3) for 3 days with regular 
changes of buffer every 4 hours. 
UV analysis give the followin apparent protein and PTX concentrations: 
 
BSA-MCC-PTX: 
[BSA]f = 9.23 * 10-8M 
[PTX]f = 3.16 * 10-6M 
IM = 34 
 
KLH-MCC-PTX: 
[KLH]f = 6.23 * 10-8M 
[PTX]f = 1.7 * 10-5M 
IM = 133 
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4) Biotinylation of palytoxin 
 
O
N
H OH
O
S
NHHN
O
 
 
4.8 mg of palytoxin (1.79 * 10-3 mmol) were dissolved in 1 mL of water. 0.5 mg of biotin N-
hydroxysuccinimide ester (1.43 * 10-3 mmol) were added and the final solution was stirred at 
room temperature for 24 hours. 
After this time the water solution was washed with dichloromethane (3 x 0.5 mL) and the 
aqueous solution was used directly. 
MS m/z: 2929.2 [M+Na]+ 
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